A novel multiplex suspension array for rapid subgenogrouping of enterovirus 71 (EV71) strains from the 2008 epidemic of Hand, Foot and Mouth Disease, and seroepidemiology of EV71 infection in a pediatric cohort in Singapore by WU YAN
  
A NOVEL MULTIPLEX SUSPENSION ARRAY FOR 
RAPID SUBGENOGROUPING OF ENTEROVIRUS 71 
(EV71) STRAINS FROM THE 2008 EPIDEMIC OF HAND, 
FOOT AND MOUTH DISEASE, AND 
SEROEPIDEMIOLOGY OF EV71 INFECTION IN A 





A  THESIS SUBMITTED 
FOR THE DEGREE OF MASTER OF SCIENCE 
DEPARTMENT OF MICROBIOLOGY 




ACKNOWLEDGEMENTS   
I would like to express my heartfelt gratitude to my supervisors –A/Prof Vincent 
Chow, A/Prof Poh Chit Laa and A/Prof Quak Seng Hock for giving me this 
opportunity to study my master and work on this project. Without their invaluable 
guidance, support and understanding, I would not have been able to finish this 
project on my own. I would like to thank them for their encouragement and 
willingness to share with me their research experiences. 
I would like to thank Mrs Phoon Meng Chee for her technical advice in virus 
isolation from clinical samples, cell culture work and plaque assays. I would also 
like to thank Dr. Koo Seok Hwee from Department of Pharmacology for her 
professional advice on development of multiplex suspension array. I sincerely 
thank Dr. Andrea Yeo from Department of Pediatrics and other doctors and 
nurses working in NUH for providing me with clinical specimens. I also thank Dr. 
Tan Eng Lee from Singapore Polytechnic for guiding me in planning of this 
project and giving constructive advice. I thank Dr. H Nishimura from Sendai 
Medical Center, Japan for providing strain Y97-1188 and 10 more other EV71 
strains, Dr. KP Chan from Singapore General Hospital for providing strain 
3437/Sin/06 and Dr. MJ Cardosa from University of Sarawak for providing strain 
MY104-9-SAR-97 and S10862-SAR-98.  I am also grateful to the NUS Academic 
Research Fund committee providing financial support for this project. 
Special thanks to my friends and family for their companionships, support and 
encouragement throughout my courses.  
Lastly, I would like to thank my labmates, Audrey-Ann, Hui Xian, Mei Lan for 






TABLE OF CONTENTS 
Acknowledgements                                                                                                 i 
 
Table of contents                                                                                                    ii 
 
List of Tables                                                                                                        vii 
 
List of Figures                                                                                                        ix 
 
Abbreviations                                                                                                      xiii 
 
Summary                                                                                                              xiv 
 
 
CHAPTER 1                 LITERATURE REVIEW 
1.1      Enteroviruses                                                                                                1 
1.2      Enterovirus 71                                                                                              4 
1.2.1    Genomic structure for EV71                                                                    4 
      1.2.1.1       5’ untranslated region (5’UTR)                                                6 
      1.2.1.2       Structural proteins                                                                    9 
      1.2.1.3       Non-structural proteins                                                           11 
      1.2.1.4       3’untranslated region (3’UTR)                                               12 
1.2.2    Clinical diseases caused by EV71                                                          16  
1.2.3    Epidemiology of EV71                                                                           21    
1.2.4    Molecular epidemiology of EV71                                                          24    
    1.2.5    Putative EV71 receptors                                                                         32     
1.3       Diagnosis of EV 71                                                                                   33     
1.3.1    Cell culture isolation and neutralization                                                 33  
 iii 
 
1.3.2    Serological approach                                                                              34   
      1.3.2.1       Enzyme linked immunosorbent assay                                    34       
      1.3.2.2       Indirect immunofluorescence assay                                       36              
1.3.3    Viral nucleic acid approach                                                                    37               
      1.3.3.1       RT-PCR microwell detection                                                 38       
      1.3.3.2       Conventional RT-PCR                                                           39             
      1.3.3.3       Real-time RT-PCR                                                                 40              
      1.3.3.4       Microarray                                                                              42                     
      1.3.3.5       Image-based approach                                                            43    
1.4       Management of EV71 infection                                                              44        
1.4.1    Treatment for EV71 infection                                                                44         
1.4.2    Prevention of EV71 infection                                                                 47         
1.5       Beads based suspension array                                                                  48         
1.5.1    Luminex Technology                                                                             48      
1.5.2    Advantages of suspension array                                                             50                          
1.5.3    Assay format                                                                                          51     
      1.5.3.1       Direct DNA hybridization                                                       51   
      1.5.3.2       Competitive DNA hybridization                                              54         
      1.5.3.3       Enzymatic methods                                                                  56          
1.5.4    Applications                                                                                           59           
 
CHAPTER 2                MATERIALS AND METHODS 
2.1       Development of multiplex suspension array for EV71 genogrouping 
                                                                                                                                62                                            
2.1.1    Virus strains, plasmid clones and clinical samples                                62     
 iv 
 
2.1.2    xTAG microspheres                                                                               65                 
2.1.3    Primers and probes design and production                                            65 
2.1.4    Principle of the multiplex assay                                                             67                                  
2.1.5    Conventional PCR                                                                                  69                  
2.1.6    Multiplex allele specific primer extension (ASPE)                                70         
2.1.7    Hybridization assay                                                                                70              
2.1.8    Plaque assay                                                                                           71          
2.1.9    Sensitivity test for multiplex suspension array assay                             71                                         
2.1.10    Cutoff value                                                                                          72                                                                        
2.2       Clinical sample processing and virus identification                             72                
2.2.1    Clinical sample processing and storage                                                 72                
2.2.2    Virus isolation                                                                                        73        
2.2.3    RNA extraction                                                                                      74      
2.2.4    Reverse Transcription Real-time PCR hybridization assay                   74      
2.2.5    Reverse transcription PCR                                                                     75      
2.2.6    Enterovirus identification PCR                                                              75       
2.2.7    Sequencing                                                                                             77         
2.2.8    VP1 Sequences of EV71 from GenBank                                               77       
2.2.9    Nucleotide sequence analysis                                                                 83         
2.2.10  Phylogenetic analysis                                                                             83             
2.3     Neutralization test                                                                                      83               
2.3.1    Patient sera                                                                                             83       




CHAPTER 3                  DEVELOPMENT OF MULTIPLEX SUSPENSION    
ARRAY FOR RAPID ENTEROVIRUS 71 GENOGROUPING  
 
3.1         Introduction                                                                                            86  
3.2         Results                                                                                                     88     
3.2.1    Amplification of the VP1 region using consensus primers                    88                            
3.2.2    Design of subgenogroup-specific probes                                               91          
3.2.3    Selection of xTAG microsphere sets                                                      92       
3.2.4    Specificity of probes designed for EV71 genogrouping                        99      
3.2.5    Detection and genogrouping of EV71from viral isolates                     106    
3.2.6    Detection limit                                                                                      108    
    3.2.7    Detection and genogrouping of EV71 from clinical samples       113          
3.3        Discussion                                                                                             115  
 
CHAPTER 4                  THE LARGEST OUTBREAK OF HAND, FOOT 
AND MOUTH DISEASE IN SINGAPORE 2008: THE ROLE OF 
ENTEROVIRUS 71 AND COXSACKIE A STRAINS  
 
4.1         Introduction                                                                                          121        
4.2         Results                                                                                                   117 
    4.2.1  Clinical features of patients with EV71 versus non-EV71 infections 
                                                                                                                              121                          
4.2.2   Pan-Enterovirus RT-PCR, direct sequencing and virus isolation elucidate 
the distribution of enterovirus types and the involvement of EV71 in HFMD 
patients                                                                                                             127  
4.2.3   Molecular epidemiology of EV71 outbreak strains identifies two major 
subgenogroups                                                                                                  132           
4.2.4   VP1 sequence comparison reveals interesting disparities between current 
outbreak and known virulent strains                                                                134              
 vi 
 
     4.2.5   Amino acid differences are detectedwithin non-structural regions      140    
4.2.6   Comparative analysis of 5′ UTR nucleotide sequences                        140    
4.3       Discussion                                                                                               144          
 
CHAPTER 5                  SEROEPIDEMIOLOGY OF EV71 INFECTION IN 
A PEDIATRIC COHORT IN THE SINGAPORE POPULATION  
 
5.1       Introduction                                                                                           150                                                                          
5.2        Results                                                                                                    151         
5.2.1    Analysis of age specific seroprevalence of  EV71                               151      
5.2.2    Analysis of seroprevalence of EV71 based on age group                    154         
5.3        Discussion                                                                                              158          
 
REFERENCES                                                                                              162    
APPENDICES 









List of Tables  
 
Table 1.1:     Clinical manifestations of enterovirus serotypes.                              3 
 
Table 2.1:     Viral isolates, plasmid clone or genomic RNAs used for                64 
                      EV71 genogrouping assay.                             
 
Table 2.2:     Consensus primers’ and specific probes’ sequences                       66 
                       used in genogrouping assay.                                                                                                
 
Table 2.3:    Primers used in enteroviruses’ identification.                                  79 
 
Table 2.4:     VP1 gene sequences of 10 Singapore outbreak EV71                     81 
                      strains compared with selected enterovirus isolates for  
                      phylogenetic analysis and dendrogram construction. 
 
Table 3.1:    Sequences, nucleotide composition and melting                              98  
                      temperature of probes used in genogrouping assay.  
                      Red letter indicate the SNP site.                 
 
Table 3.2:    Readings of EV71 subgenogroup-specific probes                          102 
                      to 11 reference strains at 53oC.                                                                                                       
 
Table 3.3:    Readings of EV71 subgenogroup-specific probes                          103 
                      to 11 reference strains at 58 oC.                                                                                                       
 
Table 3.4:    Readings of EV71 subgenogroup-specific probes                          104 
                      to 11 reference strains at 55 oC.                                                                                                       
 
Table 3.5:    Average readings of EV71 subgenogroup-specific                        105 
                      probes to 11 reference strains in genogrouping assay.                                                              
 
Table 3.6:    Specificity of EV71 subgenogroup-specific probes                      107 




Table 3.7:    Detection limit of EV71 genogroup-specific probes                     112 
                     to reference strains using either plaque forming units  
                     or number of plasmid copies.                           
 
Table 3.8:     Detection of EV71 using genogrouping methods for                    114 
                      EV71 positive clinical samples.                                                                                                   
 
Table 4.1:    Clinical information available for 42 patients in the study.           124 
 
Table 4.2:     Identification of enteroviruses by classical and real-time             129 
                      RT-PCR and virus isolation from different clinical  
                      specimens.                                          
 
Table 4.3:     Distribution of enterovirus types detected in 51 clinical               130 
                      specimens. 













List of Figures  
 
Figure 1.1:     Genome structure of EV71.                                                             5 
 
Figure 1.2:     Organization of the enterovirus 5’UTR.                                          8 
 
Figure 1.3:     Capsid Structure of bovine enterovirus (BEV).                             10                                      
 
Figure 1.4:     Proteolytic processing of enterovirus polyprotein. 13                   14     
 
Figure 1.5:     Schematic representation of the spatial organization                     15 
                        of the 3-UTRs of PV1 (-) RNA strands.                                                                                       
 
Figure 1.6:     Vesicles on the palm of a child with hand,                                    19 
                        foot and mouth disease (HFMD).                                                                                                    
 
Figure 1.7:    Clinical syndromes associated with enterovirus 71 infection.       20 
 
Figure 1.8:     Classification of 113 EV71 strains into genogroups                     28 
                         based on the VP1 gene (position 2442 to 3332).                                                                        
 
Figure 1.9:     Phylogenetic tree showing classification of 25 EV71                    29 
                        field isolates into subgenogroups based on alignment  
                        of the complete VP1 sequence  
                        (nucleotide positions 2442–3332).                                                                          
 
Figure 1.10:    Phylogenetic classification of reference EV71 strains                  30   
                          based on the complete   (891-nucleotide) VP1 sequence.                                                                                       
 
Figure 1.11:    Dendrogram constructed by using the neighbor-joining              31 
                          method showing the genetic relationships between 23  
                          human enterovirus 71 (HEV71) strains isolated in  




Figure 1.12:     Diagram of the microsphere-based direct hybridization              53 
                          assay format.                                                                                                                     
 
Figure 1.13:     Diagram of the microsphere-based competitive                           55 
                          hybridization assay format.                                                                                                          
 
Figure 1.14:     Diagram of ASPE, OLA and SBCE procedures used                  58 
                          for  microsphere capture assays.                                                             
 
Figure 2.1:      Schematic view of multiplex suspension array for EV71             68                                  
                         genogrouping. 
 
Figure 2.2:      Flowchart depicting the processing of clinical specimens            80 
                         from suspected HFMD patients during the 2008  
                         Singapore epidemic.                              
 
Figure 3.1:     Electrophoretic analysis of amplicons generated from                  90 
                        consensus primers for viral RNA.                                                                                           
 
Figure 3.2:     Electrophoretic analysis of amplicons generated from                  90 
                        consensus primers for plasmid clones.                                                                                    
 
Figure 3.3:    Alignment results of VP1 region of 31 EV71 strains.                    97 
 
Figure 3.4a:   Gel electrophoresis of PCR products by using                            110 
                        consensus primers for viral RNA.                                                                                                      
 
Figure 3.4b:   Gel electrophoresis of PCR products by using                           110 
                        consensus primers for viral RNA.                                                                                                      
 
Figure 3.5:    Gel electrophoresis of PCR products by using                            111 
                       consensus primers for plasmid clones.                                                                                               
 
Figure 4.1:    Age distribution of HFMD patients infected by EV71               125 




Figure 4.2:     Clinical characteristics of HFMD patients infected by                126 
                        EV71 and enteroviruses other than EV71.                                                                                                
 
Figure 4.3:     Distribution of enteroviruses identified in clinical                       130 
                        specimens.     
 
Figure 4.4:     Sequence alignment of 10 outbreak EV71 strains                       131 
                        against the hybridization acceptor probe for real-time  
                        RT-PCR.                                           
 
Figure 4.5:     Dendrogram constructed based on the complete VP1                 133 
                       gene sequences of 10 outbreak EV71 strains and  selected  
                       known strains.                   
 
Figure 4.6:     Alignment of VP1 nucleotides of 8 EV71 strains                        137 
                        belonging to subgenogroup B5 according to the time  
                        of specimen receipt.                            
 
Figure 4.7:     Amino acid sequence variations within the VP1                         138 
                        neutralizing antibody epitopes SP12, SP55 and SP70  
                        of 2008 outbreak EV71 strains.           
 
Figure 4.8:     Comparison of VP1 amino acid sequence between                     139 
                        EV71/Fuyang.Anhui.PRC/17.08/3, 5865/Sin/000009  
                        and 10 isolates of 2008 non-fatal strains.                                                                                                          
 
Figure 4.9:     Mutations of fatal strains 5865/Sin/0009,                                    142     
                        EV71/Fuyang.Anhui.PRC/17.08 and B5 strain  
                        NUH0083/SIN/08, C2 strain NUH0075/SIN/08 at  
                        position 73 and 362 of 3D polymerase region.                   
 
Figure 4.10:     Nucleotide sequence alignment of 5’untranslated region          143 
                          Internal Ribosome Entry Site.                                                                                            
 
Figure 5.1:     Age specific seroprevalence of neutralizing antibodies to          153 




Figure 5.2:     Age group seroprevalence of neutralizing antibodies to              155 
                        Enterovirus 71.                                                                                                             
 
Figure 5.3:     Neutralizing antibody titer distribution of EV71 antibody          156 
                        positive  samples based on age group.                                                                                            
 
Figure 5.4:     Geometric mean titer of EV71 neutralizing antibody                  157 
                        for different age-group.                                                                                                                                      




EV71    Enterovirus 71 
CA16    Coxsackievirus A16 
HFMD    Hand, foot and mouth disease 
AFP    Acute flaccid paralysis 
RD    Human Rhabdomyosarcoma cell line 
Tm    Melting temperature 
UTR    Untranslated region 
RNA    Ribonucleic acid 
cDNA    Complementary deoxyribonucleic acid 
VP1    Viral capsid protein 1 
RT-PCR   Reverse Transcription Polymerase Chain Reaction 
ASPE                                      Allele specific primer extension  




Enterovirus 71 (EV71) belongs to the Picornaviridae family and is a single-
stranded RNA virus with a linear genome. EV71 infections can cause various 
clinical syndromes.  This agent is the most common cause for hand, foot and 
mouth disease (HFMD). High fatality rate has been associated with EV71 
infections during large scale HFMD outbreaks in the Asia-Pacific region and it 
has been found to cause neurological complication in patients. EV71 has been 
classified into 3 genogroups A, B and C. Genogroups B and C are 
subgenogrouped into B1 to B5 and C1 to C5. Subgenogroups C2, B4 and C4 have 
caused high fatality rates in HFMD outbreaks in Taiwan, Singapore and China, 
respectively. However, no association has been established between virulence and 
genogroups of EV71.  
Different approaches have been studied for enterovirus’ detection and 
identification. Molecular methods are gradually replacing virus isolation and 
neutralization test due to their  rapidity, high specificity and sensitivity. PCR and 
real-time PCR specific for EV71 detection have been developed and shown to be 
very sensitive even for clinical samples. So far genogrouping of EV71 only relies 
on direct DNA sequencing and phylogenetic analysis. An additional fact is that no 
 xv 
 
antiviral drugs or vaccines are available for treatment of EV71 infections. 
Research groups are actively studying on the treatment EV71 infection. Synthetic 
or natural compounds and monoclonal antibodies are all found be to potential 
candidates. In terms of prevention, different types of vaccines have been explored 
and some of them seem promising .     
In order to develop a rapid and high-throughput method for EV71 
genogrouping, the xMAP® technology was applied. This technology utilizes up to 
100 sets of microspheres which can be differentiated by their fluorescence. The 
method may adopt different assay formats and has been applied in various fields 
such as human antibody and cytokine detection, virus and bacteria identification.  
Genogrouping of EV71 is based on the sequence of the VP1 region, therefore 
consensus primers and subgenogroup-specific probes were designed by aligning 
the VP1 sequences of different EV71 strains. Due to the single nucleotide 
differences observed among subgenogroups, allele specific primer extension 
(ASPE) assay was chosen for multiplex suspension array development. Reference 
strains of all EV71 subgenogroups were used for developing this novle array. 
Reference strains were successfully identified and genogrouped. Viral isolates 
from other sources were also tested and results were consistent with their 
 xvi 
 
documented identity. Sensitivity tests were carried out to find out how many virus 
particles or number of plasmid copies is required for detection. As low as 5 
plaque forming units (pfu) can be detected for 9 of the subgenogroups. The 
subgenogroups B4 and C4, it required 100 pfu and 50 pfu respectively.  In the 
case of plasmid detection, at least 100 plasmid copies were required. Tests with 
clinical samples gave 100% sensitivity and specificity. The result was consistent 
with those obtained by RT-PCR and direct DNA sequencing.  
Almost 30,000 children were affected during the largest HFMD outbreak that 
occurred in Singapore in 2008. Clinical samples collected from National 
University Hospital showed that 5 different enterovirus types were co-circulating 
in the outbreak. CA6 and CA10 accounted for 50% of the enterovirus positive 
samples, while EV71 alone accounted for 30% of enterovirus positive samples.  
Two subgenogroups of EV71 were found to be responsible for the outbreak. The 
predominant subgenogroups were B5 (found in 80% of EV71 positive samples) 
and C2 (found in 20% of EV71 positive samples). Mutations were found in 
different strains of subgenogroup B5 but not in the C2 strains. Mutations in the 
VP1 region may explain the high incidence of cases. Sequence analysis of the 
5’UTR and 3D regions showed that current strains may possess a low virulence.  
 xvii 
 
HFMD incidence was high in Singapore since the year 2000; therefore 
seroepidemiological study may help in disease control and management. A 
national wide seroprevalence study was carried out in collaboration with Ministry 
of Health. Serum samples from children under age 17 were collected for 
measuring neutralizing antibodies to EV71. Neutralizing antibodies were detected 
in 30% of investigated children. There was an increasing prevalence in older 
children. High prevalence in older children indicated that natural exposure to 
EV71 was common. Antibody titer analysis showed that infection occurred   most 
frequently in children younger than 7.  




CHAPTER 1   
LITERATURE REVIEW  
 
1.1 Enteroviruses  
Enteroviruses belong to the genus Enterovirus, family Picornaviridae and are 
associated with different human diseases. Enteroviruses are initially classified 
based on neutralization by antisera pools (Melnick, 1977). 89 serotypes are 
identified and 64 serotypes are found to be infectious to humans (King, 2000; 
Lindberg and Johansson, 2002). There are both human and non-human species 
under genus Enteroviruses. The human enteroviruses are originally grouped on 
the basis of human disease manifestations (poliovirus), replication and 
pathogenesis in newborn mice (coxsackieviruses A and B), as well as growth in 
cell culture without causing disease in mice (echoviruses) (Melnick, 1996a). 
Based on their molecular properties, enteroviruses are reclassified into 
Polioviruses and human enteroviruses of the A, B, C and D species (King, 2000). 
In 2009. the enterovirus genus was newly classified into 10 species, including 
Bovine enterovirus, Human enterovirus A, B, C and D, Human rhinovirus A, B 
and C, Porcine enterovirus B and Simian enterovirus A (Internatioanl Committee 
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of taxonomy of viruses, 2010). Coxsackievirus A and enterovirus 71 are both 
grouped under the human enterovirus A species. Enteroviruses are isolated using 
cell culture methods. Various cell lines such as human Rhabdomyosarcoma (RD), 
HeLa, Vero, Primary Monkey Kidney and human diploid lung (WI-38, MRC-5) may 
be suitable for enteroviruses’ isolation (Schnurr, 1999). 
All enteroviruses have a positive single-stranded RNA linear genome of 
approximately 7.5 kb length (Li, 2005). After entering the host cell, the open 
reading frame of the genome is translated into a single polyprotein, which is 
subsequently cleaved by virus-encoded proteases into 4 capsid proteins and 
several nonstructural proteins (Merkle, 2002). The stability of enteroviruses in 
acidic enviroment allows them to be ingested and to reach the intestinal tract of 
animals and humans (Levy, 1994). Although most enterovirus infections are mild 
and asymptomatic, various fatal diseases such as aseptic meningitis, respiratory 
illness, myocarditis, encephalitis and acute flaccid paralysis may occur (Rotbart, 
2002). Table 1.1 summarizes the clinical manifestations produced by different 








Table 1.1: Clinical manifestations of enterovirus serotypes.   
 
Clinical Manifestations  
 
 
Enterovirus Serotypes  
 
Paralysis and encephalitic disease 
 
 
Poliovirus 1-3; Coxsackievirus A4, A7, 
A9,  A10, B1-5; Echovirus 1,2 4, 6, 7, 
9, 11, 14-16, 18, 22, 30 
Aseptic Meningitis and 
meningoencephalitis 
Poliovirus 1-3; Coxsackievirus A1, A2, 
A4, A7, A9, A10, A14, A16, A22, B1-
6; Echovirus 1-11, 13-23, 25, 27, 28, 
30, 31; Enterovirus 71 
Hand, foot and mouth disease (HFMD) Coxsackievirus A5, A10, A16, 
Echovirus 19, Enterovirus 71 
Herpangina Coxsackievirus A2-6, A8, A10, A12 








Coxsackievirus B1-5; Echovirus 1, 6, 
9, 19, 22 
 
Coxsackievirus A4, A9, B5; Echovirus 









1.2 Enterovirus 71  
1.2.1 Genomic structure for enterovirus 71 
Enterovirus is a non-enveloped positive single-stranded RNA virus and has a 
linear genome of approximately 7.5 kb in length. The genome is comprised of a 
single open reading frame (ORF) which is flanked by untranslated regions (UTR) 
at the 5’ and 3’ end. The 3’UTR is followed by a variable length of poly-A tract. 
The single ORF is divided into 3 regions P1 to P3 and encodes a single 
polyprotein of 2194 amino acids. The polyprotein is processed by proteases to 
produce structural and non-structural proteins. The P1 region encodes for 
structural proteins VP1 to VP4. Sixty identical units, each consisting of 4 capsid 
proteins, form an icosahedral structure of 28 nm (Crowell and Landau, 1997) 
known as the viral capsid. The P2 and P3 regions encode for non-structural 
proteins including 2A to 2C and 3A to 3D. They are the viral proteases as well as 
RNA polymerases which help in virus replication and formation.  Figure 1.1 is the 








Figure 1.1: Genome structure of EV71. The single ORF is flanked by UTRs at 
the 5' and 3' ends, a variable length poly-A tail is found at the 3' UTR. The ORF is 
divided into three regions: the P1 region encodes four structural proteins VP1– 
VP4, the P2 and P3 regions encode seven non-structural proteins 2A–2C and 3A– 







1.2.1.1 5’ untranslated region (5’UTR)  
Like other picornaviruses, enterovirus 71 has a long 5’ untranslated region 
upstream of the start codon of about 750 bp. The 5’UTR is covalently linked to a 
viral protein Vpg (Lee, 1977; Flanegan, 1977) and has multiple stem-loop 
structures (Yang, 1997). Since the 5’cap is replaced by Vpg, enteroviruses use an 
alternative, cap-independent, internal pathway for initiation of translation. The 
secondary structure within the 5’UTR serves as an internal ribosome entry site 
(IRES) for recruitment of ribosomes (Jang, 1988; Pelletier and Sonenberg, 1988).  
The stem-loop structures were found to be important in both cap-independent 
translation initiation and RNA replication.  Stem-loop I is at the very beginning of 
5’UTR and is a highly conserved cloverleaf-like structure. This structure is 
involved in negative strand RNA synthesis (Andino, 1990).  Stem-loops II to VI 
serve as IRES and are required for cap-independent translation (Pelletier and 
Sonenberg, 1988) (Figure 1.2). There is a pyrimidine tract found to be located 
about 10–15 bases upstream of an AUG that is not recognized as an initiator 
codon by the translation machinery; the sequence encompassing this silent AUG 
of the enterovirus genome is termed box B (Pilipenko, 1992a and 1992b). Studies 
demonstrated that the cellular protein, heterogeneous nuclear ribonucleoprotein K 
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(hnRNP K), interacts with stem-loops I-II and IV in the 5' UTR of enteroviruses. 
Viral yields and RNA synthesis were significantly compromised in hnRNP K 
knockdown cells (Lin JY, 2008). The sequence of 5’UTR was found to be quite 
conserved among enteroviruses, and thus it has been widely utilized for the 














Figure 1.2: Organization of the enterovirus 5’UTR. The main structural 
elements along the 5′ untranslated region and the approximate positions of the 
motifs described in the text are depicted within the IRES region (in red) and the 
cloverleaf (CL) (in blue). The structural domains of the IRES are numbered (from 
II to VI) and the location of GNRA motif (where N is any nucleotide and R is a 
purine) is also denoted. The position of the initiator AUG to translate the viral 







1.2.1.2 Structural proteins  
Four structural proteins VP1, VP2, VP3 and VP4 are the main components of 
the enterovirus capsid (Putnak and Philips, 1981) (Figure 1.3). Sixty copies VP1 
to VP4 in icosahedral symmetry form the viral capsid of enterovirus 71. VP1, 
VP2, and VP3 range from 240 to 290 residues and all of them have an eight-
stranded antiparallel β sheet structures with a “jelly roll” topology (Hogle, 1985). 
These 3 structural proteins form the outer surface of the capsid. The VP1 of 
enteroviruses contains a cavity which is lined with hydrophobic residues. This 
cavity was found to be accessible from the depression on the outer surface 
(Hendry, 1999). VP1 gene sequence data have been shown to infer the 
serotype.The VP1 protein is the most exposed and immunodominant of the capsid 
proteins (Oberste 1999a and 1999b; Rossman 1985). VP4 consists of 70 amino 
acids and is much shorter than the other 3 proteins. It lies in the inner surface of 








Figure 1.3: Capsid structure of bovine enterovirus (BEV). The colour scheme 
is: VP1, blue; VP2, green; VP3, red; and VP4, yellow. Only the main chain 




1.2.1.3 Non-structural proteins  
Products of the P2 region include protein 2A, 2B and 2C. 2A mediates in 
proteolytic cleavage of polyprotein to release P1 and in the mean time, it cleaves 
3CD into 3C and 3D at the Tyr–Gly pairs (Krausslich and Wimma, 1988). 
Cleavage of 3CD was found to be non-essential (Lee, 1988). The multifunctional 
2A protease also inhibits host protein synthesis and initiation of RNA synthesis 
(Hellen and Wimmer, 1995). 2C is the most conserved among all enteroviral 
proteins. It contains three well-characterized sequence motifs: an amino terminal 
amphipathic helix, a binding site and a putative zinc finger in the carboxy-
terminal of the polypeptide (Hellen and Wimmer, 1995). The association between 
2C and replication complex-associated vesicles suggests that it is also involved in 
viral replication.  
Virus-encoded proteins 3A, 3B, 3C and 3D are in the P3 region. P3 region is 
cleaved into 3AB (precursor of 3A and 3B) and 3CD (precursor of 3C and 3D) 
(Shih, 2004). 3A is found to be closely associated with replication complex in 
infected cell (Hellen and Wimmer, 1995). 3CD is a protease participating in 
cleavage of P1 region and after cleavage by 2C, its products are 3C and 3D.  
Protease 3C is the main executor for cleavage of P2 and P3 regions and this is 
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essential for viral replication (Miyashita, 1996; Kemp, 1992). 3D polymerase is 
an RNA-dependent RNA polymerase which functions in RNA synthesis (Hellen 
and Wimmer, 1995). The proteolytic process is described in Figure 1.4.  
 
1.2.1.4 3’untranslated region (3’UTR) 
The 3’UTR of enterovirus’ genome is composed of a structured region which 
is about 100 nucleotides preceding a polyA tail. There are 4 domains named S, 
X ,Y and Z (Figure 1.5). Domain X and Y are both stem-loop structures that 
possess 8 and 12 base pairs. (Pilipenko, 1992b; Pilipenko, 1996). It was described 
by Pilipenko and colleagues that these 2 domains interacted with each other to 
form a pseudoknot structure which was found to be essential for viral RNA 
synthesis and replication (Melchers, 1997). Domain Z is not an essential part for 
virus replication, but is responsible for cell-type-specific replication of viral RNA 
(Dobrikova, 2003). The 3’UTR interacts with both viral proteins and host cell 
proteins. The RNA-dependent RNA polymerase which is encoded by the 3CD 
region is the most studied partner of 3’UTR.  Their interaction serves as the initial 
point for negative-RNA synthesis (Harris, 1994). Host factors like nucleolin bind 
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to the 3’UTR and depletion of nucleolin slowed down virus reproduction and 






Figure 1.4: Proteolytic processing of enterovirus polyprotein. The viral RNA 
is translated into a long polyprotein. This single polyprotein then undergoes 
proteolysis by virus-encoded protease 2A and 3C. Cleavage of the Tyr–Gly pairs 
which connect coat precursors P1 to P2–P3 and 3C–3D in enterovirus is 
accomplished by viral proteinase 2A. The remaining cleavage in P2–P3 at Gln–
Gly pair is executed by viral protease 3C, which is essential for enterovirus 











Figure 1.5: Schematic representation of the spatial organization of the 3-









1.2.2 Clinical diseases caused by enterovirus 71  
 EV71 was first isolated in California in 1969 from a stool sample of an infant 
suffering from encephalitis (Schmidt, 1974). It is transmitted through the faecal-
oral route and direct contact with throat discharges or fluid from blisters. Children 
under 5 years old are most susceptible for enterovirus 71 infection (Chan, 2003) 
but adults can also be infected. Most infected adults were asymptomatic (Chang, 
2004), however adults who develop severe diseases with EV71 infections were 
also reported (Tai, 2009; Hamaguchi, 2008). Household transmission is identified 
as a risk factor in EV71 infection since a high transmission rate was observed 
within family members (Chang, 2004).  
EV71 has been increasingly recognized as the main cause of hand, foot and 
mouth (HFMD) disease, although HFMD is most frequently associated with 
CA16 and can  also result from infection by different enteroviruses such as CA5, 
CA9 and CA10 (Melnick, 1996b). HFMD is a common childhood disease 
characterized by a brief febrile illness, typical rashes on hand and foot and ulcers 
in the mouth (Figure 1.6).  It is usually a mild disease with the rashes healing 
within 5 to 7 days. Clinical symptoms due to enterovirus 71 infections are almost 
indistinguishable from other enteroviruses’ infections although it was shown that 
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rashes caused by enterovirus 71 infections were more frequently papular and/or 
petechial, often with areas of diffuse erythema on the trunk and limbs (McMinn, 
2001a and 2001b). In addition, enterovirus 71 can also cause herpangina. 
Herpangina is a mild illness characterized by onset of fever and sore throat, 
associated with the development of raised papular lesions on the mucosa of the 
anterior pillars of fauces, soft palate and uvula (Melnick, 1996b). However, the 
most common etiological agents of herpangina is coxsackievirus A group 
(Melnick, 1996b).  Besides mild diseases, enterovirus 71 is found to be frequently 
related to neurological diseases like acute flaccid paralysis (AFP), aseptic 
meningitis, brainstem and/or cerebellar encephalitis. AFP caused by enterovirus 
71 was firstly reported by Hayward and colleagues in 1989 (Hayward, 1989). The 
pathogenesis is similar to poliomyelitis for some of the cases observed in Bulgaria 
and Taiwan (Chumakov, 1979; Chen, 2001) but other mechanisms are also 
suspected to be involved in enterovirus 71-associated AFP (Ramos-Alvarez, 
1969).  Aseptic meningitis and encephalitis were observed in outbreaks in the 
Asia-Pacific region (Lum, 1998; Huang, 1999).  Interestingly, EV71-associated 
neurological diseases were found to be accompanied with pulmonary edema 
(Chang, 1999; Chan, 2000).  Neurological pulmonary edema was first described 
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in 1995 from Connecticut, USA (Landry, 1995). Post-mortem studies showed 
EV71-related neurological pulmonary edema in subsequent outbreaks in Bulgaria 
(Shindarov, 1979) and Taiwan (Chang, 1999) epidemic resulted in high mortality. 
Disease seemed to be confined to the brainstem, accompanied by intense 
neutrophil and mononuclear cell inflammatory infiltrates and acute inflammatory 
encephalitis was observed by histology. Presence of EV71 in neurons further 
confirmed CNS invasion (Wang, 1999; Lum, 1998). Low counts of peripheral 
blood mononuclear  cells  (CD4+ T cells, CD8+ T cells and natural killer (NK) 
cells) as well as significant leukocytosis and thrombocytosis were observed in 
patients with pulmonary edema (Wang, 2003). On the other hand, high levels of 
cytokines like interleukin-10, interleukin -13, and interferon (IFN)-gamma were 
detected (Wang, 2003). It is recently revealed that EV71 increased the 
predestional release of cytokines in Dendritic Cells (DC) (interleukin-6, 
interleukin-12, and tumor necrosis factor-alpha). Moreover, EV71 enabled DCs to 
stimulate T-cell proliferation (Lin, 2009). Clinical syndromes associated with 










gure 1.6: Vesicles on the palm of a child infected with hand, foot and mouth 
disease (HFMD). Adapted from the Dermatologic Image Database, Department 










Figure 1.7: Clinical syndromes associated with enterovirus 71 infection. a 
Aseptic meningitis has been described in all reported epidemics of EV71 infection. 
b Neurogenic pulmonary oedema was first described in association with EV71 
infection in 1995 and has been frequently associated with EV71 epidemics in the 
Asia-Pacific region since 1997. c Only one example reported in the literature. d 
HFMD has been described in all reported epidemics of EV71 infection, with the 




1.2.3 Epidemiology of Enterovirus 71  
Early epidemics of EV71 infections were recorded in California from 1969 to 
1973, where EV71 was isolated from patients with neurological diseases (Melnick, 
1984). EV71 cases were then identified through 1972 to 1977 in New York 
(Deibel, 1975). Beside the United States, EV71 started to be identified in other 
parts of the world since 1972. EV71 was isolated in 1972 in Melbourne, Australia 
(Kennett, 1974) followed by a small epidemic in Sweden (Blomberg, 1974) and 
Japan (Hagiwara, 1978; Gobara, 1977) in 1973.  A large number of HFMD cases 
were reported in Japan again in 1978 in association with neurological diseases 
(Ishimaru, 1980). There were 2 large EV71 epidemics recorded in Europe during 
1975 to 1978. The first one occurred in Bulgaria in 1975. Seven hundred and five 
EV71infections were identified, of which 77.3% were aseptic meningitis and 
21.1% were AFP (Chumakov, 1979). Another epidemic happened in Hungary in 
1978. EV71 was found to be positive in 323 cases, 13 of whom had poliomyelitis-
like paralysis, 145 encephalitis, and 161 aseptic meningitis (Nagy, 1982).  Small 
epidemics of EV71 were subsequently observed in other parts of the world such 
as in Hong Kong (Samuda, 1987), China (Zheng, 1995), Singapore 
(Doraisingham, 1987) and Australia (Gilbert, 1988).  Major HFMD outbreaks in 
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Malaysia, Taiwan and Singapore were recorded since 1997. In Sarawak Malaysia 
1997, a total of 2,628 HFMD cases were identified to be EV71 infection. Thirty-
nine of these patients had aseptic meningitis or acute flaccid paralysis and there 
were 29 fatalities due to progressive cardiac failure and pulmonary edema (Chan, 
2000).  In the meantime, 12 deaths were reported in Peninsular Malaysia (Lum, 
1998). In 1998, Taiwan experienced the largest ever HFMD outbreak, out of 
129,106 reported cases 405 patients with severe complications were identified and 
there were 78 fatal cases. It was found that 75% of hospitalized patients and 92% 
of fatal cases were EV71 positive and from whom the virus was isolated (Ho, 
1999). Various complications included encephalitis, aseptic meningitis, 
pulmonary edema or hemorrhage, acute flaccid paralysis, and myocarditis were 
seen and pulmonary edema or hemorrhage was responsible for 83% of the 
fatalities (Ho, 1999). In Singapore 2000, a major HFMD outbreak affected a total 
of 3,790 patients and 4 fatalities were reported during the epidemic and 3 after. 
Fatalities were mainly due to interstitial pneumonitis and brainstem encephalitis 
instead of neurological pulmonary edema (Chong, 2003). In 1999, 29 severe 
HFMD cases without fatalities were reported in Perth, Western Australia. 
Neurological disease was exclusively associated with EV71 (McMinn, 
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2001).After the year 2000, small HFMD epidemics with low fatalities continued 
to take place. In 2005, Taiwan reported 4 fatalities (http://www.promedmail.org). 
In  2006, 13 deaths out of 13,000 cases were reported in Malaysia (Ministry of 
Environment, Malaysia) and no death out of 3000 cases in Singapore (Ministry of 
Health, Singapore). In the recent explosive epidemic in China in 2008, 488,955 
HFMD cases were reported, culminating in 126 deaths (www.moh.gov.cn), with 
EV71 being the main pathogen (Qiu, 2008; Huemer, 2008).  
In 2008, the largest outbreak of HFMD in Singapore afflicted 29,686 patients 
ranging from kindergarten to primary school students, 4 of whom developed 
EV71-related encephalitis. A 3-year old boy with EV71 infection died of 
encephalomyelitis in August 2008, i.e. the first HFMD-related death since 2001. 
The peak of over 10,000 cases occurred from March to May 2008, with the 
highest number of cases being observed in 2 consecutive weeks. Compared to 
previous outbreaks from 2005-2007 (Ang, 2009), the number of cases almost 
doubled during this short period. Although the HFMD cases surged to such an 
unprecedented high level, only a single fatality was documented, implying that 
the strains responsible for the 2008 Singapore HFMD outbreak were highly 
transmissible but possessed low virulence.  
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1.2.4 Molecular epidemiology of enterovirus 71 
Molecular epidemiology of enterovirus 71 was initially established by Brown 
et al (1999) through phylogenetic analysis (Figure 1.8). They sequenced and 
analyzed complete VP1 gene (891bp) for 113 strains of EV71 strains isolated 
from 1970 to 1998 all over the world for genetic and evolutional studies.  VP1 
gene is considered to be the most suitable region for analysis because it is the 
most immunodominant protein on the outer surface of EV71 capsid correlating 
with viral serotype (Oberste 1999; Rossman 1985). It is also found to provide 
useful information in distinguishing enterovirus serotypes (Oberste, 1999). Three 
distinct genogroups designated as A, B and C were demonstrated by phylogenetic 
analysis. Genetic variations between these 3 genogroups varied from 16.5 to 
19.7% in nucleotide sequence and a smaller difference (12% or fewer) was 
observed within the genogroups. The amino acid sequences of the 3 genogroups 
were highly similar, with at least 94% identity. Genogroup A only contained the 
prototype strain BrCr-CA-70, which was first isolated in California. Genogroup B 
was further divided into subgenogroups B1 and B2. Strains isolated from early 
EV71 infections in United States and Australia belonged to genogroup B. 
Genogroup C was also found to have 2 subgenogroups, C1 and C2. Genogroup C 
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strains were isolated later than genogroup B strains in various countries. 
Nucleotide sequences for strains within the same subgenogroup shared a more 
than 90% similarity (Brown, 1999).  
      After major HFMD outbreaks in the Asia-Pacific region, VP1 sequences of 
more EV71 strains had been analyzed in different areas, and due to the high 
evolutional rate of EV71, new subgenogroups have been constantly identified. 
The subgenogroup B3 strain was the main causative agent in the epidemics of 
Sarawak and Peninsular Malaysia in 1997 (Cardosa, 2003) and it was found to be 
also the dominant strain in 1999 Perth outbreak (McMinn, 2001a and 2001b) 
(Figure 1.9). Singapore has identified subgenogroup B4 in its first HFMD 
outbreak in 2000 (Chan, 2003). Hosoya et al studied the genetic diversity of 
EV71 from 1983 to 2003 in Japan, and 2 previous undescribed subgenogroups, 
B5 and C4, were found to be dominantly related in 7 epidemics since  1984 
(Hosoya, 2006) (Figure 1.10). A EV71-associated HFMD outbreak in Korea was 
also identified and a new subgenogroup C3 was reported to be responsible (Chu, 
2001). In year 2005, a previously undescribed group C5 was identified and 
isolated in Vietnam (Tu, 2007) (Figure 1.11).   
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Other than the VP1 region, other regions such as the 5’UTR (AbuBakar, 1999; 
Wang, 2000) and VP4 (Shimizu, 1999; Chu, 2001; Cardosa, 2003) were also used 
to illustrate the phylogenetic relationships of EV71 strains. The most established 
study involved the VP4 region which showed correlation with VP1 genogrouping. 
Chu et al sequenced a fragment of 207-bp length of the VP4 region from 23 
Taiwanese EV 71 isolates and together with another 21 strains from GenBank, 
they separated the 44 strains into 3 genogroups, A, B and C. Cardosa et al 
successfully reproduced the genogroups constructed based on the VP1 region, 
using full VP4 sequences of 128 EV71 strains, of which 39 were representative 
EV71 strains isolated from recent years in Sarawak, Singapore, Perth and Korea, 
and 16 were strains isolated in the United States from1972 to 1995. The 
divergence between genogroups ranged from 16 to 25%. Genogroup B strains 
shared more than 87.9% similarity while genogroup C strains were more diverse, 
with more than 84.5% identity. It was demonstrated that VP1 and VP4 sequences 
were both suitable candidates for phylogenetic studies of EV71, but higher 
bootstrap values seen in VP1 dendrograms provided greater confidence in new 
genogroup classification and molecular epidemiology (Cardosa, 2003). Since VP1 
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was also exposed on the surface of the virus particle, sequence of VP1 would 
provide more information for virus mutation and evolution (Cardosa, 2003).  
To date ta total of 11 subgenogroups of EV71 have been identified. Different 
subgenogoups of EV71 continue to circulate in the Asia-Pacific region. In the 
1997 Malaysia outbreak, B3 was the main cause (Cardosa, 2003). In the 1998 
Taiwan outbreak, C2 was responsible for most of the infections (Ho, 1999). In the 
1999 Perth outbreak, both B3 and C2 co-circulated and resulted in no fatalities 
(McMinn, 2001a and 2001b). The Singapore 2000 outbreak resulted from B4 
infection which was the same as Malaysia (Chan, 2003). During the 2008 HFMD 
outbreak that occurred in China and Singapore, C4 strains were dominant in 
China (Pan, 2009) whereas B5 accounted for most of the infections in Singapore.  
No direct association between the genetic lineage of EV71 and virulence was 
established, and no significant difference in genomic sequences was found 








Figure 1.8:  Classification of 113 EV71 strains into genogroups based on the 
VP1 gene (nucleotide positions 2442 to 3332). The dendrogram was generated 
by the neighbor-joining method with the DNADIST distance measure program 









Figure 1.9: Phylogenetic tree showing classification of 25 EV71 field isolates 
into subgenogroups based on alignment of the complete VP1 sequence 
(nucleotide positions 2442–3332). Branch lengths are proportional to the number 
of nucleotide differences. Strain names indicate a unique number/country or U.S. 
state of isolation/year of isolation: AUS – Australia; CA – California, USA; CT – 
Connecticut, USA; IA – Indiana, USA; MAA – Peninsular Malaysia; OR – 
Oregon, USA; SAR – Sarawak, Malaysia; SIN – Singapore; TW – Taiwan; TX – 
Texas, USA. The VP1 nucleotide sequence of CA16 was used as an outgroup in 





Figure 1.10: Phylogenetic classification based on the complete (891-
nucleotide) VP1 sequence. Representative EV71 strains were isolated in 





Figure 1.11: Dendrogram constructed by using the neighbor-joining method 
showing the genetic relationships between 23 human enterovirus 71 (HEV71) 
strains isolated in southern Vietnam during 2005 (underlined), based on the 




1.2.5 Putative EV71 receptors  
       Identification of cellular receptors of EV71 is of crucial importance for the 
understanding of its pathogenesis and host-virus interactions. Two putative 
receptors, P-selectin glycoprotein ligand-1 (PSGL-1;CD162) and scavenger 
receptor B2, have been discovered recently. PSGL-1 is a membrane protein which 
is expressed on leukocytes and functions in early stages of inflammation. Using 
an expression cloning method by panning, it was identified to be one of the 
functional receptors of EV71. Binding of EV71 to PSGL-1 allows entry and 
replication of EV71 in PSGL-1expression cells (Nishimura, 2009). However, not 
all EV71 strains utilize PSGL-1 for its entry and replication. Human scavenger 
receptor class B, member 2 (SCARB2, also known as lysosomal integral 
membrane protein II or CD36b like-2) was also shown to be a receptor for EV71. 
Expression of human SCARB2 in unsusceptible cells permits the replication 
EV71 and development of cytopathic effects (Yamayoshi, 2009). This receptor 
was also found be to a functional receptor for CA16. Better understanding of 
EV71 receptors will shed light on mechanisms of severe EV71 infections and cell 




1.3 Diagnosis of Enterovirus 71  
1.3.1 Cell culture isolation and neutralization  
The classical gold standard for virus identification is to isolate the virus using 
tissue culture followed by neutralization test using pooled antisera. It was shown 
that EV71 can be propagated using several cell lines like Vero (African green 
monkey kidney cell line) (Abreu Nicot, 1998), human Rhabdomyosarcoma (RD) 
cell line (Prather, 1984), MRC-5 (human lung fibroblast cell line) (Shinohara, 
1999), Hep-2 (human epidermoid cancer cells), BHK-21(baby hamster kidney 
cells) (Xie and Xiang, 2000) and MDCK (monkey kidney cell line) (Zhu, 2007). 
The neutralization test using pooled antisera could give serotypic identification. It 
was initially described that serotyping of enteroviruses can be accomplished using 
the Lim and Benyesh-Melnick (LBM) pool which was derived from serotype-
specific hyper-immune sera (Lim and Benyesh-Melnick, 1960). An alternative 
antisera pool was developed by the National Institute of Public Health and 
Environment in the Netherlands (RIVM) (Kapsenberg, 1980). Common sources 
for EV71 isolation are refrested by stools, urine, cerebrospinal fluid (CSF), serum, 
vesicle fluid, throat and rectal swabs (Hsiung and Wang, 2000). Cell culture 
isolation and serotyping using the neutralization test are accurate but have several 
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disadvantages. Firstly, it is expensive to carry out in the general diagnostic 
laboratory (Rigonan, 1998). Secondly, it is very time-consuming since virus 
isolation may take up to 3 weeks and the neutralization test takes one week to 
give a result. Thirdly, cell culture isolation has a relatively low sensitivity (Singh, 
2002a) which renders difficult detection of enterovirus 71 in clinical samples with 
low viral titer. Fourthly, the neutralization test itself has disadvantages. 
Neutralization could be hindered due to antigenic drifts or presence of multiple 
viruses in the clinical specimens (Schmidt, 1974).  
 
1.3.2 Serological approach 
1.3.2.1 Enzyme linked immunosorbent assay 
A few studies on detection of EV71 using serological assays have been carried 
out. Enzyme Linked Immunosorbent Assay (ELISA) has been used for various 
serotyping of enteroviruses and it is sensitive and specific for laboratory diagnosis 
(Bendig and Molyneaux, 1996). The detection of IgM antibody in serum samples 
from EV71-infected patients by ELISA was shown to be effective in diagnosing 
acute EV71 infections (Tano, 2002). A study in Taiwan also designed a similar 
IgM-ELISA assay which had a sensitivity and specificity of 97.7% and 93.3%, 
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compared to virus isolation and neutralization test and it only took 4 hours for 
detection (Wang, 2004). ELISA is rapid in identification and commonly used in 
diagnostic laboratories, but it has some limitations. In the IgM-capture ELISA, the 
whole EV71 virion was used as the coated antigen for detection of serum IgM 
antibody. The need to prepare large quantities of purified virions and interacting 
with secondary anti-human IgM in the ELISA assay made the method an 
expensive, laborious and lengthy process. In addition, since the whole virus was 
used as the capture antigen in the ELISA assay, cross-reactions with antibodies 
against other enteroviruses could result in false positives. Thus, the specificity of 
the IgM-based ELISA may be compromised by the presence of common epitopes 
of other enteroviruses. Recently, IgM and IgG ELISA assays using recombinant 
purified EV71VP1 protein as a coated antigen for detection have been developed. 
The sensitivity and specificity of the IgM assay to EV71 were 73% and 77% 
compared to RT-PCR results, and the IgG assay had a relatively higher accuracy 






1.3.2.2 Indirect immunofluorescence assay  
Another conventional method used by many laboratories was indirect 
immunoflorescence (IIF) assay (Wang, 2004). A type-specific monoclonal 
antibody was raised against EV71 VP1 protein (Chemicon International, USA). 
Patient samples were subjected to virus isolation in cell lines. Immunohistological 
staining with EV71 antibody was carried out then and cell culture with virus 
particles of EV71 could bind to the antibody. This complex was then detected by 
a secondary antibody labeled with  FITC (fluorescent isothiocyanate-labeled) 
which was visualized under a fluorescence microscopy (Rigonan, 1998; Tung, 
2007). This method does not require the time-consuming neutralization test using 
antisera pool but it still needs to isolate and propagate the virus. Since virus 
isolation involves a long time, it still delays diagnosis. In addition, this 
monoclonal antibody was raised against the VP1 protein of the prototype strain; it 
may not be able to recognize mutant viruses. It was also reported that cross-






1.3.3 Viral nucleic acid approach 
Development of polymerase chain reaction (PCR) greatly facilitates 
laboratory diagnosis of enteroviruses. It is gradually becoming a common practice 
for viral identification in diagnostic microbiology laboratories.  Comparing to 
traditional methods, viral nucleic acid detection is fast, sensitive and reliable. Due 
to the nature of the enterovirus genome, PCR primers for enterovirus detection 
were first designed based on the highly conserved 5’UTR region of enteroviruses 
(Rotbart, 1990; Zoll, 1992). Pan-enterovirus primers were able to detect all types 
of enteroviruses but they cannot provide any serotype-specific information 
without further sequencing analysis. Besides, 5’UTR sequences may not provide 
enough information for serotype identification. Although there were phylogenetic 
studies targeting the VP4-VP2 junction which suggested that this region might be 
more suitable for developing serotype specific diagnostics, it appeared to correlate 
only partially with serotypes (Arola, 1996; Oberste, 1999). On the other hand, 
sequence of VP1 region always appeared to correlate with serotypes (Oberste, 
1999) and it displayed the most marked divergence among enteroviruses (Brown, 
1995). In addition, it was shown that the sequence of the 3’ half of VP1 and 
antigenic typing by neutralization test had a 100% correlation (Oberste, 1999). 
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Therefore VP1 sequence was found to be suitable for virus nucleic acid typing. 
Since EV71 infection may result in fatal consequences in patients, methods for 
specific EV71 detection needs to be developed.  
 
1.3.3.1 RT-PCR microwell detection 
Rotbart developed the first RT-PCR for enterovirus identification in 1990 
(Rotbart, 1990). It amplified a portion of the 5’UTR region. Then, they described 
a new RT-PCR which utilized a single enzyme for both the RT and PCR steps 
(Rotbart, 1994). Uracil N-glycosylase and biotinylated primers were used for 
detection. Basically, the amplified enterovirus 5’UTR products hybridized to an 
enterovirus probe that was immobilized on a microwell plate (AMPLICOR® EV 
Test; Roche Diagnostic Systems, Branchburg, NJ). The biotinylated PCR product 
could be detected using streptavidin after binding to the probe. Multiple clinical 
samples were tested using this system and it had at least 77% sensitivity for all 
types of clinical samples (Rotbart, 1997). This colormetric assay took 5 hours to 





1.3.3.2 Conventional RT-PCR  
In order to specifically detect EV71, a few methods have been developed to 
target the VP1 region. A serotype-specific reverse transcription-polymerase chain 
reaction (RT/PCR) based typing method for enterovirus 71 was developed using 1 
set of primers (159S/162A) targeting  the VP1 region, and evaluation with CA16 
and other enteroviruses indicated they were specific for EV71 (Brown, 2000). 
Another pair of primers (VP1F2/EV71R2) was designed by Singh et al also 
targeting the VP1 region. They successfully amplified various strains isolated 
from different countries (Singh, 2000).  Due to the close genetic relationship 
between EV71 and CA16, RT-PCR methods were also developed to amplify both 
enteroviruses. The 2 sets of primers targeting at the VP1 regions were specific for 
EV71 and CA16 respectively and showed 100% sensitivity, although the 
specificity for CA16 was 98.8% (Yan, 2001).  Since previous primers were tested 
on viral isolates, their group carried out a study on sensitivity of primers for EV71 
detection from clinical samples. It was shown that 2 pairs of primers by Brown 
and Singh had low sensitivity in detecting virus present in clinical samples. 
Therefore nested RT-PCR was carried out and a higher sensitivity 53% was 
achieved (Singh, 2002). However, there are some drawbacks with nested PCR, it 
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is very prone to cross-contamination since there are 2 cycles of PCR and it may 
also give non-specific bands.  
 
1.3.3.3 Real-time RT-PCR 
Real-time PCR is an improvement of classical PCR. It is also known as qPCR 
which could quantify the amount of materials present in the sample. It is generally 
faster than classical PCR and does not require gel electrophoresis post-
amplification. The specificity of the assay could be analyzed using melting curve. 
In addition, standard curve can be constructed to measure the exact amount of 
nucleic acid. There are 3 major chemistries in real-time PCR system: the SYBR 
green approach which is widely used for non-specific detection of double-
stranded DNA (Wittwer, 2001), hybridization probe approach which utilizes 
fluorescence resonance energy transfer (FRET) (Mackay, 2002) and lastly the 
Taqman approach  which make use of  the 5’ exonuclease activity of Taq 
polymerase (Holland, 1991; Livak, 1995). Due to the advantage of Real-time PCR, 
several studies had applied real-time PCR for enterovirus detection. A multiplex 
real-time PCR based on SYBR green was developed to detect common viral 
infections of the central nervous system. The amplicons were detected by SYBR 
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green and were differentiated by their melting temperatures (Read, 2001). It 
allowed the differentiation among enteroviruses, herpes simplex virus type 1 
(HSV-1), HSV-2 and varicella-zoster virus (VZV).  A hybridization probe assay 
targeting the 5’UTR region of enteroviruses and rhinoviruses gave almost 
identical results with reference to conventional RT-PCR and took less time to 
perform (Kares, 2003). The Taqman approach for enterovirus detection was 
investigated by several groups. In Verstrepen’s study, the probe and primers were 
derived from the 5' untranslated region of the enterovirus genome. The sensitivity 
of the assay was 100% and the specificity was 96.2% compared to viral culture, 
although only 27.1% CSF specimens were positive for PCR (Verstrepen, 2001). 
In the meantime, another group also identified a 5’UTR probe which was able to 
detect 60 serotypes of enterovirus without cross-reactivity (Nijhuis, 2002). 
Besides, there were two Taqman PCRs which were specifically designed for CSF 
specimens which had low viral loads (Watkins-Riedel, 2002; Petitjean, 2006). 
All the real-time PCRs mentioned above only detect enteroviruses, but since 
EV71 is more and more recognized as a cause for most of neurological diseases, a 
series of real-time PCR was develop for specific EV71 detection.  Hybridization 
probe assay and Taqman assay for specific EV71 detection were developed by 
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Tan. In both studies, primers and probes target at VP1 region of EV71. 
Hybridization probe assay was able to detect as low as 5 copies of viral RNA and 
had 83.6% sensitivity for clinical sample detection (Tan, 2006) whereas Taqman 
assay had a low sensitivity of 73.1% (Tan, 2008b). As known, CA16 and EV71 
are both main causes of HFMD but CA16 possesses a low virulence, therefore 
several multiplex real-time PCRs are devoted to differentiate these 2 viruses 
which would help in early diagnosis of fatal cases. Tan developed a hybridization 
probe assay for specific detection and differentiation of Enterovirus 71 and 
Coxsackievirus A16 (Tan, 2008a) and Xiao developed a TaqMan probe real-time 
PCR with an IAC for the detection EV71 and CV-A16 (Xiao, 2009). Both  assays 
used primers designed from VP1 region of EV71 and CA16 and showed high 
specificity and sensitivity in analysis of clinical samples.    
 
1.3.3.4 Microarray 
A study combing multiplex RT-PCR with array-based assay, it successfully 
detected and differentiated EV71 and CA16 (Chen, 2006). Amplified PCR 
products of EV71and CA 16 were then labeled with fluorescent dyes and added to 
array slides. The array slides were spotted with 3 serotype-specific 60-mer probes: 
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Pan EV, EV71 and CA16. This chip successfully detected 92.0% of EV71, 95.8% 
of CA16 and 92% of other enteroviruses.  
 
1.3.3.5 Image-based approach 
An application of fluorescence resonance energy transfer (FRET) on detection 
of EV71 infection in cells was established recently (Ghukasyan, 2007). A 
recombinant plasmid was constructed to have genes of GFP2 and DsRed2 
fluorescent proteins which were linked by a short amino acid sequence recognized 
by 2A protease EV71. The plasmid was transfected and expressed in HeLa cells. 
The linker sequence kept the two fluorophores within the Forster distance and 
created a condition for FRET to occur, thus resulting in shortening of the GFP2 
fluorescence lifetime. If cells were infected with EV71, virus-encoded protease 
2A would recognize and cleave the cleavage site within the linker sequence, 
causing disruption of FRET through separation of the fluorophores. Therefore this 
method was able to detect EV71 infection in cells. This method provides higher 
efficiency and speed compared to direct electron microscopy methods. However it 
cannot identify the viral serotypes since all viruses in the family Picornavidae 
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have protease 2A, and it also requires viral isolation and growth, which makes it 
unsuitable for application in clinical settings.  
 
1.4 Management of EV71 infection 
There is currently no approved anti-viral drug for EV71 treatment. Vaccine 
development is ongoing but may take years before it can be applied to humans. 
Intravenous administration of human IgG has been used for severe diseases 
resulting from EV71 infection, with some success. However, usage of human 
blood products poses other potential of risks. Therefore many groups are actively 
working on the management of EV71 infection using different aspects.  
 
1.4.1 Treatment for EV71 infection   
Although there is no anti-EV71 drug available now, pleconaril is a promising 
candidate for treatment of enterovirus infection. Pleconaril is a capsid-binding 
molecule which has been shown to interfere with the capsid protein receptor 
binding site. It has anti-viral activities against rhinoviruses and enteroviruses by 
inhibition of virus attachment to the cell and uncoating of viral RNA (Pevear, 
1999; Kaiser, 2000; Smith, 1986). This drug candidate failed to pass the phase III 
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clinical trials (Peveon et al AAL 49:4492-99 2005). The effect of Pleconaril 
against EV71 activity was poorly since it could not block the cytopathic effect 
(CPE) in infected cells (Shia, 2002).  Based on the structure of pleconaril and its 
related molecules known as WIN group compounds, a novel class of capsid 
binder Pyridyl imidazolidinone was designed and synthesized (Shia, 2002; Chen, 
2008). A 50% plaque reduction was observed using this class of chemicals at 
micromolar level against EV71 infection. Neutralization effect was also 
prominent using these compounds. A potent inhibitor  DTriP-22 (4{4-[(2-bromo-
phenyl)-(3-methyl-thiophen-2-yl)-methyl]-piperazin-1-yl}-1-pheny-1H-
pyrazolo[3,4-d]pyrimidine) was found to target at the 3D polymerase region of 
EV71 and a substitution lysine for arginie at 163 rendered the virus resistant to the 
inhibitor (Chen, 2009). This inhibitor suppressed viral RNA replication and 
showed a broad spectrum for other picornaviruses.  
Besides traditional chemically synthesized compounds, other treatments are 
also intensively studied. Interferons have been shown to be potent inhibitors of 
most enteroviral infections (Kandolf, 1985; Langford, 1985) and it is has been 
recently shown that pre-treatment with a neutralizing antibody to IFN-α/β 
dramatically increased the susceptibility of mice to EV71. Early treatment with 
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recombinant murine IFN-A protected the mice from infection whereas late 
treatment worsened the infection (Liu, 2005). On the other hand, Li generated an 
anti-EV71 monoclonal antibody clone 22A12 by immunizing mouse with  VP1 
synthetic peptide. This antibodyshowed strong neutralizing activity against EV71 
in an in vitro neutralization assay (Li, 2009). Some compounds present in plant 
were also proven to have anti-viral effect. Allophycocyanin purified from blue-
green algae was able to delay viral RNA synthesis more efficiently in cells treated 
before viral infection compared with after infection (Shih, 2003). Ethyl acetate 
and water extraction of Salvia miltiorrhiza (danshen) neutralized EV 71-induced 
cytopathic effect in Vero, rhabdomyosarcoma and MRC-5 cells. It possessed 
specific anti-viral activity for EV71 by interfering with viral entry and RNA 
synthesis and it also delayed the apoptosis of infected cells (Wu, 2007). Tea 
polyphenols reduced the titer of progeny viruses by 95% through inhibition of 
virus replication and increase of cell viability (Ho, 2009). Tea polyphenols are 
anti-oxidant compounds that reduced reactive oxygen species, hence suppressed 
viral replication. Some pharmacologically active compounds were also 
demonstrated to inhibit EV71 infectivity (Arita, 2008). It was found that a 
chemical Ribavirin can protect cells from EV71 infection and inhibited EV71 
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replication and activation. It was shown to delay the appearance of CPE for 
treated cells compared to control cells (Zhang, 2009). Recent techniques such as 
small interference RNA (siRNA) were also employed for study of EV71 treament. 
siRNA targeting the 3D polymerase region against EV71 was established in a 
murine system. Infected suckling mice treated with siRNA did not exhibit 
paralysis or weight loss and further tests showed that EV71 replication was 
inhibited and no interferon was induced (Tan, 2007).  
 
1.4.2 Prevention of EV71 infection   
Different approaches have been investigated for prevention of EV71 infection. 
Vaccine is the most intensively studied. Formaldehyde-inactivated whole virus 
vaccine (Ong, 2010), oral vaccine with expressed and secreted recombinant VP1 
from transgenic mice (Chen, 2008),  EV71 virus-like particles (VLP) that 
resemble the original virus in appearance, capsid structure and protein 
composition (Chung, 2008), passive immunization with neutralizing antibodies 
elicited by a synthetic peptide (Foo, 2007a), DNA vaccine using VP1 gene ( Tung, 
2007) all show promising results in protection from EV71 infection as well as 
inducing IgG and IgM antibodies. However, the inactivated virus was shown to 
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produce a strongerimmune response compared to subunit vaccines and passive 
immunization (Wu, 2001). Bovine lactoferrin was shown to bind to VP1 protein 
in vitro and rescue cells from EV71 infection. In addition, it also protected mouse 
from lethal EV71 challenge (Weng, 2005). A transgenic mice model which 
expressed recombinant porcine lactoferrin in the milk was then established in 
Taiwan. Pups lactated by transgenic mothers showed higher survival rate 
comparing to wild type mouse after EV71 infection (Chen, 2008). This approach 
may also be of interest as prevention for EV71 infection.  
 
1.5 Beads-based suspension array  
1.5.1 Luminex Technology  
LuminexCorp has developed a powerful platform for a broad variety of 
diagnostic and research applications using a microsphere-based suspension array 
designated as xMAP® technology (www.luminexcorp.com). It is a combination of 
flow cytometry, microspheres, laser, digital signal processing, and traditional 
chemistry. This technology makes use of Luminex color-codedmicrospheres 
which can be read in analysis. The 5.6 um microspheres are internally dyed with 
wizth red and infrared fluorophores. 100 sets of microspheres are created by 
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putting different amounts of each internal fluorophore into the bead. Their 
identities can be addressed by laser excitation. Another reported dye is also added 
to the bioassay for laser detection and to quantify the number of events ocurring 
in the assay. Detection of the multiplex assay is carried out in a Luminex reader. 
Microspheres line up in a single stream to pass through the detection chamber and 
a red laser excites both the internal wizth red and infrared fluorophores and a 
green laser excites any orange fluroscence. High reading of median fluorescence 
intensity (MFI) emitted by internal wizth red and infrared fluorophores of the 
beads as well as the third reporter dye will indicate the presence the analytes of 
interested in the sample. Based on xMAP® technology, specific sets of 
microspheres are created for genetic tests. These microspheres are pre-coupled 
with oligo-nucleotides known as universal anti-tags. They can hybridize to the 
complementary tag sequences carried by PCR products and allow detection 
analytes of interested. When this technology is tailored for genetic analysis, it 
beecomes xTAG® technology. Microsphere suspension arrays have been widely 





1.5.2 Advantages of suspension array  
Conceptually, microsphere suspension arrays are similar to flat-surface-based 
arrays, except that one uses optical parameter and the other one uses physical 
location on a surface. The use of suspension array affects various aspects of 
experiments and provides more advantages in terms of cost, efficiency and speed 
of the analysis.  With microsphere suspension array, many analyses can be 
performed on a single sample in a single reaction, which greatly reduces the 
volume required and maximizes the speed of analysis. Consumption of reagents is 
also minimized. In Luminex system, 100 different microspheres types can be 
combined in a single assay and allow up to 100 analytes to be measured 
simultaneously, which has a significant advantage over flat-surface-based array. 
Each bead set can be coated with various types of reactant such as oligo-
nucleotides, antibodies, peptides and receptors, allowing the capture and detection 







1.5.3 Assay format  
1.5.3.1 Direct DNA hybridization  
In direct DNA hybridization assay, PCR products amplified from targeting 
DNA is labeled with a reporter dye. The xMAP microspheres are linked to 
oligonucleotide capture probes with a terminal amine and spacer for coupling to 
the carboxylated microspheres. Successful hybridization of a specific capture 
probe shows the presence of the desired PCR products. Design of sequence-
specific capture probes and PCR primers for a direct hybridization assay on the 
xMAP suspension array is based on the fact that for oligo-nucleotides 
approximately 15 to 20 nucleotides in length, hybridization of a perfectly matched 
template compared to one with a single base mismatch can differ by several 
degrees (Ikuta, 1987; Livshits and Mirzabekov, 1996). In addition, 
tetramethylammonium chloride (TMAC)-containing hybridization buffer 
minimizes the effect of base composition on hybridization (Wood, 1985). TMAC 
hybridization buffer also facilitates hybridization of probes with different 
characteristics (Jacobs, 1988). A typical capture probe is approximately 20 
nucleotides in length. Mismatches are suggested to be in the centre of the probe 
since similar sequence can be distinguished more efficiently (Gotoh, 1995).  PCR 
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products are usually 100 to 300 bp, but long sequences can also shown to give 
successful results (Diaz and Fell, 2004). Figure 1.12 provides a diagram of the 









Figure 1.12: Diagram of the microsphere-based direct hybridization assay 
format. Target DNA is PCR-amplified. One of the primers is biotinylated. The 
amplified products are denatured, hybridized to allele-specific probe-coupled 
microsphere sets and labeled for detection with streptavidin-R-phycoerythrin. 






1.5.3.2 Competitive DNA hybridization  
The approach to design PCR primers and sequence-specific capture probe is 
similar to direct DNA hybridization. The only difference is that rather than 
labeling the PCR product, a competitor probe which gives 100% signal while no 
DNA is present is labeled. This labeled probe competes with capture probe 
attached to microsphere to hybridize with PCR products (Figure 1.13). If the 
desired DNA is present, competition between the two probes will result in a 







Figure 1.13: Diagram of the microsphere-based competitive hybridization 
assay format. Left: In the absence of target DNA, the biotinylated competitor 
oligonucleotides hybridize to the allele-specific probe-coupled microsphere sets. 
The hybridized microsphere sets are labeled with streptavidin-R-phycoerythrin, 
resulting in 100% signal. Right: When target DNA is present, the biotinylated 
competitor oligonucleotides hybridize to the target DNA instead of the allele-
specific probe-coupled microsphere sets. The target DNA/competitor 
oligonucleotide hybrids are labeled with streptavidin-R-phycoerythrin, resulting 
in a reduction of signal on the allele-specific probe-coupled microsphere sets. 




1.5.3.3 Enzymatic methods  
Enzymatic methods utilize a sequence specific probe in an enzymatic step for 
amplification of target sequence and allow further hybridization to microspheres. 
There are 3 commonly used methods: allele-specific primer extension (ASPE), 
oligonucleotide ligation assay (OLA) and single base chain extension (SBCE) 
(Figure 1.14). 3 assays all require amplification of unlabeled PCR products 
containing target sequence. ASPE method uses capture probe with the SNP at 3’ 
end and tag sequence at 5’ end. This capture probe and biotin-labeled dNTP are 
applied in extension of template PCR products using thermostable polymerase. 
Since extension will only occur with perfectly complementary strand, template 
PCR products can be differentiated (Ugozolli, 1992). OLA employs capture probe 
with SNP at 3’ end also. Capture probe binds to the PCR product first and instead 
of extension, a thermostable ligase is used to ligate a biotin-labeled 
oligonucleotide (reporter probe) that is complementary to the sequence 
downstream from the SNP or mutation with the annealed capture probe and target 
PCR products (Landegren, 1988). The reporter probe is phosphorylated at the 
5’end to provide a substrate for ligase and biotin-labeled at the 3’ end for 
fluorescent detection. For SBCE, reactions of four nucleotides are performed in 
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separate tubes. After amplification of PCR products and annealing of capture 
probe designed one base before the SNP site, PCR was run using only one biotin-
labeled ddNTP. Extension occurs only if the biotin-labeled ddNTP is 
complementary to the nucleotide immediately downstream of the capture probe 
(Chen, 2000). After enzymatic reactions, all products are subject to hybridization 











Figure 1.14: Diagram of ASPE, OLA and SBCE procedures used for   
microsphere capture assays. ASPE: 1. Target DNA is combined with capture 
sequence-tagged allele specific primers and denatured; 2. Target DNA and 
primers are annealed in a reaction containing a DNA polymerase and dNTPs (one 
of which is biotinylated); 3. Primer extension; and 4. Capture sequence-tagged 
ASPE products. OLA: 1. Target DNA is combined with capture sequence-tagged 
allele specific probes and denatured; 2. Target DNA and probes are annealed in a 
reaction containing a DNA ligase and biotinylated reporter probe; 3. 
Oligonucleotide ligation; and 4. Capture sequence-tagged OLA products. SBCE: 
1. Target DNA is combined with a capture sequence-tagged primer (in separate 
reactions for each allele) and denatured; 2. Target DNA and primer is annealed in 
a reaction containing a DNA polymerase and a biotinylated ddNTP; 3. Single 
base primer extension; and 4. Capture sequence-tagged SBCE products are 
multiplexed for detection. (Adapted from Dunbar, 2006). 
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1.5.4 Applications  
xMAP technology is extensively used in many different areas mainly for 
genotyping such as identification of single nucleotide polymorphism (SNP) and 
pathogen detection. Multiplexed assay for human antibodies such as IgG, IgM 
and IgA (Gordon and McDade, 1997) and cytokines such as granulocyte 
macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), IL-4, and 
tumor necrosis factor- (TNF-α) (Oliver, 1998) were developed by using an early 
version of xMAP known as FlowMetrix System. Equivalent or better results were 
obtained compared to ELISA test.  FlexMetrix was also used for viral nucleic acid 
detection of human immunodeficiency virus (HIV), hepatitis C virus (HCV) and 
herpes simplex virus (HSV) (Keij and Steinkamp, 1998). Seventeen bacterial 
species representing a broad range of gram-negative and gram-positive bacteria 
were analyzed within 16 variable sites of 16S rDNA sequence. A series of probes 
were designed for identification by both ASPE and SBCE. Results showed that 
identification was consistent with DNA sequencing (Ye, 2001). SNP genotyping 
is greatly facilitated by the development of xMAP technology and many studies 
have been carried out. For example, it is applied to the detection of 
thrombophilia-associated SNPs. 12 sets of genotyping primers for 6 SNPs were 
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designed and they successfully grouped all patients’ genotypes. Besides 
identifying SNPs, multiple mutations contributing in disease can also been 
identified as described by Dunbar on mutations in the cystic fibrosis 
transmembrane regulator gene (CFTR) (Dunbar, 2000). HLA genotyping by allele 
specific probes using Luminex was achieved and gave at least 85% accuracy for 
all genotypes (Itoh, 2005). Commercial kits are also available for cytokine 
profiling as well as viral detection and SNP genotyping.  
Therefore, Luminex xMAP technology is a robust and flexible technology that 
can be applied in many fields like antibody and antigen detection, viral and 











Scope of study 
The objectives of this study involved: 
1. Development of beads based suspension array system for rapid 
genogrouping of enterovirus 71 and evaluation of the possibility of its 
application in clinical settings.  
2. Understanding the causative agents responsible for the largest hand, foot 
and mouth disease outbreak in Singapore in 2008 and the role of 
enterovirus 71 in the outbreak.  
3. Investigation of the national seroprevalence against enterovirus 71 in 











CHAPTER 2  
MATHERIALS AND METHODS  
 
2.1 Development of multiplex suspension array for EV71 genogrouping  
2.1.1 Virus strains, plasmid clones and clinical samples 
Reference strains or genomic RNA representing 9 subgenogroups of EV71 
were either purchased from ATCC or obtained from Singapore, Japan and 
Malaysia. For subgenogroup B1 and C3, neither viral isolates nor genomic RNA 
could be obtained. Plasmid clones carrying the full VP1 region of strain 2609-
AUS-74 (accession number AF135886) and strain 009-KOR-00 (accession 
number AY125973) were constructed using plasmid pUC57 (GenScript, USA). 
For strain MY104-9-SAR-97 and S10862-SAR-98, only RNA was obtained. 
Their VP1 sequences were also cloned to pCR®-XL-TOPO® using TOPO® 
cloning kit (Invitrogen, USA). Eleven other viral isolates from Japan, Malaysia 
and Singapore were tested for validation of the assay. The information of viral 
isolates and plasmid clones is summarized in Table 2.1.  
A total of 55 clinical specimens were collected from suspected HFMD 
patients who presented at the National University Hospital during the 2008 
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HFMD outbreak in Singapore. These samples were tested by conventional and 
real-time RT-PCR, DNA sequencing, and also by the multiplex subgenogrouping 








     Table 2.1: Viral isolates, plasmid clone or genomic RNAs used for 
     EV71 genogrouping assay. 
 
Genogroup Strains Accession Number Sources 
A BrCr U22521 ATCC 
B1 2609-AUS-74 AF135886 GenScript 
B2 7423/MS/87 U22522 Malaysia 
Y90-3205 AB433863 Japan 
Y93-2008 AB433866 Japan 
B3 MY104-9-SAR-97 DQ341368 Malaysia 
B4 5865/sin/000009 AF316321 Singapore 
SB0635/SAR/00 AF376069 Malaysia 
B5 2933-Yamagata-03 AB213648 Japan 
C1 S10862-SAR-98 DQ341359 Malaysia 
Y90-2913 AB433862 Japan 
Y90-3761 AB433864 Japan 
Y90-3896 AB433865 Japan 
4381/SIN/02 AY258319 Singapore 
4575/SIN/98 AF376120 Singapore 
C2 Y97-865 AB433867 Japan 
Y97-1134 AB433869 Japan 
Y97-1188 AB433870 Japan 
C3 009-KOR-00 AY125973 GenScript 
C4 75-Yamagata-03 AB177813 Japan 
C5 3406/Sin/08 GU222653 Singapore 
3437/Sin/06 GU222654 Singapore 




2.1.2 xTAG microspheres 
xTAG microspheres were purchased from Luminex Corp (USA). 12 sets of 
microspheres were used. 11 of them were paired with 11 specific probes of EV71 
subgenogroups and 1 set was used as negative control for scramble probe. Anti-
tag nucleotide is pre-coupled to the bead by the manufacturer at the time of 
purchasing.   
 
2.1.3 Primers and probes design and production  
VP1 sequences of different EV71 isolates of all 11 subgenogroups were 
obtained from GenBank for consensus primers and probes design. 3 strains were 
chosen for each subgenogroup except genogroup A. The prototype of EV71 was 
used for genogroup A. VP1 sequences of them were aligned using Clustal W. 
Consensus primers were designed based on the conserved region of all EV71 
subgenogroups and specific probes for each subgenogroup were designed by 
choosing the region which could differentiate each subgenogroup. Table 2.2 listed 
the sequences of all primers and probes. Primers and probes were synthesized by 
1stBase (Singapore) and dissolved in distilled water at the appropriate 





Table 2.2: Consensus primers’ and specific probes’ sequences used in 
genogrouping assay. 
a








Subgenogroup Sequences (5’- 3’) Length 
VP3Faa ATWWTRGCAYTRGCGGCRGCC 21mer 
EV2ARa TCGCKRGAGCTGTCTTCCCAVA 22mer 
A CTTTAATCTCAATCAATACAAATCCCTCACCCCAGCTTTACCT 43mer 
B1 TACACTTTATCAAATCTTACAATCAAATTGGGGCATCGTCAAAC 44mer 
B2 CAATAAACTATACTTCTTCACTAACAGATGCGCAGGAAAGTC  42mer 
B3 ATACTTCATTCATTCATCAATTCACGTGCACTCCCACCGGC 41mer 
B4 AATCAATCTTCATTCAAATCATCAGCGTGTTCTGACCTGTTGGA 44mer 
B5 CTTTAATCCTTTATCACTTTATCATCACACAGTACAGCAGAGACT  45mer 
C1 TCAATCAATTACTTACTCAAATACAAACTGCTACCAATCCCTCG 44mer 
C2 CTTTTCAAATCAATACTCAACTTTGAGTCTGGCTTGGGGGCT 42mer 
C3 TCATTCATATACATACCAATTCATGAGACCACTCTCGACAGTTTT  45mer 
C4 CAATTTCATCATTCATTCATTTCACCCCTATGGAACTTTCAATT 44mer 
C5 CTTTCTATCTTTCTACTCAATAATAATATATGTTTGTGCCACCA 44mer 
Scramble AAACAAACTTCACATCTCAATAATGCAAGCTCGAGGGAACTA 44mer 
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2.1.4 Principle of the multiplex assay. 
Figure 2.1 summarized the principle of this assay. Consensus primers were 
used for amplification of the VP1 gene. PCR products were cleaned by Exo/SAP 
treatment which removed excess nucleotides and primers. These products were 
subjected to allele specific primer extension (ASPE), which differentiated gene 
sequences with only one nucleotide difference at the 3’ end and only allowed 
amplification of the perfectly complementary probe. Biotin-dCTP was used to 
label the ASPE PCR products, which were hybridized with microspheres through 
the tag and anti-tag nucleotide sequences. Streptavidin-R-phycoerythin was then 
added into the sample for the detection of Biotin. The whole microsphere-PCR 
complex was passed through the detection chamber of the Luminex reader. Red 
laser allowed the classification of the beads and green laser allowed the detection 
of reporter dye. The highest reading of MFI indicated the genogroup of the 
analyte in the sample. Therefore by running the multiplex suspension array, the 



















Figure 2.1: Schematic view of multiplex suspension array for EV71 







2.1.5 Conventional PCR   
Viral RNA extraction was carried out using QIAmp® Viral RNA Mini Kit 
(Qiagen, Valencia, USA) following the manufacturer’s instruction for both tissue 
culture viral isolates and clinical samples. Reverse transcriptase PCR was carried 
out to synthesize cDNA by using MMLV-RT® (Invitrogen, USA) for all 
subgenogroups. VP1 region of EV71 was then amplified by using the consensus 
primers. Briefly, amplification of the 1200 bp region was performed in a 25 µl 
PCR reaction containing 2.5 µl Taq Polymerase buffer, 0.5 µl 10mM dNTP, 0.5 
µl 10mM forward primer, 0.5 µl 10mM reverse primer, 2.5 U  taq polymerase 
(New England BioLabs, Ipswich, USA), 1ul cDNA and 19.5 µl distilled water. A 
1 min denaturation step at 96°C was followed by 40 cycles of amplification with a 
PCR thermocycler (Eppendorf, Hamburg, Germany). Each cycle included a 
denaturation step at 96°C for 30 s, an annealing step at 60°C for 30 s, and an 
elongation step at 72°C for 1min 20s. The final elongation step was prolonged for 
a further 10 min. The PCR product was cleaned by using Exo-Sap-IT (Affymetrix, 





2.1.6 Multiplex allele specific primer extension (ASPE)   
Multiplex ASPE allowed the specific amplification of the PCR product 
differing by single nucleotide. The reaction comprised 2 µl 10X ASPE buffer 
(20mM Tris-HCl,50 mM KCl), 0.5 µl 50mM MgCl2, 1 µl 500nM TAG-ASPE 
probe mix, 1 µl 100uM each of dATP, dGTP, and dTTP, 0.25 µl 400µM biotin-
dCTP, 0.15 µl 5u/ µl Platinum GenoTYPE Tsp DNA polymerase (Invitrogen, 
USA), 5.1 µl distilled water and 10 µl of PCR product, in a total volume of 20 µl. 
The ASPE reactions were incubated at 96°C for 2 min and then subjected to 30 
cycles at 94°C for 30 s, 55°C for 1 min, and 72°C for 2 min. The reactions were 
then held at 4°C until use. 
 
2.1.7 Hybridization assay   
Following multiplex ASPE amplification, 10 µl of each reaction was 
transferred to a tube containing 12 sets of microspheres in 25 µl of 2X Tm 
hybridization buffer (0.4 M NaCl, 0.2 M Tris (pH 8.0), 0.16% Triton X-100) and 
15 µl of distilled water was added to make the final volume to 50 µl. The tube 
was denatured at 96°C for 90 s followed by hybridization at 37°C for 1 hour. 
After incubation, the samples were washed twice with 1X Tm hybridization 
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buffer (0.2 M NaCl, 0.1 M Tris (pH 8.0), 0.08% Triton X-100) and the 
microspheres were resuspended in 75 µl 1X Tm hybridization buffer containing 2 
µg/ml streptavidin-R-phycoerythrin (Invitrogen, USA) and incubated at 37°C for 
15 min. 75 µl of the reactions were transferred to flat-bottom 96-well plate and 
analyzed on the Luminex analyzer. 
 
2.1.8 Plaque assay    
Overnight confluent human rhabdomyosacoma (RD) cells in 24-well plate 
were infected with 10-fold serial dilutions of viruses for 1 h at 37°C. After 
incubation, inoculums were discarded and RD cells were overlaid with 1.2% 
Avicel TM (FMC Biopolymer, Philadelphia, USA). The plates were then incubated 
at 37°C in 5% CO2 for 60 h. Plaques of EV71 were observed by fixing with 20% 
formalin in PBS for 60 min and staining with 1% crystal violet for 30 min at room 
temperature. 
 
2.1.9 Sensitivity test for multiplex suspension array assay 
For subgenogroups A, B2, B4, B5, C1, C2, C4 and C5 with viral isolates, 
sensitivity test was carried out based on how many plaque forming units (pfu) it 
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can detect. Samples were diluted to 1, 5, 20 and 50 pfu for RNA extraction and 
reverse transcription. For subgenogroups B1, B3, C1 and C3 with plasmid clones, 
sensitivity was tested based on how many copies of plasmid it can detect. Serial 
dilutions of plasmids were done in order to get 1, 10, 100, 1000 copies of plasmid 
for analysis.  
 
2.1.10 Cutoff value  
The read-out is the median fluorescence intensity (MFI) and it depends on the 
number of viral particles present. The highest reading of MFI indicated the 
genogroup of the analyte in the sample. The cut of value (COV) that was specific 
for a particular subgenogroup was arbitrarily accepted when the COV was at least 
5 times of the reading for the scramble control and when the COV exceeded 100. 
 
2.2 Clinical sample processing and virus identification  
2.2.1 Clinical sample processing and storage 
Clinical samples were collected from children admitted to Children’s 
Emergency or pediatric wards with suspected HFMD in National University 
Hospital. 43 patients with suspected HFMD were included in this study. A total of 
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51 samples including throat swab, nasal swab, rectal swab, foot ulcer swab, saliva, 
urine and blood were collected from 43 patients.  Nasal, throat, foot ulcer and 
rectal swabs were transferred and stored in Virus Transport Medium (VTM) at 4 
oC and membrane filtered before processing. Saliva and urine were directly 
membrane filtered and also stored at 4 oC. Whole blood sample was collected and 
stored in EDTA tube before centrifugationat 2500 rpm for 15 min at 4oC. Serum 
was collected from supernatant and stored at -20 oC whereas red blood cells at the 
bottom were stored at 4 oC.  
 
2.2.2 Virus isolation  
Enteroviruses from clinical specimens were isolated using human 
rabdomyosarcoma (RD) cells. Briefly, overnight confluent RD cells in a 24-well 
plate were prepared using MEM medium (GIBCO®, Invitrogen, USA) with 10% 
FBS (Biowest, USA). The entire medium was removed from the well in the 
second day and each well was inoculated with 0.1ml of clinical sample into the 
well. The virus and the cells were incubated for around 5 min at room temperature, 
then1ml MEM with 5% FBS was added into the well and incubated at 37oC. For 
virus isolation, viruses went through at most 3 passages. If cytopathic effect (CPE) 
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was observed, virus was successfully isolated. The virus was then harvested and 
stored at -80 oC.  
 
2.2.3 RNA extraction 
Viral RNA extraction was carried out using QIAmp® Viral RNA Mini Kit 
(Qiagen, Valencia, USA) following the manufacturer’s instruction. Briefly,   the 
specimen was first treated with the lysis buffer provided. Then it went through a 
membrane which would retain the released RNA. After washes, RNA was eluted 
in elution buffer and quantified by Nano-drop®.  
 
2.2.4 Reverse Transcription Real-time PCR hybridization assay 
Identification of EV71 in each specimen was carried out by using a reverse 
transcription Real-time PCR hybridization assay. EV71 specific primers and 
probes were applied in this assay as described earlier (Tan, 2006) (Table 2.3). The 
LightCycler RNA amplification hybridization probes kit (Roche, Germany) was 
used in this study. This kit allows a one-step RT-PCR in one single capillary. In 
brief, each 10µL of reaction contained 1µL of RNA, 5mM MgCl2, 0.5mM EV71 
forward primer, 0.3mM EV71 reverse primers, 0.2mM of hybridization probe FL 
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and LC, 2µL hybridization reaction mix, 0.2µL enzyme mix containing reverse 
transcriptase and ‘Faststart’ Taq polymerase and nuclease-free water. cDNA was 
first synthesized at 55°C for 20min, subsequently the target gene was amplified 
for 40 cycles at 95°C for 35s, 55°C for 15s and 72°C for 9s. 
 
2.2.5 Reverse transcription PCR 
Reverse transcription PCR was carried out to synthesize cDNA by using 
MMLV-RT® (Invitrogen, USA). In brief, 1µg of RNA was added into 1µL of 
random primers and topped up to 15µL with nuclease-free water. Then it was 
incubated at 70°C for 5 minutes. After that, 10µL of reverse transcription master 
mix was added and then incubated at 37°C for 1 hour. The reaction was stopped 
at 70°C for 15 minutes.  
 
2.2.6 Enterovirus identification PCR  
3 sets of primers were applied for identification of enterovirus in clinical 
samples (Table 2.3). First, Pan-enterovirus primers (Pan EV) were used for the 
identification of presence of enterovirus in the samples (Robart, 1990 and Zoll, 
1992). The Pan-EV primers amplified a 154bp long region in the 5’untranslated 
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region and PCR product was analyzed using gel electrophoresis. In order to 
identify the type of enterovirus, a pair of primers, 5UTR-F and 5UTR-R (Zoll, 
1992), was chosen to amplify a 439bp long region in the 5’UTR of all 
enteroviruses. PCR product was subjected to gel extraction and sequencing after 
amplification. For confirmation with real-time PCR result, a pair of primers 
targeting the VP1 gene for all genogroups of EV71 was designed. The forward 
primer VP3-Fa and reverse primer EV2A-R amplified a 1200bp long region and 
PCR product underwent gel extraction and sequencing. Primer sequences are 
summarized in Table 2.3. In the amplification step, a 50µL reaction contained 
2µL of cDNA, 5µL of 10X buffer containing MgCl2, 0.2µM of forward and 
reverse primers, 2mM dNTP and 2.5U Taq DNA polymerase (New England 
BioLabs, Ipswich, USA) underwent denaturation step at 94°C for 1min, followed 
by 37 cycles of 94°C for 30s, 58°C for 30s, 72°C for 1min. The final extension 
step was at 72°C for 10 min.  To confirm the identity of non-EV71 enteroviruses, 
primers were designed to amplify the 3’ segment of VP1 (Oberste, 1996b) for 
CA4 (5’-CCTAAGCCTGATGCCCGAGA-3’) and 5’-
TTGTGATCTCAAAGGCCTAGGGA-3’), CA6 (5’-
GTGTCCGTCCCATTCATGTC-3’ and 5’-GTTCTCTGTGGGTCTGCTGG-3’), 
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CA10 (5’-AAACCGACTGGAAGGGATGC-3’ and 5’-
CGATCTCGTGCACTGTTGGC-3’), and CA16 (5’-
TGAAAATGACGGACCCACCA-3’ and 5’-
ATCTTGTCTCTACTAGTGCTGGTG-3’). The processing of clinical samples is 
illustrated in Figure 2.2.  
 
2.2.7 Sequencing  
All amplicons were sequenced for both strands by using the BigDye® Cycle 
Sequencing kit (Applied Biosystems, Singapore) and ABI automated DNA 
sequencer (Applied Biosystems, Singapore). The same primers used for 
amplification and newly designed internal primers were used for sequencing.  
 
2.2.8 VP1 Sequences of EV71 from GenBank 
25 VP1 gene nucleotide sequences were selected from GenBank for the 
construction of phylogenetic tree with current EV71 strains. The selected strains 
were isolated from different parts of the world from 1974 to 2003 and they were 
used by Brown et al. to construct the tripartite genogroup structure of EV71 
(Brown, 1999). In addition, sequences of two fatal strains from 2000 Singapore 
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outbreak and 2008 China outbreak were selected for nucleotide sequence analysis. 




Table 2.3: Primers used in enteroviruses’ identification  




Pan-EV F TCCTCCGGCCCCTGAATGCG 5UTR/All EV 
Pan-EV R ATTGTCACCATAAGCAGCCA 
5’UTR F CAAGCACTTCTGTTTCCCCGG 
5’UTR R ATTGTCACCATAAGCAGCCA 
VP3Faa ATWWTRGCAYTRGCGGCRGCC VP1/EV71 




EvVP1 F GAGAGCTCTATAGGAGATAGTGTG 
EvVP1R TGCCGTACTGTGTGAATTAAGAA 
EvVP1 FLb GATGACTGCTCACCTGTGTGTTTT 
GACC-FL 




 W=A/T, R=A/G, Y=C/T, K=G/T, V=G/C/A. 
b
 EvVP1-FL was labeled with fluorescein at the 3’ end an d EvVP1-LC was 





















Figure 2.2: Flowchart depicting the processing of clinical specimens from 
suspected HFMD patients during the 2008 Singapore epidemic.          .
Patient samples including 
throat, nasal, rectal swabs, 
saliva, urine, blood 
Virus isolation using RD 
cell line 
RNA extraction 
Real-time RT-PCR using EV71-
specific primers and probes 
Classical RT-PCR with pan-




Table 2.4: VP1 gene sequences of 10 Singapore outbreak EV71 strains 
compared with selected enterovirus isolates for phylogenetic analysis and 
dendrogram construction. 
















































2.2.9 Nucleotide sequence analysis 
Sequences from different samples were subjected to nucleotide analysis using 
BLAST available at NCBI (www.ncbi.nlm.nih.gov/blast). ClustalW available at 
EBI (www.ebi.ac.uk/tools/clustalW2/index.html) was applied for multiple 
sequences alignment. 
 
2.2.10 Phylogenetic analysis  
The phylogenetic analysis between current strains and reference strains was 
carried out. A dengrogram was constructed by neighbor-joining method with 
MEGA 4.0 
 
2.3 Neutralization test 
2.3.1 Patient sera  
This was a one year cross-sectional seroprevalence study spanned from 
October 2008 to December 2009. To carry out this survey, 1,078 serum samples 
were collected from children in KK Children and Woman’s Hospital and National 
University Hospital of Singapore under section 7 of the Infectious Disease Act 
(IDA). These serum samples were “leftover samples” which were collected for 
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other diagnostic purposes during the hospitalization of the patients who did not 
have HFMD. Age, gender, race were recorded when the samples were taken. 
Serum samples were membrane-filtered and 60 µl of them was inactivated at 56 
oC for half an hour.   
 
2.3.2 EV71 neutralization test  
For the analysis of seroprevalence against EV71, microneutralization test was 
applied. Briefly, inactivated sera underwent serial dilutions (2-fold dilution) in 96-
well tissue culture plates (NUNC, Thermo Fisher Scientific, Waltham, MA, USA) 
and sample dilutions of 1:8 to 1:1,024 were assayed. An equal volume of EV71 
suspension (5865/sin/0000009) containing 100TCID50 was then added to the 
wells containing serum dilutions. Positive serum and virus titration were also 
included. Serum-virus mixtures were vortexed briefly and incubated for 2 hours at 
37oC. Then serum-virus mixtures, positive serum control and virus control were 
inoculated into overnight confluent Rhabdomyosarcoma (RD) cell (ATCC, USA) 
monolayer in 96-well plates.  Plates were incubated at 37oC in CO2 incubator and 
read daily to record viral cytopathic effect (CPE) for 1 week. The highest dilution 
of serum that neutralized the virus gave the antibody titre. A reference antiserum 
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of known neutralizing activity was included in each test to control reproducibility. 
An antibody titer of >= 8 is considered positive. The geometric mean titer (GMT) 


















CHAPTER 3  
DEVELOPMENT OF BEADS BASED MULTIPLEX 




Hand, foot and mouth disease (HFMD) is a mild form of exanthema that 
mainly affects children and is characterized by fever, ulcers in the mouth and 
vesicles on the palm, limbs and buttocks. Fatalities due to EV71 infection in 
outbreaks in the Asia Pacific region has also been identified since 1997 (McMinn, 
2001a).  
Enterovirus 71 is a positive single stranded RNA virus with a linear genome. 
Four capsid proteins VP1, VP2, VP3 and VP4 were present on the outermost of 
the virus (McMinn, 2001a). Molecular phylogenetic study based on the sequence 
of VP1 gene has grouped strains of EV71 into different genogroups (Brown, 
1999). The choice of VP1 as the gene to genogroup EV71 is based on the fact that 
the VP1 gene sequence data have been shown to infer serotype and VP1 protein is 
the most exposed and immunodominant of the capsid proteins (Oberste, 1999a; 
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Rossmann, 1985). EV71 has been classified into 3 main genogroups A, B and C, 
which is further subgenogrouped into B1 to B5 and C1 to C4 (Brown, 1999; 
Cardosa, 2003; Chan, 2003; Chu, 2001; Hosoya, 2006). In 2005, a previously 
undescribed group C5 was isolated and identified in Vietnam (Tu, 2007).  
HFMD outbreaks have stricken the Asia-Pacific region since 1997 and 
constant outbreaks were identified (Bible, 2007). The circulating subgenogroups 
were found to change constantly through years in many regions and fatality rates 
also varied for different subgenogroups. Although no direct association between 
the severity of HFMD and genetic lineage of EV71 has been established, 
genogrouping of EV71 is important for epidemiological study in both HFMD 
endemic and epidemic and it also facilitates further EV71 virulence studies. 
Many diagnostics methods have been developed for EV71 detection. Cell 
culture and neutralization test were classical methods for enterovirus detection. 
Recently, molecular methods such as RT-PCR (Brown, 2000; Singh, 2002), Real-
time PCR (Tan, 2008a; Tan, 2008b; Tan, 2006) gradually replace the time-
consuming classical methods. But until now, genogrouping of EV71 is still 
dependent on traditional direct DNA sequencing. Sequencing requires a lot of 
work and it is not possible to process the large number of samples during 
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outbreaks. Therefore, with increased outbreaks in the Asia Pacific region, we 
developed a high-throughput EV71 detection platform based on Luminex xTAG 
technology with rapid genogrouping capability, which can be applied in clinical 
diagnostics.  
 
3.2 Results  
3.2.1 Amplification of the VP1 region using consensus primers                            
Consensus primers were initially designed by aligning VP1 sequences of 
different EV71 subgenogroups. It was found that the forward primer overlapped 
with one of the subgenogroup-specific probes, therefore in order to avoid the 
overlapping of primers and probes, VP3 and 2A sequences of different EV71 
strains were aligned and consensus primers were designed from these 2 regions. 
As mentioned in section 2.2.4, the forward primer VP3Fa and reverse primer 
EV2AR were used to amplify the full VP1region of 11 subgenogroups of EV71. 
Gel electrophoresis was carried out after PCR amplification and it was 
demonstrated that the consensus primers were able to amplify 9 reference strains 
of EV71 with viral RNA (Figure 3.1). Subgenogroups A and C1 showed a 
relatively faint band compared to the other strains. It might be due to low viral 
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titer or low binding efficiency. For subgenogroups constructed from plasmid 
clones, amplification was also successful (Figure 3.2).  The desired 1200bp bands 
were observed for all plasmid clones, but smear was present for B1 and C3 which 





















Figure 3.1: Electrophoretic analysis of amplicons generated from consensus 
primers for viral RNA. M – 100bp DNA molecular weight markers; Lane A – 
BrCr; Lane B2 – 7423/MS/87; Lane B3 – MY104-9-SAR-97; Lane B4 – 
5865/sin/000009; Lane B5 – 2933/Yamagata/03; Lane C1 – S10862/SAR/98; 
Lane C2 – Y97-1188; Lane C4 – 75/Yamagata/03; Lane C5 – 3437/Sin/06; Lane -




Figure 3.2: Electrophoretic analysis of amplicons generated from consensus 
primers for plasmid clones. M – 100bp DNA molecular weight markers; Lane 
B3 – MY104-9/SAR/97; Lane C1 – S10862/SAR/98; Lane B1-2609/AUS/74; 
Lane C3- 009/KOR/00; Lane -ve –Negative control (water). 
M       A      B2    B3     B4     B5     C1    C2     C4     C5    -ve 
M                   B3                    C1                    B1                      C3               -ve 
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3.2.2 Design of subgenogroup-specific probes  
Subgenogroup-specific probes were designed by aligning the VP1 region of 
all EV71 subgenogroups. Three strains were chosen for each subgenogroup 
except genogroup A. Therefore, a total of 31 strains were aligned using ClustalW 
for probe design. Figure 3.3 showed the alignment results of the 31 strains. It was 
found that only single nucleotide difference (SNP) (position highlighted in red) 
was present among different subgenogroups except for subgenogroup C1.  All 
these SNPs were positioned at the 3’ end of the probe as required by ASPE 
reaction. Since ASPE needed the probes to have a melting temperature at 51oC to 
56 oC, sequences upstream and downstream of SNPs were analyzed. Letters in 
black shown in Figure 3.4 were sequences chosen for probe design after analysis. . 
Since there was no single nucleotide difference unique for C1, we selected a 
nucleotide position that could distinguish C1 and C3 from the other 9 
subgenogroups, but whose nucleotide polymorphism site was different from the 
C3 probe. The C1 probe was designed to thus identify both C1 and C3, but these 
subgenogroups could be differentiated by the C3 probe reading. Hence, high 
readings of both C1 and C3 probes indicated that the sample was from 
subgenogroup C3, whereas a high reading only for C1 revealed a sample 
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belonging to subgenogroup C1. A tag sequence was added at the 5’ end of the 
probes, which allowed hybridization to the anti-tag sequence of the corresponding 
microsphere. A scramble probe was also designed to use as a negative control. 
Table 3.1 provides information on the sequence and nucleotide composition of all 
probes.  
 
3.2.3 Selection of xTAG microsphere sets  
There were 2 groups of xTAG® microspheres.  Group I microspheres met QC 
specifications of 5000 MFI or greater at 25 femtomoles of biotin-TAG oligo 
target and group II microspheres met QC specifications of 2500 to 5000 MFI. In 
order to make the results comparable, all sets of beads were chosen from group II. 
Every set of beads were coupled to a xTAG® universal sequence know as “anti-
tag”. The complement tag sequence to the anti-tag of the beads were added to the 
probe during oligo-synthesis and followed by secondary structure and hairpin 












7673-CT-87-B2          GATCGAGAGTTCTATAGGAG ACTTACCCAGGCCCTGCCA 
7628-PA-87-B2          GATCGAGAGTTCTATAGGAG ACTTACCCGGGCCCTGCCA 
2222-IA-88-B2          GATCGAGAGTTCTATAGGAG ACTTACCCAGGCCCTGCCA 
2609-AUS-74-B1         GATCGAGAGCTCTATAGGAG ACTTACCCAGGCCCTGCCA 
2258-CA-79-B1          GATTGAGAGTTCTATAGGGG ACTAACCCAGGCCCTGCCA 
2234-NY-77-B1         GATCGAGAGCTCTATAGGAG ACTCACCCAGGCCCTGCCA 
MY821-3-SAR-97-B3     GATTGAGAGCTCTATAGGAG ACTTACCCAGGCTCTGCCA 
26M-AUS-2-99-B3        GATCGAGAGCTCTATAGGAG ACTTACCCAGGCCCTGCCA 
MY104-9-SAR-97-B3      GATCGAGAGCTCTATAGGAG ACTTACCCAGGCCCTGCCA 
CN4104-SAR-00-B4      GATAGAGAGCTCTATAGGAG ACTTACCCAGGCCCTGCCA 
2027-SIN-01-B4         GATAGAGAGCTCTATAGGAG ACTTACCCAGGCCCTGCCA 
SB2864-SAR-00-B4       GATCGAGAGCTCTATAGGAG ACTTACCCAGGCCCTGCCA 
S23141-SAR-03-B5       GATCGAGAGCTCTATAGGAG ACTCACCCAGGCCCTGCCA 
S19871-SAR-03-B5       GATCGAGAGCTCTATAGGAG ACTCACCCAGGCCCTGCCA 
S19841-SAR-03-B5       GATCGAGAGCTCTATAGGAG ACTCACCCAGGCCCTGCCA 
S11051-SAR-98-C1       GATTGAGAGTTCTATAGGGG TCTCACCCAAGCTTTACCG 
0926-OR-91-C1         GATTGAGAGTTCTATAGGGG TCTCACCCAAGCTCTACCG 
1M-AUS-12-00-C1        GATTGAGAGTTCTATAGGGG TCTCACCCAAGCTTTACCA 
009-KOR-00-C3          GATCGAGAGTTCCATAGGGG CCTCACCCAAGCTCTACCA 
011-KOR-00-C3          GATCGAGAGTTCCATAGGGG CCTCACCCAAGCTCTACCA 
010-KOR-00-C3          GATCGAGAGTTCCATAGGGG CCTCACCCAAGCTCTACCA 
2644-AUS-95-C2         GATTGAGAGTTCTATAGGGG CCTCACCCGAGCTCTACCG 
2286-TX-97-C2          GATTGAGAGTTCTATAGGGG TCTCACCCAAGCTCTACCG 
2M-AUS-3-99-C2         GATTGAGAGTTCTATAGGGG CCTCACCCGAGCTCTACCG 
H25-CHN-00-C4          AATTGAGAGTTCCATAGGAG CCTCACCCAAGCTCTACCG 
H26-CHN-00-C4          AATTGAGAGTTCCATAGGAG CCTCACCCAAGCTCTACCG 
F2-CHN-00-C4           AATTGAAAGTTCCATAGGGG CCTCACTCAAGCTCTACCG 
BrCr-CA-70-A           GATTGAGAGCTCTATAGGAG CCTCACCCCAGCTTTACCT 
999T/VNM/05-C5         GATTGAAAGTTCTATAGGGG CCTCACCCAAGCCCTACCG 
1277S/VNM/05-C5        GATTGAAAGTTCTATAGGGG CCTCACCCAAGCCCTACCG 













7673-CT-87-B2          ACCCACAGGTCAAAACACAC AAATTGGGGCATCGTCAAAT 
7628-PA-87-B2          ACCCACAGGTCAAAACACAC AAATTGGGGCATCGTCAAAT 
2222-IA-88-B2          ACCCACAGGTCAAAACACAC AAATTGGGGCATCGTCAAAT 
2609-AUS-74-B1         ACCCACAGGTCAAAACACAC AAATTGGGGCATCGTCAAAC 
2258-CA-79-B1          ACCCACAGGTCAAAACACAC AAATTGGGGCATCGTCAAAC 
2234-NY-77-B1         ACCCACAGGTCAAAACACAC AAATTGGGGCATCGTCAAAC 
MY821-3-SAR-97-B3     ACCCACAGGTCAAAACACAC AAATTGGGGCATCGTCAAAT 
26M-AUS-2-99-B3        ACCCACAGGTCAAAACACAC AAATTGGGGCATCGTCAAAT 
MY104-9-SAR-97-B3      ACCCACAGGTCAAAACACAC AAATTGGGGCATCGTCAAAT 
CN4104-SAR-00-B4      TCCAACAGGTCAGAACACGC AAATTGGGGCATCGTCAAAT 
2027-SIN-01-B4         TCCAACAGGTCAGAACACGC AAATTGGGGCATCGTCAAAT 
SB2864-SAR-00-B4       TCCAACAGGTCAGAACACGC AAATTGGGGCATCGTCAAAT 
S23141-SAR-03-B5       ACCCACAGGTCAAAACACAC AGATCGGGGCATCGTCAAAT 
S19871-SAR-03-B5       ACCCACAGGTCAAAACACAC AGATCGGGGCATCGTCAAAT 
S19841-SAR-03-B5       ACCCACAGGTCAAAACACAC AGATCGGGGCATCGTCAAAT 
S11051-SAR-98-C1       ACCCACAGGCCAGAATACGC AGATTGGAGCATCATCAAAT 
0926-OR-91-C1         ACCCACAGGCCAGAACACGC AAATTGGAGCATCATCAAAT 
1M-AUS-12-00-C1        ACCCACAGGCCAGAACACGC AAATTGGAGCATCATCAAAT 
009-KOR-00-C3          ACCCACAGGCCAGAACACAC AAATTGGAGCATCATCAAAT 
011-KOR-00-C3          ACCCACAGGCCAGAACACAC AAATTGGAGCATCATCAAAT 
010-KOR-00-C3          ACCCACAGGCCAGAACACAC AAATTGGAGCATCATCAAAT 
2644-AUS-95-C2         ACCTACAGGCCAAAATACGC AAATTGGAGCATCATCAAAT 
2286-TX-97-C2          ACCTACAGGCCAAAATACGC AAATCGGAGCATCATCGAAT 
2M-AUS-3-99-C2         ACCTACAGGTCAAGATACGC AAATTGGAGCATCATCAAAT 
H25-CHN-00-C4          ACCCACAGGCCAGAACACAC AAATTGGAGCATCATCAAAT 
H26-CHN-00-C4          ACCCACAGGCCAGAACACAC AAATTGGAGCATCATCAAAT 
F2-CHN-00-C4           ACCCACAGGCCAGAACACAC AAATTGGAGCGTCATCGAAT 
BrCr-CA-70-A           ACCCACAGGCCCAGACACCC AAATCGGAGCTTCGTCGAAT 
999T/VNM/05-C5         ACCTACAGGCCAGAACACGC AGATTGGAGCATCGTCAAAT 
1277S/VNM/05-C5        ACCTACAGGCCAGAACACGC AGATTGGAGCGTCGTCAAAT 










7673-CT-87-B2          TCACATAGCACAGCAGAGACC GAGACCACCTTGGACAGTTTC 
7628-PA-87-B2          TCACATAGCACAGCAGAGACC GAGACCACCTTGGATAGTTTC 
2222-IA-88-B2          TCACATAGCACAGCAGAGACC GAGACCACCTTGGACAGTTTC 
2609-AUS-74-B1         TCACATAGCACAGCAGAAACC GAAACCACTTTGGATAGCTTC 
2258-CA-79-B1          TCACATAGTACAGCAGAAACC GAAACCACTTTGGACAGCTTC 
2234-NY-77-B1         TCACATAGTACAGCAGAAACC GAAACCACTTTGGACAGCTTC 
MY821-3-SAR-97-B3     TCACACAGCACAGCGGAAACC GAAACCACCTTGGATAGCTTC 
26M-AUS-2-99-B3        TCACACAGCACAGCAGAAACC GAAACCACCTTGGATAGCTTC 
MY104-9-SAR-97-B3      TCACACAGCACAGCAGAAACC GAAACCACCTTGGATAGCTTC 
CN4104-SAR-00-B4      TCACACAGTACGGCAGAGACC GAGACCACCTTGGACAGCTTC 
2027-SIN-01-B4         TCACACAGTACGGCAGAGACC GAGACCACCTTGGACAGCTTC 
SB2864-SAR-00-B4       TCACACAGTACGGCAGAGACC GAGACCACCTTGGACAGCTTC 
S23141-SAR-03-B5       TCACACAGTACAGCAGAGACT GAGACTACCCTGGACAGTTTC 
S19871-SAR-03-B5       TCACACAGTACAGCAGAGACT GAGACTACCCTGGACAGTTTC 
S19841-SAR-03-B5       TCACACAGTACAGCAGAGACT GAGACTACCCTGGACAGTTTC 
S11051-SAR-98-C1       TCGCACAGCACAGCTGAGACC GAGACCACCCTAGATAGTTTC 
0926-OR-91-C1         TCGCACAGCACAGCTGAGACC GAGACCACTCTCGATAGTTTC 
1M-AUS-12-00-C1        TCGCACAGCACAGCTGAGACC GAGACCACTCTCGATAGTTTC 
009-KOR-00-C3          TCGCACAGTACAGCTGAGACC GAGACCACTCTCGACAGTTTT 
011-KOR-00-C3          TCGCACAGTACAGCTGAGACC GAGACCACTCTCGACAGTTTT 
010-KOR-00-C3          TCGCATAGTACAGCTGAGACC GAGACCACTCTCGACAGTTTT 
2644-AUS-95-C2         TCACATAGCACAGCTGAGACC GAGACCACTCTTGATAGCTTC 
2286-TX-97-C2          TCACACAGCACAGCTGAGACC GAGACCACTCTTGATAGCTTC 
2M-AUS-3-99-C2         TCACATAGCACAGCTGAGACC GAGACCACTCTTGATAGCTTC 
H25-CHN-00-C4          TCGCACAGCACAGCTGAGACC GAGACCACTCTCGATAGTTTC 
H26-CHN-00-C4          TCGCACAGCACAGCTGAGACC GAGACCACTCTCGATAGTTTC 
F2-CHN-00-C4           TCGCACAGCACAGCTGAGACC GAGACCACTCTCGATAGTTTC 
BrCr-CA-70-A           TCACATAGCACAGCTGAAACC GAAACCACCCTTGATAGTTTC 
999T/VNM/05-C5         TCGCACAGCACGGCTGAAACC GAAACCACTCTCGACAGCTTC 
1277S/VNM/05-C5        TCGCACAGTACGGCTGAAACC GAAACCACTCTCGACAGCTTC 














7673-CT-87-B2          CAGATGCGCAGGAAAGTC CGTGTACCCCTACTGGT 
7628-PA-87-B2          CAGATGCGCAGGAAAGTC CGTGTACCCCTACTGGT 
2222-IA-88-B2           CAGATGCGCAGGAAAGTC CGTGTACCCCTACTGGT 
2609-AUS-74-B1         CAGATGCGCAGGAAAGTG CGTGTACCCCTACTGGT 
2258-CA-79-B1          CAGATGCGCAGGAAAGTG CGTGTACCCCTACTGGT 
2234-NY-77-B1          CAGATGCGCAGGAAAGTG CGTGTACCCCTACTGGT 
MY821-3-SAR-97-B3     CAGATGCGCAGGAAAGTG CGTGCACTCCCACCGGC 
26M-AUS-2-99-B3        CAGATGCGCAGGAAAGTG CGTGCACTCCCACCGGC 
MY104-9-SAR-97-B3      CAGATGCGCAGGAAAGTG CGTGCACTCCCACCGGC 
CN4104-SAR-00-B4      CAGATGCGCAGGAAAGTG CGTGCACTCCTACTGGT 
2027-SIN-01-B4          CAGATGCGCAGGAAAGTG CGTGCACTCCTACTGGT 
SB2864-SAR-00-B4       CAGATGCGCAGGAAAGTG CGTGCACTCCTACTGGT 
S23141-SAR-03-B5       CAGATGCGCAGGAAAGTG CGTGCACTCCTACTGGT 
S19871-SAR-03-B5       CAGATGCGCAGGAAAGTG CGTGCACTCCTACTGGT 
S19841-SAR-03-B5       CAGATGCGCAGGAAAGTG CGTGCACTCCTACTGGT 
S11051-SAR-98-C1       CAAATGCGCAGAAAGGTG CATGTACGCCTACCGGG 
0926-OR-91-C1          CAAATGCGTAGAAAGGTG CGTGCACGCCCACCGGG 
1M-AUS-12-00-C1        CAAATGCGTAGAAAGGTG CATGTACACCCACCGGG 
009-KOR-00-C3          CAAATGCGTAGAAAAGTG CGTGCACGCCTACCGGG 
011-KOR-00-C3          CAAATGCGTAGAAAAGTG CGTGCACGCCTACCGGG 
010-KOR-00-C3          CAAATGCGTAGAAAAGTG CGTGCACGCCTACCGGG 
2644-AUS-95-C2         CAAATGCGTAGAAAGGTG CATGCACGCCTACCGGG 
2286-TX-97-C2          CAAATGCGTAGAAAGGTG CGTGCACGCCTACCGGG 
2M-AUS-3-99-C2         CAAATGCGTAGAAAGGTG CGTGCACGCCTACCGGG 
H25-CHN-00-C4          CAAATGCGTAGAAAGGTG CGTGCACACCCACCGGG 
H26-CHN-00-C4          CAAATGCGTAGAAAGGTG CGTGCACACCCACCGGG 
F2-CHN-00-C4           CAAATGCGTAGAAAAGTG CGTGTACACCCACTGGG 
BrCr-CA-70-A           CAGATGCGCAGAAAAGTG CGTGCACACCTACCGGA 
999T/VNM/05-C5         CAAATGCGCAGGAAAGTG CGTGCACGCCTACCGGG 
1277S/VNM/05-C5        CAAATGCGCAGGAAGGTG CGTGCACGCCTACCGGG 







Figure 3.3: Alignment results of the VP1 region of 31 EV71 strains. Letters in 
red indicate the single nucleotide difference observed for corresponding 






7673-CT-87-B2          AGTATATGTTTGTTCCCCCT CGCTCCCAAACCAGAATC AGACTGCTACAAACCCCTCA 
7628-PA-87-B2          AGTATATGTTTGTTCCCCCT CGCTCCCAAACCAGAATC AGACTGCTACAAACCCCTCA 
2222-IA-88-B2           AGTATATGTTTGTTCCCCCT TGCTCCCAAACCAGAATC AGACTGCTACAAACCCCTCA 
2609-AUS-74-B1         AGTATATGTTTGTTCCCCCT CGCTCCCAAGCCAGAATC AGACTGCTACAAACCCCTCA 
2258-CA-79-B1          AGTATATGTTTGTTCCCCCT CGCTCCCAAACCAGAATC AGACTGCTACAAACCCCTCA 
2234-NY-77-B1          AGTATATGTTTGTTCCCCCT CGCTCCCAAGCCAGAATC AGACTGCTACAAACCCCTCA 
MY821-3-SAR-97-B3     AGTATATGTTTGTTCCCCCT TGCTCCCAAACCAGAATC AAACAGCCACAAACCCCTCA 
26M-AUS-2-99-B3        AGTATATGTTTGTTCCCCCT TGCTCCCAAACCAGAATC AAACAGCCACAAACCCCTCA 
MY104-9-SAR-97-B3      AGTATATGTTTGTTCCCCCT TGCTCCCAAACCAGAATC AAACAGCCACAAACCCCTCA 
CN4104-SAR-00-B4      AGTATATGTTTGTTCCCCCT TGCTCCTAAACCAGAGTC AGACAGCCACGAACCCCTCA 
2027-SIN-01-B4          AGTATATGTTTGTTCCCCCT TGCTCCCAAACCAGAGTC AGACAGCCACGAACCCCTCA 
SB2864-SAR-00-B4       AGTATATGTTTGTTCCCCCT TGCTCCCAAACCAGAGTC AGACAGCCACGAACCCCTCA 
S23141-SAR-03-B5       AGTATATGTTTGTTCCCCCT TGCTCCTAAACCAGATTC AGACAGCCACAAACCCTTCA 
S19871-SAR-03-B5       AGTATATGTTTGTTCCCCCT TGCTCCTAAACCAGATTC AGACAGCCACAAACCCTTCA 
S19841-SAR-03-B5       AGTATATGTTTGTTCCCCCT TGCTCCTAAACCAGATTC AGACAGCCACAAACCCTTCA 
S11051-SAR-98-C1       AATATATGTTTGTGCCACCT GGCCCCCAAGCCAGACTC AAACTGCTACCAATCCCTCG 
0926-OR-91-C1          AATATATGTTTGTGCCACCT GGCCCCCAAGCCAGACTC AAACTGCCACCAATCCCTCG 
1M-AUS-12-00-C1        AATACATGTTTGTGCCACCT GGCTCCCAAGCCAGACTC AAACTGCCACCAATCCCTCG 
009-KOR-00-C3          AATATATGTTTGTACCACCT GGCCCCCAAACCGGATTC AAACTGCTACCAATCCCTCG 
011-KOR-00-C3          AATATATGTTTGTACCACCT GGCCCCCAAGCCGGACTC AAACTGCTACCAATCCCTCG 
010-KOR-00-C3          AATATATGTTTGTACCACCT GGCCCCCAAGCCGGACTC AAACTGCTACCAATCCCTCG 
2644-AUS-95-C2         AATATATGTTTGTACCACCC AGCCCCCAAGCCAGACTC AAACTGCCACTAATCCCTCA 
2286-TX-97-C2          AATATATGTTTGTACCACCC AGCCCCCAAGCCAGACTC AAACTGCCACTAATCCCTCA 
2M-AUS-3-99-C2         AGTATATGTTTGTACCACCC AGCCCCCAAACCAGACTC AGACTGCCACTAATCCCTCA 
H25-CHN-00-C4          AATATATGTTTGTGCCACCT GGCCCCCAAGCCAGATTC AAACTGCTACCAACCCCTCA 
H26-CHN-00-C4          AATATATGTTTGTGCCACCT GGCCCCCAAGCCAGATTC AAACTGCTACCAACCCCTCA 
F2-CHN-00-C4           AATATATGTTTGTGCCACCT GGCCCCCAAGCCAGATTC AAACTGCTACCAACCCCTCA 
BrCr-CA-70-A           AATACATGTTTGTTCCACCC GGCCCCCAAACCAGACTC CAACGGCCACGAACCCCTCA 
999T/VNM/05-C5         AATATATGTTTGTGCCACCA GGCTCCAAAGCCAGACTC AAACTGCCACCAATCCCTCA 
1277S/VNM/05-C5        AATATATGTTTGTGCCACCA GGCTCCAAAGCCAGACTC AAACTGCCACCAATCCCTCA 







Table 3.1: Sequences, nucleotide composition and melting temperature of 
probes used in genogrouping assay. Red letter indicates the SNP site.  
 
Genogroup Probe sequences GC% Melting 
temperature 
(oC) 
A 5’-CCTCACCCCAGCTTTACCT-3’ 57.9 55.5 
B1 5’-AAATTGGGGCATCGTCAAAC-3’ 45 59 
B2 5’-CAGATGCGCAGGAAAGTC-3’ 55.6 52.5 
B3 5’-CGTGCACTCCCACCGGC-3’ 76.5 61.6 
B4 5’-GCGTGTTCTGACCTGTTGGA-3’ 55 57.5 
B5 5’-TCACACAGTACAGCAGAGACT-3’ 47.6 48.2 
C1 5’- AAACTGCTACCAATCCCTCG-3’ 50 56.1 
C2 5’- GAGTCTGGCTTGGGGGCT-3’ 66.7 58.1 
C3 5’- GAGACCACTCTCGACAGTTTT-3’ 47.6 52.2 
C4 5’- CCCCTATGGAACTTTCAATT-3’ 40 53 
C5 5’- AATATATGTTTGTGCCACCA-3’ 35 50.2 
Scramble 5’-GCAAGCTCGAGGGAACTA-3’ 55.6 51.9 
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3.2.4 Specificity of probes designed for EV71 genogrouping                         
The optimal temperature for ASPE was determined by running the test using 
reference strains with viral RNA at temperature of 53oC, 55 oC and 58 oC. At 53oC, 
all subgenogroups were detected and genogrouped specifically but readings for 
B5, C2 and C4 were below one thousand which was considered as low signal 
(Table 3.2). It was also shown that 8 out of 11 probes used at this temperature 
gave at least one relatively high non-specific reading for other genogroups.  At 
58oC, the assay failed to detect subgenogroup A and C4 and readings for B5 and 
C2 did not improve (Table 3.3). It was also noticed that readings for genogroup B 
were reduced substantially compared to those at the previous temperature (53oC), 
although number of probes giving non-specific readings also reduced by 1.  At 55 
oC, all the subgenogroups were detected with higher readings. Readings for B5 
and C4 were considerably increased to over a thousand and C2 even had a reading 
of more than 3000 (Table 3.4). There were still 7 probes giving non-specific 
readings more than 100, but these signals were negligible when compared to the 
high specific readings. From results above, 55°C was decided to be the optimal 
temperature for ASPE reaction. Therefore genogrouping assay was repeated 4 
times using all reference strains at 55°C.  
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A mixture of 11 subgenogroup-specific probes and 1 scramble probe were 
hybridized to VP1 PCR products of reference strains representing 11 
subgenogroups and Coxsackiervirus A16 was used as a negative control. It was 
found that all the probes were able to identify its specific subgenogroup and 
negative control and scramble probe gave non-significant readings (Table 3.5). 
Due to the difference in concentration of PCR products and sensitivity of 
subgenogroup-specific probe, signal generated was between one thousand and 
eight thousand. It was noticed that the C1 probe can detect both subgenogroups 
C1 and C3, which was expected according to probe design. Average readings of 
probes from repeated experiments for all subgenogroups except B5 and C4 were 
at least 3000 and at least 10 times more than the non-specific readings of 
corresponding probe. Although B5 and C4 probes only had an average reading 
around 1300, the signals were more than enough to distinguish these 2 from other 
genogroups since non-specific readings were all below 150. Non-specific readings 
above 200 were underlined in Table 3.5. It was found that probes for genogroup B 
had a lower specificity because cross-reactivity was observed for B1, B2 and B3. 
B2 probe showed cross activity for 4 genogroups and gave a very high non-
specific reading of 1395 for strain 2609-AUS-74 which was constructed by 
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cloning. It is postulated that the high signal observed was a result ofboth the cross 
activity of the B2 probe and the high plasmid concentration of 2609-AUS-74. If 
compared with the respective specific reading, there was still a 6 times difference. 
Probe of B1 and B3 also gave relatively strong non-specific signals but may also 
be considered trivial as compared to specific readings. For genogroup C, no cross-
activity was observed except for C1.  Probe C1 gave a signal one tenth of the 










Table 3.2: Readings of EV71 subgenogroup-specific probes to 11 reference 





A  B1  B2  B3  B4  B5  C1  C2  C3  C4  C5 
BrCr  1743 47 0 29 81 62 0 0 75 0 178 
7423/MS/87 22 48 3078 39 58 81 108 56 218 35 162 
MY104-9-SAR-97 77 72 205 3678 46 150 0 28 0 45 168 
5865/sin/000009 135 51 19 68 1265 0 77 0 79 42 126 
2933-Yamagata-03 27 118 91 0 79 442 73 48 101 48 202 
S10862-SAR-98 43 69 55 76 54 0 4135 27 42 96 126 
Y97-1188 16 117 5 53 45 70 200 394 10 57 161 
75-Yamagata-03 27 1 17 223 47 138 209 7 92 797 176 









Table 3.3: Readings of EV71 subgenogroup-specific probes to 11 reference 













A  B1  B2  B3  B4  B5  C1  C2  C3  C4  C5 
BrCr  127 97 56 46 39 2 302 44 24 86 99 
7423/MS/87 122 57 1553 0 24 92 236 29 150 0 266 
MY104-9-SAR-97 0 77 104 1629 73 306 59 45 107 11 215 
5865/sin/000009 50 28 67 65 1052 38 24 6 137 28 181 
2933-Yamagata-03 0 24 12 14 0 507 101 44 75 0 82 
S10862-SAR-98 80 0 121 77 46 0 5492 51 41 37 79 
Y97-1188 0 61 59 19 61 65 21 296 108 6 168 
75-Yamagata-03 121 0 50 61 35 165 0 64 0 31 199 









Table 3.4: Readings of EV71 subgenogroup-specific probes to 11 reference 

















A  B1  B2  B3  B4  B5  C1  C2  C3  C4  C5 
BrCr  3021 29 32 19 0 30 24 66 22 13 49 
7423/MS/87 37 304 6885 39 31 67 48 37 55 30 39 
MY104-9-SAR-97 22 189 637 7671 40 92 39 40 40 33 46 
5865/sin/000009 43 212 408 52 6063 103 90 45 62 54 34 
2933-Yamagata-03 46 106 420 28 30 1529 29 23 35 21 49 
S10862-SAR-98 23 39 13 18 11 40 3598 137 20 10 79 
Y97-1188 45 115 38 16 62 83 135 3657 37 25 178 
75-Yamagata-03 61 153 28 625 71 139 149 204 42 1844 95 
3437/Sin/06 37 383 28 27 34 41 189 104 37 26 4470 
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            Table 3.5: Average readings of EV71 subgenogroup-specific probes to 11 reference strains in genogrouping assay. 
 
VP1 PCR products 
EV71 subgenogroup-specific probes   
A  B1  B2  B3  B4  B5  C1  C2  C3  C4  C5 Scramble 
Blank 10 11 7 12 12 14 10 12 17 14 30 64 
BrCr  3244 20 23 11 10 16 15 44 14 11 38 25 
2609-AUS-74 77 8414 1395 98 121 150 84 66 84 44 46 30 
7423/MS/87 17 208 5832 18 18 36 24 17 27 14 33 23 
MY104-9-SAR-97 16 148 520 6738 23 56 21 19 20 15 34 59 
5865/sin/000009 23 148 346 25 4691 78 37 20 28 21 33 32 
2933-Yamagata-03 23 51 384 18 22 1368 20 18 19 14 37 25 
S10862-SAR-98 23 29 11 14 11 21 4761 130 17 14 73 3 
Y97-1188 25 53 16 13 27 43 199 3185 23 12 149 31 
009-KOR-00 122 142 37 27 46 114 9984 26 3903 37 130 50 
75-Yamagata-03 26 58 16 426 35 59 57 104 24 1284 58 54 
3437/Sin/06 29 777 28 22 35 38 415 92 53 22 5292 29 
CA16 25 7 0 4 20 0 0 14 10 2 38 37 
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3.2.5 Detection and genogrouping of EV71from viral isolates                        
Besides reference strains, other EV71 viral isolated were also obtained from 
various sources. There were a total of 11 other viral isolates tested. These strains 
were isolated in Malaysia, Japan or Singapore in different years and phylogenetic 
studies were used to identify which genogroup they were belonging to. Our assay 
successfully genogrouped them and results obtained were identical to what was 
found from phylogenetic tree (Table 3.6). Cross-activity was strong for probe C1 
which was observed in our previous tests before, but specific signal also increased 
proportionally. Probes of B1 and B3 were also found to have non-specific 
readings above 100. Although non-specific readings were still present, correct 
genogroup of tested strains could be easily identified. It was also noticed that 
readings for some of the viral samples were low; it was most probably due to the 
low viral titer in the tested sample. 
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                        Table 3.6: Specificity of EV71 subgenogroup-specific probes to 11 viral isolates in genogrouping assay. 
 
VP1 PCR products 
EV71 subgenogroup-specific probes   
A  B1  B2  B3  B4  B5  C1  C2  C3  C4  C5 Scramble 
Blank 3 0 3 16 11 15 0 14 0 28 21 30 
90-3205 18 376 1173 24 26 292 20 30 29 15 27 11 
93-2008 21 324 1214 28 30 175 4 15 31 13 36 12 
SB0635/SAR/00 18 78 50 9 1466 22 10 16 10 10 33 8 
90-3761 26 164 27 242 33 70 7889 148 35 24 173 0 
90-2913 9 36 18 118 14 18 7665 75 111 19 84 19 
90-3896 11 16 10 84 14 14 4506 29 67 16 54 24 
4381/SIN/02 27 115 24 25 19 23 7214 97 145 21 146 40 
4575/SIN/98 47 101 14 14 16 19 4656 30 51 16 80 8 
97-865 34 60 23 28 31 71 1291 4066 59 16 181 32 
97-1134 33 62 15 22 29 53 1038 3652 47 18 163 27 
3406/Sin/08 21 1172 29 17 36 34 640 80 68 18 6113 16 
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3.2.6 Detection limit  
Virus titer of reference strains from subgenogroups A, B2, B4, B5, C1, C2, C4 
and C5 were successfully determined by plaque assay. Upon dilution, 1, 5, 20 and 
50 pfu were obtained for analysis. Gel electrophoresis was carried out for each 
dilution after amplification using consensus primers by conventional PCR. It was 
noticed that subgenogroups A, B2, B5, C1, C2 and C5 were able to produce 
visible bands at 50 pfu or less (Figure 3.4). The highest affinity was observed in 
genogroup C2 which gave a faint band at even 1 pfu. In contrast, subgenogroup 
B4 did not show any bands even at the highest concentration and C4 only 
displayed a very faint band at 50 pfu. Therefore, it was concluded that the 
sensitivity of the assay was different for subgenogroups due to differences in 
binding efficiency to consensus primers. Table 3.7 showed the number of pfu 
needed for detection of these 8 subgenogroups. The highest sensitivity was 
observed in genogroup C, C1, C2 and C5 probes were able to detect the virus as 
low as 1 pfu whereas subgenogroup C4 had a relatively low sensitivity at 50 pfu. 
Comparing to genogroup C, probes of genogroups A and B were less sensitive, as 
the detection limit of A, B2 and B5 was 5 pfu. It was realized that the detection 
limit correlated well with gel electrophoresis results. In other words, when a band 
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was produced after gel electrophoresis, the Luminex system was able to detect it 
using the ASPE assay. In addition, even when no bands were observed at 5 and 1 
pfu for subgenogroups B5 and C5, the virus was still detected with low signal, 
indicating the high sensitivity of these 2 probes. Since no positive results of 
subgenogroup B4 was observed for 1 to 50 pfu, we further increased the amount 
of virus to 100 pfu and it was found that  at least 100 pfu for B4 were required.  
On the other hand, 1, 10, 100 and 1000 copies of plasmid were tested for 
subgenogroups B1, B3, C1 and C3 with plasmid clones (Table 3.7). Conventional 
PCR with consensus primers were also followed by gel electrophoresis. All 
plasmids had the ability to show bands at 10,000 copies but none of them showed 
band at 100 copies (Figure 3.5), however all 4 subgenogroups can be detected by 
beads based multiplex suspension assay using the Luminex reader if there were at 
least 100 copies of plasmid. B1, B3 and C1 gave high signal although C3 only 
had a signal just above cut-off value. It is likely that the probe for C3 had a lower 
sensitivity.  
Therefore, it was concluded that most of the subgenogroups could be detected 
at the titer of 5 pfu except for B4 and C4 which required at least 100 and 50 pfu to 






Figure 3.4a: Gel electrophoresis of PCR products by using consensus primers 
for viral RNA. Lane 1 to 4 – 1, 5, 20, 50 pfu of BrCr (subgenogroup A); Lane 5 
to 8 –1, 5, 20, 50 pfu of 7423/MS/87 (subgenogroup B2); Lane 9 to 12 –1, 5, 20, 
50 pfu of 5865/sin/0000009 (subgenogroup B4); Lane 13 to 16 –1, 5, 20, 50 pfu 




Figure 3.4b: Gel electrophoresis of PCR products by using consensus 
primers for viral RNA. Lane 1 to 4 –1, 5, 20, 50 pfu of Y90-3761 
(subgenogroup C1); Lane 5 to 8 –1, 5, 20, 50 pfu of Y97-1188 (subgenogroup 
C2); Lane 9 to 12 –1, 5, 20, 50 pfu of 75-Yamagata-03 (subgenogroup C4); Lane 
13 to 16 –1, 5, 20, 50 pfu of 3437/Sin/06 (subgenogroup C5). 
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Figure 3.5: Gel electrophoresis of PCR products by using consensus primers 
for plasmid clones. Lane 1 to 3 – 104, 103, 102 copies of S10862-SAR-98 
(subgenogroup C1); Lane 4 to 6 –104, 103, 102 copies of MY104-9-SAR-97 
(subgenogroup B3); Lane 7 to 9 -104, 103, 102 copies of 009-KOR-00 
(subgenogroup C3); Lane 10 to 12 - 104, 103, 102 copies of 2609-AUS-74 
(subgenogroup B1).








Table 3.7: Detection limit of EV71 genogroup-specific probes to reference 









Plaque forming units 
1 5 20 50 100 
A BrCr  12 841 1374 2619 - 
B2 7423/MS/87 54 1412 1336 3114 - 
B4 5865/sin/000009 10 17 20 33 186 
B5 2933-Yamagata-03 42 441 1062 1144 - 
C1 Y90-3761 282 2150 6740 7678 - 
C2 Y97-1188 279 1549 1898 2116 - 
C4 75-Yamagata-03 21 26 64 578 - 
C5 3437/Sin/06 209 1413 2948 3186 - 
 
Copies of Plasmid 
1 10 100 1000 
  
B1 2609-AUS-74 9 41 1640 4464 
B3 MY104-9-SAR-97 11 18 1273 3603 
C1 S10862-SAR-98 29 55 877 2802 
C3 009-KOR-00 14 25 176 2136 
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3.2.7 Detection and genogrouping of EV71 from clinical samples 
55 clinical samples from HFMD suspected patients were collected from NUH. 
All the samples underwent conventional PCR and direct DNA sequencing to 
identify the viruses in the sample. There were 39 samples found to be enterovirus 
positive and it was further shown that 11 samples were positive for EV71. On the 
other hand, these clinical samples were also tested using genogrouping assay. 11 
samples showed readings more than the cut-off value of 100 MFI; the other 44 
samples did not give significant signals (data not shown). The genogrouping 
results of EV71 positive clinical samples shown by genogrouping assay were 1 
B4, 8 B5 and 2 C2 (Table 3.8), which was consistent with PCR and sequencing 
results of EV71 positive samples. Signals produced from clinical samples varied 
from 100 to 3000 MFI and a high reading indicated high virus titer. Strong cross-











EV71 subgenogroup-specific probes   
A  B1  B2  B3  B4  B5  C1  C2  C3  C4  C5 Scramble 
1 15 14 20 9 7 799 8 4 10 10 30 28 
2 12 10 8 8 10 116 11 14 9 5 31 44 
3 15 5 30 17 11 1167 10 10 10 12 32 35 
4 21 79 142 22 18 1921 11 15 27 12 31 18 
5 28 115 32 15 14 1431 9 3333 16 13 450 16 
6 0 12 14 26 10 432 10 12 7 11 32 24 
7 31 99 10 12 22 26 13 3201 19 16 263 14 
8 14 23 58 165 12 1761 19 8 28 12 33 13 
9 18 13 25 7 1 1025 9 9 8 3 33 14 
10 16 10 28 9 11 1474 12 6 10 3 33 15 
11 49 91 122 6 4037 22 0 24 23 38 20 20 
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3.3 Discussion  
Different types of methods such as serological assay (Zhou, 2008), molecular 
assay (Brown, 2000; Singh, 2002; Tan, 2008a; Tan, 2008b; Tan, 2006; Xiao, 
2009), microarray (Chen, 2006) and image-based assays (Ghukasyan, 2007) have 
been developed for EV71 detection. But in terms of genogrouping, direct DNA 
sequencing and phylogenetic analysis are the only methods which are used 
worldwide. However this method is laborious and time-consuming which limits 
the number of samples being processed and analyzed during EV71 outbreaks. 
Here, we developed a high-throughput genogrouping method based on the 
multiplex suspension array platform which allows both EV71 detection and 
genogrouping. 
Reference strains of 11 EV71 subgenogroups were used for the optimization 
of the system. It was found that all the subgenogroups could be detected by 
subgenogroup-specific probes. And 9 of them could give an average reading 
higher than 3000 MFI while readings of negative control were below 50. For 
genogroups B5 and C4, the readings were relatively low but were still good 
enough for differentiation purpose. After analyzing the probes’ sequences, it was 
found that the GC content of B5 probe is 47.6% and the GC content of C4 probe 
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is 40%. It was known that template with low GC/AT ratio is hard to amplify 
(Baskaran, 1996; Robertson and Walsh-Weller, 1998), therefore the primary 
cause of low reading may be low GC content. It was also noticed that there is 
cross-reaction between and within genogroups which is expected since the 
sequence similarity of EV71 is over 85% within the same genogroup. Comparing 
to the direct DNA sequencing methods, results generated from our method were 
consistent and reproducible. Validation with other known viral isolates 
demonstrated that our assay was able to detect and genogroup viral isolates other 
than the reference strains and was specific to different subgenogroups of EV71.  
The detection limit of the assay was illustrated using either pfu or copies of 
plasmid. 4 different starting amounts were chosen for each assay. It was reported 
that real-time RT-PCR was able to detect as low as 3 viral RNA copies per 
reaction (Chen, 2007) and real-time PCR has a detection limit of 10 copies of 
plasmid (Guo, 2009), therefore 1, 5, 20 and 50 pfu and 1, 10, 100 and 1000 copies 
of plasmid were used for analysis. For genogroups with viral isolates it was found 
that all subgenogroups could be detected when at least 100 pfu were present. For 
subgenogroups C1, C2 and C5, they could even be detected at 1 pfu and 
genogroups A, B2 and B5 at 5 pfu. Surprisingly, subgenogroup B4 can only be 
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detected at 100 pfu given its relatively high reading shown in specificity test. B4 
probe has 55% GC ratio and an annealing temperature of 57.5°C. It was able to 
give a high reading for specificity test when larger amount of virus particles were 
present, therefore it was suspected that low sensitivity may be a result of poor 
amplification from consensus primers.  This was proven by gel electrophoresis, 
which showed that no bands were observed for subgenogorup B4 even at the 
100pfu, whereas other subgenogroups showed band at 5 or 20 pfu level. As for 
subgenogroup C4, more virus particles required for detection were within 
expectation since C4 probe had low binding affinity according to prior analysis. 
For genogroup B5, its high probe sensitivity compensated for low binding 
efficacy to consensus primers. For genogroups with plasmid clones, it was shown 
that all plasmids could be detected when at least 100 copies were present. The 
variation of detection limit among different subgenogroups was expected to be 
smaller for plasmid clones since procedure of sensitivity test was simpler because 
it did not require RNA extraction and reverse transcription. 
EV71 positive clinical samples could be detected by our assay and the 
genogrouping results were in an agreement with DNA sequencing. This 
demonstrates that our assay has the ability to detect the presence of EV71 in 
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clinical samples as well as giving correct genogrouping results. Comparing the 
genogrouping results of clinical samples with reference strains, the clinical 
samples generally yielded a weaker MFI signal. This can be attributed to low viral 
titer in clinical samples. Although the amount of virus present in the clinical 
sample was low, virus detection and genogrouping were still successfully. 
Therefore we can conclude our assay is sensitive enough for clinical diagnosis. 
Moreover, avoiding DNA sequencing and subsequent phylogenetic analysis can 
save time for clinical diagnosis.  
One factor which has great impact on genogrouping and viral evolution is 
mutation. Due to the absence of proofreading in replication, the misinsertion rate 
of the RNA polymerase is high, averaging up to one mutation per newly 
synthesized genome (Drake, 1993). Consequently, the number of EV71 
subgenogroups gradullay increases over the years. Mutations at the conserved 
VP1 region may hinder detection and identification of EV71 subgenogroups, 
therefore multiplex suspension array may be useful as a preliminary test for 
genogrouping. Direct DNA sequencing may be carried out for further anlaysis.  
The xMAP technology has been applied for single nucleotide polymorphism 
(SNP) genotyping in different areas, such as analysis for SNP-linked clinical 
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conditions (Bortolin, 2004; King, 2008; Koo, 2007; Ye, 2001), plant improvement 
(Lee, 2004) and pathogen detection (Diaz, 2004). This approach is high-
throughput since 96 samples can be processed by Luminex analyzer at one time 
within 1 hour and half and it is also cost-saving which makes it possible to be 
applied in clinical setting. Besides its robustness, it is also highly flexible. It 
allows addition of new primers or probes or replacement of old probes with new 
ones. As we know, the number of subgenogroups of EV71 keeps increasing due 
to mutations in constant outbreaks. Therefore when new subgenogroup emerges, 
probe for new subgenogroup could be directly added to the existing system. 
Moreover, more primers and probes for detection of other enteroviruses could 
also be designed and added into this platform to make this assay more useful. 
Despite the many advantages of this technology, it should be noticed that there are 
also pitfalls. For instance, it cannot detect mutant strains in the outbreak and it is 
only applicable to known subgengroups. In addition, the start-up cost is relative 
high and it requires experienced personnel to operate. 
In conclusion, the assay we presented here is a specific, sensitive, reliable and 
high-throughput method for EV71 detection and genogrouping. It is also shown 
that it could be applied in clinical settings and is affordable during large outbreaks. 
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This application would greatly facilitate genogrouping and epidemiological 
analysis for EV71 studies. This new approach may be applied for identification of 
















CHAPTER 4  
THE LARGEST OUTBREAK OF HAND, FOOT AND 
MOUTH DISEASE IN SINGAPORE 2008: THE ROLE OF 
ENTEROVIRUS 71 AND COXSACKIE A STRAINS  
 
4.1 Introduction  
Hand, foot and mouth disease (HFMD) is a common childhood disease 
characterized by a brief febrile illness, typical vesicular rashes on the palms, soles 
or buttocks, and oropharyngeal ulcers. HFMD is usually a mild disease with the 
rashes healing within 5-7 days. Children under 5 years of age are more susceptible, 
although adult patients can present with HFMD. In addition, males are at higher 
risk than females. In rare cases, patients may also develop neurological 
complications such as encephalomyelitis, aseptic meningitis, and acute flaccid 
paralysis (McMinn, 2002; Pérez-Vélez, 2007). Many viruses can cause HFMD, 
and they belong to the genus Enterovirus within the family Picornaviridae. The 
most common etiologic agents are coxsackievirus A16 (CA16) and enterovirus 
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type 71 (EV71). However, throughout an outbreak, many other enteroviruses such 
as coxsackievirus A4, A6 and certain echoviruses may cocirculate.  
In this study, clinical samples from HFMD patients were investigated in order 
to identify the circulating virus serotypes in the 2008 HFMD outbreak in 
Singapore. The predominant enteroviruses and EV71 subgenogroups were 
characterized by phylogenetic analysis. In addition, EV71 genome sequence 
analysis was performed to elucidate the viral genetic features conferring high 
transmissibility but low virulence.  
 
4.2 Results  
4.2.1 Clinical Features of Patients with EV71 Versus Non-EV71 Infections  
Out of the 43 hospitalized patients with suspected HFMD, clinical data were 
not available for one patient. Of the 42 patients included in the clinical data 
analysis (Table 4.1), the number of females and males was similar, while the 
majority of patients (28 children or 66.7%) were under 5 years of age. The highest 
percentages were observed in children aged 3 years (40% of EV71 and 18.8% of 
non-EV71) and 4 years (20% of EV71 and 21.9% of non-EV71) (Figure 4.1). 
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Figure 4.2 compares the symptoms of HFMD patients infected with EV71 and 
other enteroviruses. Notably, papules were observed for all cases, while mouth 
ulcers were seen in almost all cases (i.e. 90% for EV71 versus 100% for non-
EV71 infections). Papules and mouth ulcers are two clinical criteria for the 
diagnosis of HFMD and herpangina. Figure shows the difference in the number of 
papules observed in patients positive for EV71 and CA16 infection compared 
with other infected patients. Interestingly, 75% of EV71 and CA16 infected 
patients exhibited more than 5 papular lesions compared with only 43.3% of other 
patients, but this was not statistically significant (p>0.05). Rhinorrhea was only 
observed in non-EV71 infections (31.2%), whereas only 50% of EV71 patients 
presented with fever compared with 93.8% of non-EV71 infections (p<0.05). 
Poor feeding was documented in 30% of EV71infected cases compared with 25% 
of cases with non-EV71 infections. For other clinical signs, non-EV71 patients 
presented these more frequently, but this was not statistically significant (p>0.05). 
For example, in the case of  cough (25% of non-EV71 versus 10% of EV71) and 
vomiting (21.9% of non-EV71 versus 10% of EV71), the difference was about 
two-fold. Diarrhea was only occasionally observed (6.25% of non-EV71 versus 





Table 4.1: Clinical information available for 42 hospitalized patients with 










Characteristic Number of cases (%) 
Gender 21 males (50%) 
21 females (50%) 
Age 28 (66.7%) < 5 years old 
14 (33.3%) > 5 years old 
Location in 
hospital 
37 (88%) from Children’s Emergency Department 











Figure 4.1. Age distribution of HFMD patients infected by EV71 and 
























Figure 4.2: Clinical characteristics of HFMD patients infected by EV71 and 
entroviruses other than EV71. (A) Percentage distribution of clinical symptoms 
in EV71 versus non-EV71 patients. (B) Percentage of patients (positive or 




4.2.2 Pan-Enterovirus RT-PCR, Direct Sequencing and Virus Isolation Elucidate 
the Distribution of Enterovirus Types and the Involvement of EV71 in HFMD 
Patients 
Only one clinical sample was collected from each of 37 patients, while 3 and 
2 different clinical samples were taken from 2 and 4 patients, respectively, giving 
a total of 51 samples from 43 patients. Table 4.2 summarizes the detection rate 
based on sample type, and highlights the throat swab as a good clinical specimen 
for HFMD virus detection and isolation.  
Classical RT-PCR assays with both pairs of pan-EV primers targeting the 
5′UTR were able to detect enteroviruses in 34 samples (66.7%), with 17 samples 
(33.3%) being enterovirus-negative. RT-PCR with EV71-specific primers VP3-Fa 
and EV2A-R detected 11 EV71-positive samples (21.6%). In addition, the non-
EV71 enterovirus types were identified via sequencing of 5′UTR and VP1 
amplicons. The circulating enteroviruses responsible for the 2008 Singapore 
outbreak include CA4, CA6, CA10, CA16 and EV71, the most prevalent being 
CA6 (23.5%), EV71 (21.6%) and CA10 (11.8%) as shown in Table 4.3 and 
Figure 4.3A. It is noteworthy that CA4 and CA16 account for only 10%, even 
though CA16 has played a major role in previous HFMD outbreaks. If the 
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enterovirus-negative samples were excluded, more than 50% of the samples were 
positive for CA6 and CA10, while 32% were EV71-positive (Figure 4.3B), thus 
reiterating the predominant role of CA6, CA10 and EV71 in this outbreak. This 
was corroborated by cell culture inoculation which successfully isolated 
enteroviruses from 19 out of 51 samples (~40%), later confirmed as 9 CA6 
(47.3%), 6 CA10 (31.5%), 3 EV71 (15.8%) and 1 CA4 (5%). 
        The EV71 real-time RT-PCR hybridization assay failed to detect EV71 in 
the 51 specimens. VP1 sequence alignment of the 10 EV71 strains with the RT-
PCR primers and hybridization probes revealed one mismatch in each primer. 
However, 3 mismatches were found for the probe with acceptor fluorophore 
spanning nucleotides 2518-2496, one of which was near the 3′ end (Figure 4.4) 
and may compromise binding of the probe to the target product leading to failure 
of detection (Ayyadevara, 2000). This mismatch of the latter probe rather than 
primers was supported by classical RT-PCR using the primers which could 
amplify specific bands for all EV71 strains as detected by gel electrophoresis 







Table 4.2: Identification of enteroviruses by classical and real-time RT-PCR 



























Pan-EV 154 bp 26 3 0 2 2 1 0 66.7 
Pan-EV 439 bp 26 3 0 2 2 1 0 66.7 
VP3-Fa & 
EV2A-R 
8 2 0 0 1 0 0 21.6 
Real-time  
RT-PCR 
    0 0 0 0 0 0 0 0 























Figure 4.3: Distribution of enteroviruses identified in clinical specimens. (A) 
Percentage distribution of enterovirus types in (A) enterovirus-positive samples 




Enterovirus type                                                No. of positive 
samples 
CA4                                                                                   3 
CA6                                                                                  12 
CA10                                                                                 6 
CA16                                                                                 2 
EV71                                                                                11 
Enterovirus negative                                                        17 






NUH0049/SIN/08 G C T G G C A G G G C C C G G G T G A G C G C C 
NUH0047/SIN/08 G C T G G C A G G G C C C G G G T G A G C G C C 
NUH0086/SIN/08 G C T G G C A G G G C C C G G G T G A G C G C C 
NUH0083/SIN/08 G C T G G C A G G G C C C G G G T G A G C G C C 
NUH0085/SIN/08 G C T G G C A G G G C C C G G G T G A G C G C C 
NUH0043/SIN/08 G C T G G C A G G G C C C G G G T G A G C G C C 
NUH0037/SIN/08 G C T G G C A G G G C C C G G G T G A G C G C C 
NUH0012/SIN/08 G C T G G C A G G G C C C G G G T G A G C G C C 
NUH0075/SIN/08 G C C G G T A G A G C T C G G G T G A G G G C T 
NUH0013/SIN/08 G C C G G T A G A G C T C G G G T G A G G G C T 
Hybridization probe G C T G G C A G G G C C T G G G T A A G T G C C 
 
Figure 4.4: Sequence alignment of 10 outbreak EV71 strains against the 
hybridization acceptor probe for real-time RT-PCR. The highlighted 











4.2.3 Molecular Epidemiology of EV71 Outbreak Strains Identifies Two Major 
Subgenogroups 
Out of the 11 EV71-positive samples, 2 were from the same patient, with the 
rest from individual patients. Thus, the distribution of EV71 subgenogroups of 10 
strains was determined by RT-PCR amplification of their complete VP1 
fragments followed by nucleotide sequencing and phylogenetic analysis. The 
sublineage structure of EV71 was reconstructed (Brown, 1999), and revealed two 
circulating subgenogroups (Figure 4.5) belonging to B5 (8 strains or 80%) and C2 
(2 strains or 20%). Three EV71 strains were successfully isolated from the 
samples, two of which were B5 and the other was C2. Interestingly, the VP1 
sequences of strains from the dominant B5 subgenogroup displayed differences, 
whereas those of the 2 subgenogroup C2 strains were identical. The complete 
viral genomes of two representative subgenogroups B5 (NUH0083/SIN/08) and 
C2 (NUH0075/SIN/08) were sequenced and deposited into the GenBank database 








Figure 4.5: Dendrogram constructed based on the complete VP1 gene 
sequences of 10 outbreak EV71 strains and selected known strains, 
elucidating B5 and C2 as the respective major and minor EV71 subgenogroups 
circulating during the 2008 Singapore epidemic. 
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4.2.4 VP1 Sequence Comparison Reveals Interesting Disparities Between Current 
Outbreak and Known Virulent Strains 
Twelve VP1 gene sequence disparities of B5 strains were identified, 
suggesting the occurrence of viral evolution and mutation during this outbreak 
(Figure 4.6). An interesting trend was noticed at nucleotides 19, 373 and 756, 
whereby 3 B5 samples obtained in April and May 2008 (NUH0049, 0047, 0086) 
were identical at these positions, in contrast to the existence of disparities for the 
other 5 B5 strains that were received later during mid-May to August 2008 
(NUH0083, 0085, 0043, 0037, 0012). Furthermore, 2 B5 strains that were 
collected later harbored non-conservative VP1 amino acid substitutions, i.e. K to 
E at position 215 of NUH0043, and T to A at position 289 of NUH0037. These 
phenomena provide strong evidence for virus mutational events through the 
course of the outbreak that may partly arise from strong immunological pressure 
on the immunodominant VP1 region. In addition, for the 2008 strains, disparities 
were discovered at 3 VP1 epitopes that are capable of eliciting neutralizing 
antibodies against EV71 in vitro and in vivo (Foo, 2007a; Foo, 2007b; Ho,2008). 
Figure 4.7 highlights the differences, especially the non-polar to polar amino acid 
change within the SP55 peptide. Therefore, the neutralizing antibodies of patients 
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infected with previous EV71 strains may not be able to recognize the 2008 
counterpart strains. 
In 2008, EV71 epidemics were documented in many other countries in East 
Asia, but the behavior of the causative strains were quite different. For example, 
the predominant strain in the 2008 China and Vietnam epidemics belonged to 
subgenogroup C4 (Huemer, 2008), and exerted relatively high virulence 
culminating in numerous child fatalities. In contrast, the B5 and C2 strains of the 
2008 Singapore outbreak were highly infectious but low in virulence. VP1 
constitutes the major capsid protein and is considered to be an important factor 
that mediates viral pathogenesis (Lal, 2006). To better understand differences in 
their VP1 amino acid composition, the 10 Singapore 2008 strains were compared 
with 2 virulent strains from fatal cases (Figure 4.8), i.e. 
Fuyang.Anhui.PRC/17.08/3 from the 2008 China outbreak and 5865/Sin/000009 
from the 2000 Singapore outbreak. A disparity at position 22 was noted, with R 
being replaced by Q or H in virulent strains, making it less basic. The Fuyang 
strain displayed an E to K substitution at position 98 that could result in 
conformational change at the hydrophobic pocket of VP1 (Chen, 2008). Another 
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mutation at amino acid 164 of the virulent 2000 Singapore strain was identified 




















Figure 4.6: Alignment of VP1 nucleotides of 8 EV71 strains belonging to 
subgenogroup B5 according to the time of specimen receipt. The disparities at 
12 different positions highlight the evolution of the VP1 regions of B5 strains 
during the course of the large epidemic. For example, 5 disparities at positions 
644, 658, 820, 832 and 866 emerged in strains that were obtained later in the 
outbreak. Common disparities at nucleotides 19, 373 and 756 were also identified 
only in strains detected later. 
EV71 B5 strain 
Collection  
date 
(2008) 7 19 373 427 439 604 644 658 756 820 832 866 
NUH0049/SIN/08 7 Apr T C A T T C A T T C A A 
NUH0047/SIN/08 7 Apr T C A T T C A T T C A A 
NUH0086/SIN/08 6 May T C A T T C A T T C A A 
NUH0083/SIN/08 15 May C T G T C T A T C C A A 
NUH0085/SIN/08 3 Jun T T G C T C A C C C A A 
NUH0043/SIN/08 12 Jun T T G C T C G T C C A A 
NUH0037/SIN/08 14 Aug C T G T C T A T C T G G 






SP12 (34–48) VSSHRLDTG    E      VPALQ  C 
2008 Strains    VSSHRLDTG  (K/E)  VPALQ  A 
  
SP55 (163–177)   P E SRESLAWQTATNP C 
2008 Strains    P D SRESLAWQTATNP S 
  
SP70 (208–222)   YPTFGEHKQEKDLEY C 
2008 Strains    YPTFGEHKQEKDLEY G 
 
Figure 4.7: Amino acid sequence variations within the VP1 neutralizing 




















Figure 4.8: Comparison of the VP1 amino acid sequences of 








4.2.5 Amino Acid Differences Occurred Within Non-Structural Regions  
Two important mutations that may influence viral virulence were found in the 
B5 and C2 isolates, i.e. within the non-structural 3D polymerase region that 
encodes the RNA-dependent RNA polymerase crucial for viral RNA replication 
(Whitton, 2005). The C2 isolate but not the B5 isolate (Figure 4.9) harbored a 
mutation at position 73 involving the substitution of Tyr by another amino acid 
that is associated with attenuation in mice. The B5 and C2 isolates together with 
the Singapore and Fuyang virulent strains contained a Thr to Pro mutation at 
amino acid 362 (Figure 4.9) that contributes to temperature sensitivity (Georgescu, 
1995). 
4.2.6 Comparative Analysis of 5′ UTR Nucleotide Sequences 
The 5′UTR is important in virus replication since it has an internal ribosome 
entry site (IRES) which serves as the translation initiation point. Figure 4.10 
shows that all the 10 outbreak strains together with neurovirulent EV71 strains 
contain a cytidine at position 472 that contributes to the neurovirulence of 
poliovirus serotype 3. Furthermore, all these strains displayed a spacing of 29 
nucleotides, i.e. an identical distance between the polypyrimidine motif and the 
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AUG codon, implying that they possess good replication ability (Kung, 2007). 
However, compared with the B5 and C2 strains, there were mutations within the 




















Figure 4.9: Mutations of fatal strains 5865/Sin/0009, 
EV71/Fuyang.Anhui.PRC/17.08, B5 strain NUH0083/SIN/08 andC2 strain 


























Figure 4.10: Nucleotide sequence alignment of 5’untranslated region Internal 
Ribosome Entry Site. All of the strains have a cytidine at position 472 as well as 
polypyrimidine motif from position 558 to 586. And the distance between the 
motif and the AUG codon is the same. Mutations were identified for fatal strains 









4.3 Discussion  
The 2008 outbreak represents the largest HFMD epidemic in Singapore since 
the year 2000, with almost 30,000 cases, 4 patients with encephalitis, and 1 
fatality. However, the actual number of HFMD cases may be much higher given 
that most infections are asymptomatic. There were 2 periods within which the 
number of infected cases increased significantly above the epidemic threshold, i.e. 
a large peak from mid-March to the end of May (10,927 cases in weeks 12-22), 
and a smaller peak from early October to early December 2008 (5391 cases in 
weeks 42-49). However, in 2009, the number of HFMD cases did not exceed the 
epidemic threshold, with 12,433 cases reported until the second week of October 
2009 (without any encephalitis cases or deaths), compared with 22,249 cases 
within the same period for 2008 
(www.moh.gov.sg/mohcorp/statisticsweeklybulletins.aspx).  
The most prevalent enterovirus infections associated with the 2008 Singapore 
outbreak were attributed to CA6 followed by EV71 and CA10. Both CA6 and 
CA10 are common etiologic agents of herpangina that are prevalent in Japan since 
2005 (Yamashita, 2005; Sano, 2008), and are less virulent but apparently more 
infectious compared to EV71. Consequently, the high transmissibility of HFMD 
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during the 2008 Singapore epidemic may be due to the dominance of CA6 and 
CA10. The similar clinical presentations of HFMD and herpangina make it 
difficult for physicians to distinguish the two disease entities. Most patients 
infected by non-EV71 and non-CA16 enteroviruses presented fewer than 5 
papules, whereas the significant majority of EV71 and CA16 patients exhibited 
more than 5 papules. From a general clinical perspective, it is suspected that 
patients with fewer than 5 papules may actually be suffering from herpangina 
rather than HFMD. Hence, we postulate that this outbreak comprised a mixture of 
HFMD as well as herpangina cases. Moreover, the percentage of patients who had 
fever was significantly different between patients with EV71 versus non-EV71 
infections.  
Besides CA6 and CA10, another major contributor was EV71 which 
accounted for more than one third of the enterovirus-positive cases. VP1-based 
phylogenetic analysis revealed two EV71 subgenogroups, namely B5 and C2. 
There are two major lineages (B and C) circulating during HFMD outbreaks in 
Southeast Asia since 1997, with 5 subgenogroups under genogroup B. B1 and B2 
were identified throughout the world during the 1970s and 1980s, but these 
subgenogroups were not implicated in recent HFMD outbreaks in Southeast Asia. 
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Instead, B3 and B4 later emerged as the dominant subgenogroups in Australia, 
Malaysia and Singapore (MicMinn, 2001; Cardosa, 2003; Shimizu, 1999). 
Subgenogroup B5 was first identified in Japan in 2003, and replaced the previous 
dominant strain within a short period (Mizuta, 2005). In Singapore, the transition 
of the predominant EV71 subgenogroup from B4 in 2000 (Singh, 2000) to B5 in 
2008 correlated with the reduced fatality rate from ~7/4,000 to ~1/30,000. 
Replacement of subgenogroups was also witnessed in Taiwan and Sarawak in 
2008 (Huang, 2009). Subgenogroup C2 was initially identified in Taiwan, being 
responsible for the largest ever HFMD outbreak in 1998. Subgenogroups C1, C3 
and C4 also surfaced in outbreaks in Taiwan, Korea, and China (Cardosa, 2003; 
Li, 2005). A new subgenogroup C5 was first isolated in Vietnam (Tu, 2005), and 
also appeared in Taiwan (Huang, 2008). In the 2008 Singapore outbreak, C2 
subgenogroup accounted for only one-fifth of EV71-positive samples, relegating 
it to a minor role. Nevertheless, this reiterates that multiple genetic lineages of 
EV71 circulate endemically in the Singapore population all year round.  
      In our study, we did not detect coinfections with more than one enterovirus 
type by molecular techniques and virus isolation. Nonetheless, dual infections 
were reported in the background of the EV71-associated HFMD outbreak in 
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Sarawak, Malaysia in 1999. However, dual infection does not increase the 
likelihood of acquiring neurological complications. The interaction between two 
enteroviruses may explain unusual manifestations, although how viruses co-
circulating during an outbreak interact with one another is unclear (Ooi, 2007). 
Double infection in the same patient provides great opportunities for genetic 
exchange between various strains. Recombination event is observed among 
enteroviruses (Santti, 1999). Higher-than-average similarity in pairwise 
comparison among serotypes provides evidence for homologous recombination, 
leading to genetic drift between various strains. Recombination occurs most 
commonly in the non-strucutral region and is virtually absence in P1 region 
(Simmond and Welch, 2006).  It is postulated that recombination within the 
capsid region, especially between those enteroviruses with different cellular 
receptors, is less likely to generate a viable offspring (Burke, 1988).  
Recombinations are constrained to regions that have less impact on viral infection, 
thus the potential impact on genogrouping is minimal. Nevertheless, 
recombination plays an important role in viral evolution.  
The complete nucleotide sequence analyses of whole EV71 genomes facilitate 
the characterization of circulating strains at the genetic level and of their predicted 
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viral proteins. Interactions between viruses and their hosts play critical roles in 
virus evolution of structural and non-structural genes. Quite a number of VP1 
mutations were observed in the 10 studied EV71 strains in comparison with 
known sequenced strains. This reflects the relatively high mutation rate of EV71 
that helps it to escape human immune surveillance. The rapid change in 
nucleotide and even amino acid sequences within such a short period alludes to 
the intriguing capability of EV71 to adapt to the host immune system. These VP1 
mutations render it impossible to detect the outbreak strains using previously 
designed “EV71-specific” primers and probes for RT-PCR (Tan, 2006; Tan, 
2008b), an adverse experience commonly shared by many diagnostic laboratories 
and well known, for instance, for hepatitis viruses (Kay and Zoulim, 2007). The 
considerable mutation rate of the EV71 capsid protein may also have implications 
on future vaccine development (Bible, 2007). Furthermore, disparities were also 
discovered in other non-structural and non-coding regions such as the 3D 
polymerase and 5′UTR (data not shown). The total sum of such disparities may be 
associated with low replication ability, high sensitivity to temperature and 
attenuation of the analyzed EV71 strains, which may explain the relatively low 
fatality rate witnessed in this outbreak. Finally, a safe and effective vaccine 
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against EV71 is certainly warranted in view of its potential neurovirulence, and its 
role in HFMD epidemics of recurring frequency with resultant fatalities in Asia as 


















CHAPTER 5  
SEROEPIDEMIOLOGY OF EV71 INFECTION IN A 
PEDIATRIC COHORT IN THE SINGAPORE 
POPULATION  
 
5.1 Introduction  
Childhood vaccinations provide an effective method of protection against 
many diseases. Routine vaccination for infants is a common practice in Singapore. 
The national immunization program in Singapore recommends children to take 5 
types of vaccines before entering primary school.  Hand, foot and mouth disease 
(HFMD) is a common childhood disease caused by viruses belonging to the genus 
Enteroviruses. It is characterized by a brief febrile illness, typical rashes on hand 
and foot and ulcers in the mouth and usually a mild disease with the rashes 
healing within 5 to 7 days (Melnick, 1996a). HFMD is most frequently associated 
with CA16 and EV71. HFMD caused by EV71 is of public concern because 
EV71 infections are associated with neurological diseases like meningitis, acute 
flaccid paralysis and other complications like pulmonary edema (McMinn, 2001). 
HFMD outbreaks have been observed in the last two decades in Singapore. There 
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were 2 major outbreaks in 2000 and 2008 respectively. Four children died of 
pneumonitis and encephalitis during the 2000 epidemic (Chong, 2003) and almost 
30,000 children were infected with enteroviruses in the largest ever HFMD 
outbreak in 2008 (www.moh.gov.sg). Since there are currently no anti-viral drugs 
or vaccines available for EV71 treatment, it would be useful to know the immune 
status of the Singapore population with respect to EV71, which will also provide a 
strategy to control HFMD in Singapore.  
In this study, a national pediatric seroprevalence survey on hand, foot and 
mouth disease was performed by collaboration between Ministry of Health and 
Department of Microbiology National University of Singapore. I am one of the 3 
researchers working on the neutralization test against EV71 and in my thesis I 
will only provide preliminary data on the seroprevalance in children younger than 
17 years old.  
 
5.2 Results  
5.2.1 Analysis of age-specific seroprevalence of EV71 
A total of 1078 serum samples were obtained from hospitalized non-HFMD 
patients from October 2008 to December 2009, 327 samples of which were found 
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to be positive for EV71 antibody, with an antibody titer of at least 8. Figure 5.1 
demonstrated the age-specific percentages of positive samples for EV71 antibody. 
For children up tp 2 years old, the positive rates were approximately 10%, which 
indicated uncommon EV71 infection among very young. However, prevalence 
rapidly increased to 25% at 3 years old and fluctuated between 20% and 25% 
until age 7.  It was also noticed that there was a drastic reduction at age 4, which 
was also observed at age 8. This may be explained by variation in sample 
collection. From 9 years onwards, there was an increasing trend for prevalence, 
although fluctuations were still present. The percentage jumped from 30% to 40% 
from 9-year-old to 12-year-old and remained around 40% for children older than 














Figure 5.1: Age-specific seroprevalence of neutralizing antibodies to 








5.2.2 Analysis of seroprevalence of EV71 based on age group 
Participants were grouped into 3 age groups (1 to 6, 7 to 12 and 13 to 17) 
according to their education level. For children younger than 7 years old, 16% of 
them had antibodies to EV71. 28% children in the group aged 7 to 12 were 
positive for EV71 antibodies but at age 8, only 6% of the samples were positive. 
In the aged group 13 to 17, the rate increased to 39% (Figure 5.2). The differences 
between the age groups were statistically significant (p<0.05). Besides 
seropositive rate, the pattern for antibody titer distribution was also compared 
among 3 age groups (Figure 5.3). For children who were 1 to 6 years old, 27% of 
the positive samples had an antibody titer of 128 and 25% with antibody titer of 
64, therefore more than 50% of the positive samples had antibody titer higher than 
64. The distributions of antibody titer were very similar for the age groups 7 to 12 
and 13 to 17.  30% and 42% of positive samples were detected to have antibody 
titer 32 in age group 7 to 12 and 13 to 17.  21% of both age groups had antibody 
titer of 64. These 2 antibody titers accounted for around 50% of the positive 
samples. In age group 13 to 17, a very high antibody titer 512 was observed in 1% 










Figure 5.2: Age group seroprevalence of neutralizing antibodies to 












Figure 5.3: Neutralizing antibody titer distribution of EV71 antibody positive 








Figure 5.4 showed the geometric mean titers in samples with a more than 8 
antibody titer based on age groups. The GMT of anti-HEV71 antibodies for the 3 
age groups were 51.33, 38.05 and 35.97 respectively. The GMT differences 
between  age group 1 to 6 and the other 2 age groups were statistically significant 
with a p<0.001 by student t-test.  
 
Figure 5.4: Geometric mean titer of EV71 neutralizing antibody for different 




5.3 Discussion  
This study details the seroepidemiology of EV71 in the Singapore population. 
Result of age-specific seroprevalence of EV71 neutralizing antibody analysis 
indicates that transmission of EV71 is uncommon in very young children. It is 
highly likely that the transmission happens during pre-school period since 
seroprevalence increases rapidly from age 3. Sero-positive rate keeps increasing 
until year 12 indicating frequent natural exposure to EV71. Although reported 
cases of HFMD patients are mostly from children 3 to 5 years old, older children 
may still get it from their siblings and do not show any symptoms due to stronger 
immunity. The proportion of seropositive children reached a steady state after 12 
years of age, showing the incidence of transmission and infection of EV71 
decreases. Analysis of prevalence based on age group further supports the 
observations we made previously. There is a significant difference of prevalence 
between each 2 age groups, which is an evidence of increasing EV71 immunity in 
older age group. This further validates that transmission of EV71 is very common 
among school children.   
Antibody titre analysis indicates that children in age group 1 to 6 are recently 
infected. The EV71 strain we used in neutralization test was isolated from a fatal 
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case in the 2000 Singapore outbreak, therefore children of these ages had never 
been exposed to this strain before. However, more than 50% of the positive 
samples still demonstrate a high antibody titre against this strain, revealing a 
recent infection of EV71. Antibody titre distribution of 7 to12 and 13 to 17 are 
similar. A relatively low antibody titre indicates no recent infection of EV71 for 
most of the older children. However, we did detect 1% of patients’ samples in age 
group 13 to 17 having antibody titer of 512. This is the evidence to support that 
EV71 infection not only occurs in young children but also in older children.  
Difference of GMT between age group 1 to 6 and other 2 groups further proves 
infection occurred most frequently in younger children. Declining of GMT is 
associated with reduced frequency of EV71 infection.  
Serum samples used in this study were collected from Oct 2008 to Dec 2009 
and subjected to neutralization test against EV71 strain 5865/sin/0000009. There 
was a largest ever HFMD outbreak in Singapore in 2008, during which more than 
30,000 children were affected. The dominant viruses for this outbreak were 
Coxsackievirus A6 and A10 whereas EV71 was responsible for around one fifth 
of the infections. Therefore, before or during the sample collection, EV71 was 
circulating in Singapore, although the percentage of children with EV71 antibody 
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may be lower compared to EV71 dominant outbreaks. Comparing to previous 
studies on seroepidemiology of EV71 in Singapore (Ooi, 2002), the profiles of 
EV71 prevalence are similar for our 2008 to 2009 study and more than 10 years 
ago, although it is  realized that there is a reduction in prevalence for the younger 
age group. The reduction may be contributed to cleaner environment, improving 
hygiene in schools, awareness and successful public control of HFMD in 
Singapore.  
It is also revealed by this study that 30% of children younger than 17 in 
Singapore have antibody against EV71. Although HFMD is not a serious disease, 
its prevalence in south-east Asia since 1997 and large number of fatalities 
reported are undeniable. More and more countries in this region start to 
experience outbreaks of this re-emerging infectious disease, such as China (Qiu, 
2008) and Vietnam (Tu, 2007). If a virulent strain appeared in an outbreak, large 
fatalities could result. Therefore, it is suggested that the best strategy for 
controlling the spread of this virus is to develop an EV71 vaccine. Vaccination 
could help children combat early infections of EV71 and reduce the chance of 
getting neurological diseases and other complications. It is well-known that 
poliomyelitis is almost eradicated after successful implementation of oral 
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poliomyelitis vaccine world-wide, as EV71 and polio virus are similar in genetic 
structures and life cycles, it is highly possible that EV71 vaccine can effectively 
reduce the incidence of HFMD cases and also decrease the number of deadly 
cases.  
Therefore, we can conclude that EV71 infection is a common childhood 
disease in Singapore and happens frequently in children younger than 7 years old. 
Infection is most common in pre-school and silent transmissions among older 
children are also observed but the incidence is reduced. In order to prevent the 
disease and reduce the spread of the virus, the most effective approach for control 
of HFMD is to implement vaccination for EV71. Since there is no EV71 vaccine 
available currently, it is suggested that measures to improve hygiene should be 
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Luria-Bertoni (LB) broth: 
Tryptone  10.0 g 
NaCl   10.0 g 
Yeast extract  5.0 g 





Luria-Bertoni (LB) agar: 
Tryptone  10.0 g 
NaCl   10.0 g 
Yeast extract  5.0 g 
Agar   15.0 g 
 
The mixture was made up to 1 litre with water. After autoclaving, the molten media was 
































10X Minimum essential medium (MEM) powder (Gibco BRL) 
The powdered medium is supplemented with Earle’s salt, L-glutamate, non-essential 
amino acids, without sodium bicarbonate. The MEM medium was prepared by dissolving 
the MEM powder in 1L of sterile water (20oC to 30o
 
C) with gentle stirring, and the media 
was sterilized by membrane filtration.  
 
 
Growth media for RD cells: 
Fetal calf serum (FCS)  10.0 ml 
HEPES buffer (1M) 2.0 ml 
Sodium Bicarbonate (7%) 1.0 ml 
MEM (1X) 87.0 ml 




Media for cell freezing: 
Growth media with 10% FCS 9.0 ml 
Dimethyl sulphoxide (DMSO) 1.0 ml 
Total 10.0 ml 
 
The media for cell freezing was freshly prepared before carrying out the procedure for 




Media for cell thawing: 
Fetal calf serum (FCS)  20.0 ml 
HEPES buffer (1M) 2.0 ml 
Sodium Bicarbonate (7%) 1.0 ml 
MEM (1X) 77.0 ml 














Fetal calf serum (FCS)  25.0 ml 
HEPES buffer (1M) 10.0 ml 
Sodium Bicarbonate (7%) 5.0 ml 
MEM (2X) 210.0 ml 
Total 250.0 ml 
 
A final concentration of 1.2% w/v Avicel was prepared by dissolving 6.0g of Avicel 
powder in 250ml of sterile water. Autoclaving was carried out to aid in complete 
dissolving of the powder and sterilization. A total volume of 250ml of the plaque media 




































2X Tm Hybridization buffer: 
1.0 M Tris                     40.0 ml 
1.0 M NaCl 20.0 ml 
Triton X-100    0.16 ml 
Sterile water 39.84 ml 





1X Tm Hybridization buffer: 
1.0 M Tris                     20.0 ml 
1.0 M NaCl 10.0 ml 
Triton X-100    0.08 ml 
Sterile water 69.92 ml 
Total 100.0 ml 
 
Hybridization buffers are membrane filtered and aliquot into separate tubes to keep 
sterility.  
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A B S T R A C T
Background: During 2008, Singapore experienced its largest ever outbreak of hand, foot and mouth
disease (HFMD), resulting in 29 686 cases, including four cases of encephalitis and one fatality.
Methods: A total of 51 clinical specimens from 43 patients with suspected HFMD at the National
University Hospital, Singapore were collected for virus isolation and identiﬁcation by reverse
transcription polymerase chain reaction (RT-PCR) and sequencing.
Results: Enteroviruses were identiﬁed in 34 samples (66.7%), with 11 samples (21.6%) being positive for
enterovirus 71 (EV71). Other non-EV71 enteroviruses (including coxsackievirus A4, A6, A10, and A16)
were identiﬁed in 23 samples (45.1%). The most prevalent virus serotypes were CA6, CA10, and EV71.
CA6 and CA10 accounted for 35.3% of all HFMD cases, which may explain the high transmissibility and
low fatality that characterized this unprecedented epidemic associated with relatively mild disease.
Phylogenetic analyses of 10 circulating EV71 strains indicated that they belonged to two subgenogroups,
i.e., B5 (80%) and C2 (20%). The VP1 sequences of the 2008 EV71 strains also exhibited continuous
mutations during the outbreak, reﬂecting the relatively high mutation rate of the EV71 capsid protein,
which may have implications for future vaccine development.
Conclusions: A safe and effective vaccine against EV71 is certainly warranted in view of its potential
neurovirulence and its role in HFMD epidemics of recurring frequency with resultant fatalities in Asia, as
well as other parts of the world.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Hand, foot and mouth disease (HFMD) is a common childhood
disease characterized by a brief febrile illness, typical vesicular
rashes on the palms, soles, or buttocks, and oropharyngeal ulcers.
In rare cases, patients may also develop neurological complica-
tions, such as encephalomyelitis, aseptic meningitis, and acute
ﬂaccid paralysis.1,2 The most common etiologic agents are
coxsackievirus A16 (CA16) and enterovirus type 71 (EV71).
However, throughout an outbreak, many other enteroviruses,
such as coxsackieviruses A4 and A6 and certain echoviruses, may
co-circulate. EV71 has been strongly associated with neurological
complications, especially during large HFMD epidemics triggered
by EV71 within the Southeast and East Asian regions in recent
times.3
In 2008, the largest outbreak of HFMD in Singapore afﬂicted
29 686 patients ranging from kindergarten to primary school* Corresponding author. Tel.: +65 65163691; fax: +65 67766872.
E-mail address: micctk@nus.edu.sg (Vincent T.K. Chow).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.07.006students, four of whom developed EV71-related encephalitis.
Moreover, a 3-year-old boy with EV71 infection died of encepha-
lomyelitis in August 2008 – the ﬁrst HFMD-related death since
2001.4 Although the HFMD cases surged to an unprecedented high
level, only a single fatality was documented, suggesting that the
strains responsible for the 2008 Singapore outbreak caused highly
transmissible but relatively mild disease.
In this study, clinical samples from HFMD patients were
investigated in order to identify the circulating virus serotypes in
the 2008 HFMD outbreak in Singapore. The predominant
enteroviruses and EV71 subgenogroups were characterized by
phylogenetic and genome sequence analyses.
2. Materials and methods
2.1. Patients, clinical specimens, virus isolation, and statistical tests
This study was approved by the Institutional Review Board of
the National University of Singapore (Approval No. NUS-301).
Between March 13 and August 15, 2008, clinical samples were
obtained from 43 children presenting with suspected HFMD at theses. Published by Elsevier Ltd. All rights reserved.
[(Figure_1)TD$FIG]
Figure 1. Distribution of clinical features in EV71 and non-EV71 patients.
Y. Wu et al. / International Journal of Infectious Diseases 14 (2010) e1076–e1081 e1077National University Hospital, Singapore. The study inclusion
criteria were the presence of papules and/or ulcers on the palms,
soles, or buttocks or in the mouth. A similar HFMD case deﬁnition
was used in a previous study of the HFMD outbreak in 2000.4 A
total of 51 samples, including throat swabs, nasal swabs, rectal
swabs, saliva, urine, and blood were collected. Throat, nasal, and
rectal swabs were transferred into virus transport medium. For
virus isolation, all specimens were immediately inoculated upon
receipt into the human rhabdomyosarcoma (RD) cell line, and
cultured for up to three passages.5,6 Pathogens other than
enteroviruses were not investigated. The statistical differences
between proportions were tested using the Chi-square test or
Fisher’s exact test.
2.2. RNA extraction and reverse transcription
Viral RNA was extracted using the QIAamp viral RNA mini kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. Reverse transcription (RT) was performed to synthe-
size cDNA using MMLV (Moloney murine leukemia virus) reverse
transcriptase.7
2.3. EV71 real-time RT-PCR hybridization assay
Each specimen was subjected to a real-time one-step RT-PCR
hybridization assay with EV71-speciﬁc primers and probes FL and
LC using the LightCycler RNA ampliﬁcation hybridization probe kit
(Roche Applied Science, Indianapolis, IN, USA), as reported
previously.7
2.4. Classical RT-PCR and direct sequencing for enterovirus
identiﬁcation
Several pairs of primers were employed for the identiﬁcation of
enteroviruses. Firstly, pan-enterovirus (pan-EV) primers were used
for enterovirus detection by amplifying a target within the 50
untranslated region (50UTR).8 To conﬁrm the enterovirus type,
50UTR-F and 50UTR-R primers were employed to amplify a segment
also within the 50UTR of all enteroviruses,9 and ampliﬁed products
were subjected todirectDNAsequencing. ForEV71detection,VP3-Fa
and EV2A-R primers targeting the VP1 gene of all EV71 genogroups
(50-ATWWTRGCAYTRGCGGCRGCC-30 and 50-TCGCKRGAGCTGT
CTTCCCAVA-30, respectively) were newly designed to amplify a
1200-bp segment, followed by DNA sequencing. To conﬁrm the
identity of non-EV71 enteroviruses, primers were designed to
amplify the 30 segment of VP110 for CA4 (50-CCTAAGCCTGATGCCC-
GAGA-30 and 50-TTGTGATCTCAAAGGCCTAGGGA-30), CA6 (50-
GTGTCCGTCCCATTCATGTC-30 and 50-GTTCTCTGTGGGTCTGCTGG-
30), CA10 (50-AAACCGACTGGAAGGGATGC-30 and 50-CGATCTCGTG-
CACTGTTGGC-30), and CA16 (50-TGAAAATGACGGACCCACCA-30 and
50-ATCTTGTCTCTACTAGTGCTGGTG-30).
2.5. DNA sequencing, nucleotide and amino acid sequences, and
phylogenetic analyses
All amplicons were sequenced in both directions using the
BigDye cycle sequencing kit and ABI automated DNA sequence
analyzer (Applied Biosystems, Carlsbad, CA, USA). Sequences were
subjected to BLAST analysis (www.ncbi.nlm.nih.gov/blast), while
ClustalW (www.ebi.ac.uk/tools/clustalW2/index.html) was ap-
plied for multiple sequence alignment.11 A phylogenetic tree
was constructed based on EV71 VP1 nucleotide sequences of 10
Singapore 2008 strains togetherwith selected strains isolated from
different geographic regions from 1974 to 2003 that were used to
construct the tripartite genogroup structure of EV71.12 In addition,
two strains from fatal cases of the 2000 Singapore outbreak and2008 China outbreak were selected for comparative sequence
analysis. The dendrogramwas constructed by the neighbor-joining
method using MEGA 4.0 software, and bootstrapping was
performed from 1000 replicates.
3. Results
3.1. Clinical features of patients with EV71 versus non-EV71 infections
Clinical data were available for 42 out of 43 patients; most of
them (n = 37, 88.1%) received outpatient treatment at the
Children’s Emergency Department, while only 12.0% (n = 5) were
hospitalized on the pediatric ward. The number of females and
maleswas similar, and themajority of patients (n = 28, 66.7%)were
under 5 years of age. With regard to age group, the highest
percentages of patients were children aged 3 years (40% of EV71
and 19% of non-EV71) and 4 years (20% of EV71 and 22% of non-
EV71).
Figure 1 compares the symptoms of HFMD patients infected
with EV71 and other enteroviruses. None of the patients presented
with severe symptoms, and there were no fatal or encephalitis
cases. Notably, papules were observed for all cases, while mouth
ulcers were also seen in almost all cases, i.e., 90% (n = 10) for EV71
versus 100% (n = 32) for non-EV71 infections. Papules and mouth
ulcers are two of the clinical criteria for the diagnosis of HFMD and
herpangina. Interestingly, more than ﬁve papular lesions per
patient were noticed in 75% (n = 9) of those positive for EV71 and
CA16, compared to only 43% (n = 13) of other patients, but this was
not statistically signiﬁcant (p > 0.05). Rhinorrhea was only
observed in 31% (n = 10) of non-EV71 infections and not in any
EV71 infections. Poor feeding was documented in 30% (n = 3) of
EV71 cases and in 25% (n = 8) of non-EV71 infections. With regard
to other clinical signs, non-EV71 patients displayed these more
frequently, but the differences were not statistically signiﬁcant
(p > 0.05). For example, the difference was about two-fold for
cough and vomiting, while diarrhea was only occasionally
observed.
3.2. Pan-enterovirus RT-PCR, direct sequencing, and virus isolation
elucidate the distribution of enterovirus types and the involvement of
EV71 in HFMD patients
Only one clinical sample was collected from each of 37 patients,
while three different clinical samples were collected from two
patients and two from four patients, giving a total of 51 samples
from 43 patients. Table 1 summarizes the detection rate based on
clinical sample type, and highlights the throat swab as a good
clinical specimen for HFMD virus detection and isolation. This
Table 1



















Pan-EV 154bp 26 3 0 2 2 1 0 66.7
Pan-EV 439bp 26 3 0 2 2 1 0 66.7
VP3-Fa and EV2A-R 8 2 0 0 1 0 0 21.6
Real-time RT-PCR 0 0 0 0 0 0 0 0
Virus isolation 17 0 0 2 0 0 0 37.2
RT-PCR, reverse transcription polymerase chain reaction.
Table 2
Distribution of enteroviruses identiﬁed in clinical specimens.
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expected in patientswithmultiple vesicles and/or ulcers in the oral
mucosa. We did not collect vesicular ﬂuid samples from our
patients as their parents perceived this procedure to be invasive
and painful.
Classical RT-PCR assays with both pairs of pan-EV primers
targeting the 50UTR were able to detect enteroviruses in 34
samples (66.7%), with 17 samples (33.3%) being enterovirus-
negative (Table 2). RT-PCR with EV71-speciﬁc primers VP3-Fa and
EV2A-R detected 11 EV71-positive samples (21.6%). In addition,
the non-EV71 enterovirus types were identiﬁed via sequencing of
50UTR and VP1 amplicons. The circulating enteroviruses responsi-
ble for the 2008 Singapore outbreak included CA4, CA6, CA10,
CA16, and EV71, the most prevalent being CA6 (23.5%), EV71
(21.6%), and CA10 (11.8%). It is noteworthy that CA4 and CA16
accounted for only 9.8%, even though CA16 has played amajor role
in previous HFMD outbreaks. If the enterovirus-negative samples
were excluded,more than 50% of the sampleswere positive for CA6
and CA10, while 32% were EV71-positive, thus reiterating the
predominant role of CA6, CA10, and EV71 in this outbreak. Thiswas
corroborated by cell culture inoculation, which successfully
isolated enteroviruses from 19 out of 51 samples (approximately
40%), later conﬁrmed as nine CA6 (47.4%), six CA10 (31.6%), three
EV71 (15.8%), and one CA4 (5.3%).
[(Figure_2)TD$FIG]
2519 2496
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Hybridizaon probe G C T G G C A G G G C C T G G G T A A G T G C C
Figure 2. Sequence alignment of 10 outbreak EV71 strains against the hybridization
acceptor probe for real-time RT-PCR. The highlighted mismatches may explain the
failure of detection of the EV71 strains using this assay. The subgenogroups of the
strains, and nucleotide positions at the 50 (2496) and 30 (2519) ends of the probe are
shown.The EV71 real-time RT-PCR hybridization assay failed to detect
EV71 in all 51 specimens. VP1 sequence alignment of the 10 EV71
strains with the RT-PCR primers and hybridization probes revealed
one mismatch in each primer. However, three mismatches were
found for the probe with acceptor ﬂuorophore spanning nucleo-
tides 2519–2496, one of which was near the 30 end (Figure 2) and
may compromise binding of the probe to the target product
leading to failure of detection. This mismatch of the latter probe
rather than primers was supported by classical RT-PCR using the
primers which could amplify speciﬁc bands for all EV71 strains as
detected by gel electrophoresis (data not shown).
3.3. Molecular epidemiology of EV71 outbreak strains identiﬁes two
major subgenogroups
Out of the 11 EV71-positive samples, 2 were from the same
patient, with the rest from individual patients. Thus, the
distribution of EV71 subgenogroups of 10 strains was determined
by RT-PCR ampliﬁcation of their complete VP1 fragments, followed
by nucleotide sequencing and phylogenetic analyses. The sub-
lineage structure of EV71 was reconstructed,12 and revealed two
circulating subgenogroups (Figure 3) belonging to B5 (eight strains
or 80%) and C2 (two strains or 20%). Three EV71 strains were
successfully isolated from the samples, two of which were B5 and
the other was C2. Interestingly, the VP1 sequences of strains from
the dominant B5 subgenogroup displayed differences, whereas
those of the two subgenogroup C2 strains were identical. The
complete viral genomes of the two representative subgenogroups
B5 (NUH0083/SIN/08) and C2 (NUH0075/SIN/08) were sequenced
and deposited in the GenBank database under accession numbers
FJ461781 and EU868611, respectively. The GenBank accession
numbers for the other sequences are FJ461782–FJ461789 and
GU198753–GU198764.
3.4. VP1 sequence comparison reveals interesting disparities between
2008 outbreak and known virulent strains
Twelve VP1 gene sequence disparities of B5 strains were
identiﬁed, suggesting the occurrence of viral evolution and
mutation during this outbreak (Figure 4). An interesting trend
was noticed at nucleotides 19, 373, and 756, whereby three B5
samples obtained in April and May 2008 (NUH0049, 0047, 0086)
were identical at these positions, in contrast to the existence of
disparities for the other ﬁve B5 strains that were received later,
during mid-May to August 2008 (NUH0083, 0085, 0043, 0037,
0012). Furthermore, two B5 strains that were collected later
harbored non-conservative VP1 amino acid substitutions, i.e., K to
E at position 215 of NUH0043, and T to A at position 289 of
NUH0037. These phenomena provide strong evidence for virus
mutational events through the course of the outbreak that may
partly arise from strong immunological pressure on the immuno-
dominant VP1 region. In addition, for the 2008 strains, disparities
were discovered at three VP1 epitopes that are capable of eliciting























































































Figure 3.Dendrogram constructed based on the complete VP1 gene sequences of 10 outbreak EV71 strains and selected known strains, elucidating B5 and C2 as the respective
major andminor EV71 subgenogroups circulating during the 2008 Singapore epidemic. The percentages of replicate trees in which the associated taxa are clustered together
are shown next to the branches. Branch lengths are proportional to the number of nucleotide differences.
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polar amino acid change within the SP55 peptide. Therefore, the
neutralizing antibodies of patients infected with previous EV71
strains may not be able to recognize the 2008 counterpart strains.In 2008, EV71 epidemics were documented in many other
countries in East Asia, but the behavior of the causative strains
varied somewhat. For example, the predominant strain in the 2008





(2008) 7 19 373 427 439 604 644 658 756 820 832 866
NUH0049/SIN/08 7 Apr T C A T T C A T T C A A
NUH0047/SIN/08 7 Apr T C A T T C A T T C A A
NUH0086/SIN/08 6 May T C A T T C A T T C A A
NUH0083/SIN/08 15 May C T G T C T A T C C A A
NUH0085/SIN/08 3 Jun T T G C T C A C C C A A
NUH0043/SIN/08 12 Jun T T G C T C G T C C A A
NUH0037/SIN/08 14 Aug C T G T C T A T C T G G
NUH0012/SIN/08 15 Aug T T G T C T A T C C A A
Figure 4. Alignment of VP1 nucleotides of eight EV71 strains belonging to subgenogroup B5 according to the time of specimen receipt. The disparities at 12 different positions
highlight the evolution of the VP1 regions of B5 strains during the course of the large epidemic. For example, ﬁve disparities at positions 644, 658, 820, 832, and 866 emerged
in strains that were obtained later in the outbreak. Common disparities at nucleotides 19, 373, and 756 were also identiﬁed only in strains detected later.
[(Figure_5)TD$FIG]
SP12 (34–48) VSSHRLDTG E VPALQ C
2008 strains VSSHRLDTG (K/E) VPALQ A
SP55 (163–177) P E SRESLAWQTATNP C
2008 strains P D SRESLAWQTATNP S
SP70 (208–222) YPTFGEHKQEKDLEY C
2008 strains YPTFGEHKQEKDLEY G
Figure 5. Amino acid sequence variations within the VP1 neutralizing antibody
epitopes SP12, SP55, and SP70 of the 2008 outbreak EV71 strains.
[(Figure_6)TD$FIG]
Figure 6. Weekly incidence of hand, foot and mouth disease in Singapore during
2008 and 2009. The dotted line depicts the epidemic threshold of 665 cases
(www.moh.gov.sg/mohcorp/statisticsweeklybulletins.aspx).
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fatalities. In contrast, the B5 and C2 strains of the 2008 Singapore
outbreak caused generally mild disease. VP1 constitutes the major
capsid protein and is considered to be an important factor that
mediates viral pathogenesis.17 To better understand differences in
their VP1 amino acid composition, the 10 Singapore 2008 strains
were compared with two virulent strains from fatal cases, i.e.,
Fuyang.Anhui.PRC/17.08/3 from the 2008 China outbreak and
5865/Sin/000009 from the 2000 Singapore outbreak. A disparity at
position 22 was noted, with R being replaced by Q or H in virulent
strains, making it less basic. The Fuyang strain displayed an E to K
substitution at position 98 that could result in conformational
change at the hydrophobic pocket of VP1.18 Another mutation at
amino acid 164 of the virulent 2000 Singapore strain was
identiﬁed, but this was a conservative substitution.
4. Discussion
HFMD has been a legally notiﬁable communicable disease in
Singapore since October 1, 2000, and the capture of epidemiologic
data on HFMD has been effective since then. The 2008 outbreak
represents the largest HFMD epidemic in Singapore since the year
2000, with almost 30 000 cases, four patients with encephalitis,
and one fatality. However, the actual number of HFMD cases may
have been much higher given that most infections are asymptom-
atic. There were two periods within which the number of infected
cases increased signiﬁcantly above the epidemic threshold, i.e., a
large peak from mid-March to the end of May (10 927 cases in
weeks 12–22), and a smaller peak from early October to early
December 2008 (5391 cases in weeks 42–49). However, in 2009,
the number of HFMD cases did not exceed the epidemic threshold,
and 17 278 cases were reported in 2009 (without any encephalitis
cases or deaths), compared with 29 686 for the whole of 2008
(Figure 6).
The specimens in our cohort were collected from patients with
mild disease andwithout complications or sequelae, of whom only12% were hospitalized. Despite the relatively small sample size,
this cohort is a subset representative of the pediatric HFMD cases
in the community during the 2008 Singapore outbreak, as the
specimenswere obtained during and after the peak of the epidemic
curve based on distinct recruitment criteria. The most prevalent
enterovirus infections associated with the 2008 Singapore
outbreak were attributed to CA6, followed by EV71 and CA10.
Both CA6 and CA10 are common etiologic agents of herpangina and
have been prevalent in Japan since 2005,19,20 and are less virulent
but apparently more infectious than EV71. Consequently, the high
transmissibility of HFMD during the 2008 Singapore epidemicmay
be due to the dominance of CA6 and CA10. In the autumn of 2008 in
Finland, CA6 and CA10 were also reported to be the predominant
enteroviruses causing a large outbreak of HFMDwith onychomad-
esis.21,22
The similar clinical presentations of HFMD and herpangina
make it difﬁcult for physicians to accurately diagnose the two
disease entities. Most patients infected by non-EV71 and non-
CA16 enteroviruses presented fewer than ﬁve papules, whereas
the signiﬁcant majority of EV71 and CA16 patients exhibited more
than ﬁve papules. From a general clinical perspective, it is
suspected that patients with fewer than ﬁve papules may actually
be suffering from herpangina rather than HFMD. Hence, we
postulate that this outbreak comprised a mixture of HFMD as well
as herpangina cases. Moreover, the percentage of patients who had
fever was signiﬁcantly different between patients with EV71 and
those with non-EV71 infections.
Besides CA6 and CA10, another major contributor was EV71,
which accounted for more than one third of enterovirus-positive
cases. VP1-based phylogenetic analysis revealed two EV71
subgenogroups, namely B5 and C2. There have been two major
lineages (B and C) circulating during HFMD outbreaks in Southeast
Asia since 1997, with ﬁve subgenogroups under genogroup B. B1
and B2were identiﬁed throughout the world during the 1970s and
Y. Wu et al. / International Journal of Infectious Diseases 14 (2010) e1076–e1081 e10811980s. B3 and B4 later emerged as the dominant subgenogroups in
Australia, Malaysia, and Singapore.23–25 Subgenogroup B5was ﬁrst
identiﬁed in Japan in 2003, and replaced the previous dominant
strain within a short period of time.26 In Singapore, the transition
of the predominant EV71 subgenogroup from B4 in 200027 to B5 in
2008 correlatedwith the reduced fatality rate from7/4000 to1/
30 000. Replacement of subgenogroups was also witnessed in
Taiwan and Sarawak in 2008.28 Subgenogroup C2 was initially
identiﬁed in Taiwan, being responsible for the largest ever HFMD
outbreak in 1998. In the 2008 Singapore outbreak, C2 subge-
nogroup accounted for only one-ﬁfth of EV71-positive samples,
relegating it to a minor role. Nevertheless, this reiterates that
multiple genetic lineages of EV71 circulate endemically in the
Singapore population all year round.
The complete nucleotide sequence analyses of whole EV71
genomes facilitate the characterization of circulating strains at the
genetic level and of their predicted viral proteins. Interactions
between viruses and their hosts play critical roles in virus
evolution of structural and non-structural genes. Quite a number
of VP1 mutations were observed in the 10 studied EV71 strains in
comparison with known sequenced strains. This reﬂects the
relatively high mutation rate of EV71, which helps it to escape
human immune surveillance. The considerable mutation rate of
the EV71 capsid protein may also have implications on future
vaccine development.29 Furthermore, disparities were also dis-
covered in other non-structural and non-coding regions such as the
3D polymerase and 50UTR (data not shown). Finally, a safe and
effective vaccine against EV71 is certainly warranted in view of its
potential neurovirulence and its role in HFMD epidemics of
recurring frequency with resultant fatalities in Asia, as well as
other parts of the world.15
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A high-throughput multiplex bead suspension array was developed for the rapid 27 
subgenogrouping of EV71 strains, based on single nucleotide polymorphisms 28 
observed within the VP1 region with a high sensitivity of down to 1 plaque-forming 29 
unit. Of 33 viral isolates and 55 clinical samples, all EV71 strains were successfully 30 





Hand, foot and mouth disease (HFMD) mainly afflicts children, and is 36 
characterized by fever, vesicles and ulcers on the mouth, palms, limbs and buttocks. 37 
Although several enteroviruses are etiologic agents of HFMD, neurologic 38 
complications such as aseptic meningitis, brainstem encephalitis and 39 
poliomyelitis-like paralysis have been associated with enterovirus 71 (EV71) 40 
infection. Fatalities due to EV71 infection have occurred during large outbreaks of 41 
HFMD in the Asia-Pacific region since 1997. EV71 possesses a positive 42 
single-stranded linear RNA genome, with 4 capsid proteins (VP1, VP2, VP3 and VP4) 43 
present on the outermost part of the non-enveloped virus (6, 11). Molecular 44 
phylogenetic analyses based on EV71 VP1 sequences have classified EV71 strains 45 
into 3 main genogroups A, B and C, which are further classified into subgenogroups 46 
B1 to B5 and C1 to C5 (2-4, 11).  47 
 3 
Although no direct association between the severe neurologic complications of 48 
HFMD and different EV71 genetic lineages has been established, subgenogrouping of 49 
EV71 is important for epidemiologic studies in the surveillance of both endemic and 50 
epidemic HFMD, and also facilitates further studies on EV71 virulence and evolution. 51 
However, subgenogrouping of EV71 is hitherto dependent on classical RT-PCR and 52 
direct DNA sequencing which is relatively labor-intensive for processing large 53 
numbers of samples during outbreaks. Therefore, with the ever-increasing number of 54 
HFMD outbreaks, we developed a high-throughput EV71 detection platform based on 55 
Luminex xTAG technology (5) with rapid genogrouping capability that can be applied 56 
in routine clinical diagnosis, and that may be beneficial for epidemiologic surveillance 57 
of EV71 infections. 58 
Virus isolates or viral RNA representing 9 EV71 subgenogroups were initially 59 
employed as reference strains to develop the assay. However, for subgenogroups B1 60 
and C3, viral isolates could not be obtained. Thus, corresponding plasmids 61 
incorporating the full-length VP1 genes of strains 609-AUS-74 and 009-KOR-00 62 
were constructed using synthetic DNA cloned into the pUC57 vector (GenScript, 63 
Piscataway, NJ). Only viral RNA of strain MY104-9-SAR-97 (subgenogroup B3) was 64 
obtained, and its VP1 gene was also cloned into the pCR-XL-TOPO vector for 65 
ascertaining sensitivity. Thirty three other viral isolates from Japan, Malaysia and 66 
Singapore were tested for validation of the assay, with new VP1 nucleotide sequences 67 
deposited in GenBank under accession numbers HQ285091-HQ285109. A total of 55 68 
clinical specimens were also collected from suspected HFMD patients who presented 69 
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at the National University Hospital mainly during the 2008 HFMD outbreak in 70 
Singapore (12). These samples were tested by conventional and real-time RT-PCR, 71 
DNA sequencing (8-10, 12), and also by the multiplex subgenogrouping assay. This 72 
clinical study was approved by the Institutional Review Board of the National 73 
University of Singapore (Approval No. NUS-301). 74 
Consensus primers were designed based on the VP1 region of all EV71 75 
subgenogroups. The 1.2-kb VP1 fragment was amplified from each cDNA sample 76 
using the consensus primers, amplicons were purified by ExoSAP-IT treatment 77 
(Affymetrix, Santa Clara, CA) to remove excess nucleotides and primers. Alignment 78 
of sequences showed that all EV71 subgenogroups (except C1) differed by only a 79 
single nucleotide at different regions within VP1 (see Fig. S1 in the supplemental 80 
material). Therefore, multiplex allele-specific primer extension (ASPE) which 81 
differentiates gene sequences by only one nucleotide difference at the 3′ end, and only 82 
permits amplification of the perfectly complementary probe was chosen instead of the 83 
direct DNA hybridization Luminex assay. Initially, the latter was analyzed, but it 84 
suffered from very low specificity. Specific ASPE probes were designed for 11 85 
subgenogroups based on the single nucleotide disparity located at the 3′ end of each 86 
probe (see Table S1 in the supplemental material). A tag sequence was incorporated at 87 
the 5′ end of each probe to allow hybridization to the anti-tag sequence of the 88 
corresponding xTAG microspheres (Luminex, Austin, TX) as portrayed in Figure 1. 89 
Since there was no single nucleotide difference unique for C1, we selected a 90 
nucleotide position that could distinguish C1 and C3 from the other 9 subgenogroups, 91 
 5 
but whose nucleotide polymorphism site was different from the C3 probe. The C1 92 
probe was designed to thus identify both C1 and C3, but these subgenogroups could 93 
be differentiated by the C3 probe reading. Hence, high readings of both C1 and C3 94 
probes indicated that the sample was from subgenogroup C3, whereas a high reading 95 
only for C1 revealed a sample belonging to subgenogroup C1. The multiplex ASPE 96 
reaction mix comprised 10 µl of PCR product, 2 µl of 10× ASPE buffer (20 mM 97 
Tris-HCl, 50 mM KCl), 0.5 µl of 50 mM MgCl2, 1 µl of 500 nM xTAG-ASPE primer 98 
mix, 1 µl each of 100 µM dATP, dGTP, and dTTP, 0.25 µl of 400 µM biotin-dCTP, 99 
0.15 µl of Platinum GenoTYPE Tsp DNA polymerase (5 U/µl) (Invitrogen, Carlsbad, 100 
CA), and water in a total volume of 20 µl. The ASPE reactions were incubated at 96°C 101 
for 2 min, and then subjected to 30 cycles each at 94°C for 0.5 min, 55°C for 1 min, and 102 
72°C for 2 min, and held at 4°C until used. ASPE products were labeled with 103 
biotin-dCTP, and were hybridized with microspheres through the tag and anti-tag 104 
nucleotide sequences. Streptavidin-phycoerythrin (SAPE) was added last for the 105 
detection of biotin, and the whole microsphere-PCR complex passed through the 106 
detection chamber of the Luminex reader (www.luminexcorp.com). The read-out was 107 
the median fluorescence intensity (MFI), and is dependent on the number of viral 108 
copies present. Relative rather than absolute readings were compared, i.e. the highest 109 
sample-to-blank control ratio identified the subgenogroup of the analyte in the sample. 110 
The cutoff value (COV) specific for a particular subgenogroup was arbitrarily 111 
assigned as the ratio that was at least 10 times that of the blank sample. Each sample 112 
assay was performed at least four times, and the mean value calculated. Virus isolates 113 
 6 
were available for subgenogroups A, B2, B4, B5, C1, C2, C4 and C5, and the assay 114 
sensitivity was based on the lowest number of plaque-forming units (pfu) detected (7). 115 
Samples corresponding to 1, 5, 20, 50 and 100 pfu were subjected to RNA extraction, 116 
RT-PCR, multiplex ASPE and hybridization. However, viral isolates were not 117 
available for 3 subgenogroups (B1, B3 and C3), and sensitivity was determined by the 118 
lowest number of plasmid copies detected (out of 1, 10, 100 and 1000 copies 119 
analyzed).  120 
For optimization of the system, reference strains representing the 11 121 
subgenogroups of EV71 were tested with coxsackievirus A16 (CA16) as a negative 122 
control, and all could be detected by subgenogroup-specific probes. Nine probes 123 
yielded average ratios that were at least 100 times relative to the blank control (Table 124 
1). For probes B5 and C4, the ratios were comparatively lower but still close to 100. 125 
These relatively lower ratios may be explained by the lower GC content of B5 and C4 126 
probes (48% and 40%, respectively) that culminates in less efficient hybridization and 127 
linear amplification (1). Compared to direct DNA sequencing of amplified products as 128 
the benchmark, the results generated from our multiplex technique were consistent 129 
and reproducible. Validation with 33 additional viral isolates demonstrated that our 130 
assay could specifically identify the subgenogroups of other EV71 strains (see Table 131 
S2 in the supplemental material). In addition, by testing 55 clinical specimens, 11 132 
EV71-positive samples could be reliably distinguished from 44 EV71-negative 133 
samples by our assay, with the subgenogrouping data being congruent with DNA 134 
sequencing (Table 1). One drawback is that a definite conclusion cannot be made that 135 
 7 
our assay can be used for the identification of all 11 EV71 subgenogroups. Although 136 
quite a number of clinical samples and isolates were correctly identified for 137 
subgenogroups B5, C1 and C2, more samples belonging to the other subgenogroups 138 
should be tested in future. Real-time RT-PCR can detect as few as 3 viral RNA copies, 139 
and 10 plasmid copies (9, 10). Therefore, varying amounts of the subgenogroups were 140 
subjected to analysis by our assay, and the sensitivity varied among the 141 
subgenogroup-specific probes (Table 2). With our multiplex assay, at least 100 pfu 142 
could be detected for all subgenogroups by plaque assay. As low as 1 pfu of C1, C2 143 
and C5, and 5 pfu of A, B2 and B5 were detectable. Surprisingly, B4 could only be 144 
detected from 100 pfu, despite its relatively high reading in the specificity testing. The 145 
B4 probe has a GC percentage of 55%, with a melting temperature of 57.5°C, and it 146 
yielded a high reading when a larger viral load was tested for specificity. Therefore, 147 
this apparently lower sensitivity may be due to relatively poorer amplification 148 
efficiency of B4 with the consensus primers. Gel electrophoresis of amplicons 149 
supported this notion since no bands were observed with 100 pfu of B4, whereas other 150 
subgenogroups exhibited bands with 5 or 20 pfu of template (data not shown). As 151 
expected, more virus particles were required for detection of subgenogroup C4, since 152 
the C4 probe had displayed lower binding activity. One potential limitation of 153 
determining the detection limit using the virus plaque assay is that it identifies only 154 
live virions, and may thus overestimate the sensitivity. The sensitivity of the assay for 155 
the B1, B3 and C3 probes was evaluated using plasmid DNA templates, resulting in a 156 
detection limit of at least 100 copies. The use of plasmid DNA involves fewer steps 157 
 8 
and variables, and may explain the smaller variations in detection limits between 158 
these 3 subgenogroups.  159 
In general, we noticed some cross-reactivity between certain subgenogroups, e.g. 160 
with reference strains and viral isolates. These samples carry relatively higher virus 161 
titers or plasmid copy numbers, and may explain the cross-reactivity, whereas 162 
virtually no cross-reactivity was observed in clinical specimens that had relatively 163 
lower viral loads. Moreover, a mixed infection is not commonly encountered in 164 
clinical settings due to viral interference that favors one dominant strain. In addition, 165 
despite some cross-reactivity observed for certain reference strains and viral isolates, 166 
the specific ratios were relatively much higher than non-specific signals. However, in 167 
the titration experiments, the numbers of viral copies were at relatively low levels, 168 
and thus ratios that were 10-fold greater than the blanks were considered positive.  169 
In conclusion, the multiplex suspension assay represents a specific, sensitive, 170 
reliable and high-throughput method for EV71 detection and subgenogrouping. Its 171 
application was shown to be sensitive enough for clinical specimens, and would 172 
greatly facilitate subgenogrouping to enhance epidemiologic analyses of EV71 173 
infections.  174 
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S.H. Lau for technical assistance, and FMC Asia Pacific, Hong Kong for providing 177 
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FIGURE LEGEND 234 
 235 
 236 
FIG. 1. Schematic representation of the multiplex suspension array system for EV71 237 
subgenogrouping. The VP1 region was amplified by consensus primers, and the 238 
RT-PCR product was purified by ExoSAP-IT. ASPE was performed, and only 239 
perfectly complementary strands would be amplified. The ASPE products were 240 
labeled using biotin-dCTP (black stars), and hybridized to their complementary 241 
anti-tag oligonucleotide sequences on the beads or microspheres. The complex was 242 
subjected to the Luminex reader, and was identified by both lasers and 243 









































ASPE: No basepair match 














TABLE 1. Mean sample-to-blank controla ratios using EV71 subgenogroup-specific probes in the multiplex bead suspension assay. Numbers in 
boldface accurately identify the subgenogroups which correlated with the sequencing data of the 11 EV71 reference strains, and 11 
EV71-positive clinical specimens from the 2008 HFMD outbreak in Singapore. 
 
EV71 subgenogroup-specific probes Sequencing Reference strains and 




BrCr  324.4 1.8 3.3 0.9 0.8 1.1 1.5 3.7 0.8 0.8 1.3 0.4 A 
2609-AUS-74 7.7 764.9 199.3 8.2 10.1 10.7 8.4 5.5 4.9 3.1 1.5 0.5 B1 
7423/MS/87 1.7 18.9 833.1 1.5 1.5 2.6 2.4 1.4 1.6 1.0 1.1 0.4 B2 
MY104-9-SAR-97 1.6 13.5 74.3 561.5 1.9 4.0 2.1 1.6 1.2 1.1 1.1 0.9 B3 
5865/SIN/000009 2.3 13.5 49.4 2.1 390.9 5.6 3.7 1.7 1.6 1.5 1.1 0.5 B4 
2933-Yamagata-03 2.3 4.6 54.9 1.5 1.8 97.7 2.0 1.5 1.1 1.0 1.2 0.4 B5 
S10862-SAR-98 2.3 2.6 1.6 1.2 0.9 1.5 476.1 10.8 1.0 1.0 2.4 0.0 C1 
Y97-1188 2.5 4.8 2.3 1.1 2.3 3.1 19.9 265.4 1.4 0.9 5.0 0.5 C2 
009-KOR-00 12.2 12.9 5.3 2.3 3.8 8.1 998.4 2.2 229.6 2.6 4.3 0.8 C3 
75-Yamagata-03 2.6 5.3 2.3 35.5 2.9 4.2 5.7 8.7 1.4 91.7 1.9 0.8 C4 
3437/SIN/06 2.9 70.6 4.0 1.8 2.9 2.7 41.5 7.7 3.1 1.6 176.4 0.5 C5 
CA16 control 2.5 0.6 0.0 0.3 1.7 0.0 0.0 1.2 0.6 0.1 1.3 0.6 CA16 
EV71 subgenogroup-specific probes Sequencing Clinical specimens 




NUH0029/SIN/08 1.6 8.3 10.1 1.5 96.1 1.0 0.0 1.1 7.6 2.9 0.7 1.0 B4 
NUH0012/SIN/08 4.0 1.0 2.3 3.0 1.0 86.7 1.7 0.5 0.8 0.3 0.9 0.8 B5 
NUH0037/SIN/08 4.5 1.3 2.1 2.3 0.1 60.3 1.3 0.7 0.6 0.3 0.9 0.7 B5 
NUH0043/SIN/08 3.5 2.3 4.8 5.5 1.1 103.6 2.7 0.6 2.2 1.2 0.9 0.7 B5 
 3 
NUH0047/SIN/08 2.3 0.0 1.9 5.0 2.3 27.5 4.9 1.3 0.5 0.2 1.5 2.2 B5 
NUH0049/SIN/08 3.8 1.4 1.7 3.0 0.6 47.0 1.1 0.3 0.8 1.0 0.8 1.4 B5 
NUH0083/SIN/08 3.8 0.5 2.5 5.7 1.0 68.6 1.4 0.8 0.8 1.2 0.9 0.9 B5 
NUH0085/SIN/08 1.8 1.1 1.5 2.7 1.2 27.2 1.4 0.9 0.7 1.1 0.8 0.8 B5 
NUH0086/SIN/08 0.0 1.2 1.2 8.7 0.9 25.4 1.4 0.9 0.5 1.1 0.9 1.8 B5 
NUH0013/SIN/08 3.5 2.5 0.8 4.0 1.7 0.2 3.7 151.3 1.2 5.1 0.5 0.7 C2 
NUH0075/SIN/08 3.3 2.1 0.8 5.3 1.1 3.9 4.1 160.3 1.3 6.5 1.2 1.2 C2 
 
 a
 The blank control is the background signal obtained with the respective probe in the absence of consensus PCR product. 






TABLE 2. Mean sample-to-blank controla ratios using EV71 subgenogroup-specific probes for determination of assay sensitivity using reference 
strains. Numbers in boldface depict the detection limit expressed either as the number of virus plaque-forming units or plasmid copies. 
 
 
Probe       Reference strains Virus plaque-forming units 
    1 5 20 50 100 
A BrCr  0.8 56.1 91.6 174.6 - 
B2 7423/MS/87 3.6 94.1 89.1 207.6 - 
B4 5865/SIN/000009 0.7 1.1 1.3 2.2 12.4 
B5 2933-Yamagata-03 2.8 29.4 70.8 76.3 - 
C1 90-3761 18.8 143.3 449.3 511.9 - 
C2 Y97-1188 18.6 103.3 126.5 141.1 - 
C4 75-Yamagata-03 1.4 1.7 4.3 38.5 - 
C5 3437/SIN/06 13.9 94.2 196.5 212.4 - 
Number of plasmid copies  
 
1 10 100 1000 
B1 2609-AUS-74 0.5 2.1 82.0 223.2 
B3 MY104-9-SAR-97 0.6 0.9 63.7 180.2 
C3 009-KOR-00 0.9 1.6 11.7 142.4 
  
  
                         a
 The blank control is the background signal obtained with the respective probe in the absence of consensus PCR product. 
 
 
 
